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ABSTRACT 
Acinetobacter is gaining importance as a pathogen in intensive care units (ICUs) due to the 
numerous outbreaks reported and the severity of the infections caused. Of particular interest 
in this project are neonates whose immune systems have not fully developed and affected by 
their prematurity, low birth weight, or various other conditions. The vulnerability of these 
neonates combined with the multidrug resistance of the clinical isolates of this organism 
poses a real threat to neonates. The understanding of its pathogenicity is still at an elementary 
stage despite the clinical evidence of nosocomial infections, and the concern of the FAO-
WHO (2006) regarding neonatal health due to the consumption of powdered infant formula 
(PIF). The ingestion of contaminated infant formula is a particularly unexplored mechanism 
of acquiring Acinetobacter infections. Therefore, this research work aimed to analyse the 
potential risk factors associated with the consumption of a contaminated infant formula 
administered enterally. The detection of the organism in PIF was examined. A selective 
chromogenic medium was designed, primarily for this purpose, and evaluated against other 
specific media. In addition, the desiccation persistence in infant formula was assessed. 
Biofilm formation inside nasogastric feeding tubes, survival in gastrointestinal fluids, and 
subsequent interactions with the host, as consequences of the ingestion of a feed containing 
Acinetobacter, were also investigated. Strains were finally screened for the presence of 
phospholipase genes. Based on the main findings, Acinetobacter showed the ability to persist 
over an extended storage period (2 years) in desiccated infant formula and recover after 
reconstitution. Bacterial cells in the contaminated formula formed biofilms and multiplied 
over time inside enteral feeding tubes causing all the subsequent fresh feeds to be also 
contaminated. When exposed to simulated gastrointestinal fluids, these cells did not show 
signs of complete viability loss except at an acidity level of pH 2.5 (lower than the normal 
neonatal stomach pH). Strains also successfully attached to colonic epithelial cells (Caco-2), 
and the majority were subsequently able invade the host cells. Twenty-four hour survival 
within the Caco-2 cells was also shown. Furthermore, Acinetobacter demonstrated the 
capacity to evade the bactericidal activity of macrophages, persist, and moreover multiply 
within these phagocytic cells. Genes encoding for the cytotoxic phospholipase enzymes were 
also detected in all the clinical isolates of this organism. In conclusion, Acinetobacter was 
established to possess multiple virulence factors that can potentially contribute to its 
pathogenicity once ingested. 
II 
AKNOWLEDGMENTS 
First, I dedicate this thesis and my PhD achievement to my beloved father, husband, son, 
brothers and sisters. I will never be able to thank you enough for all your time, love, 
support, and encouragement, and for being the driving force behind my efforts to succeed. 
I am very proud and blessed to have you in my life. My heartfelt dedication is moreover 
expressed to the memory of my dear mother. 
Second, I would like to convey my appreciation to my supervisors Prof. Stephen Forsythe 
and Dr. Georgina Manning whose advice and support will always be remembered. I 
would like to also thank Dr. Juncal Caubilla-Barron, the technical staff of the 
Microbiology laboratory, the research group, and my friends at Nottingham Trent 
University past and present. My thanks are extended to King Abdul-Aziz University for 
funding my studies. 
I l l 
CONTENTS 
COPYRIGHT S T A T E M E N T I 
A B S T R A C T II 
A K N O W L E D G M E N T S I l l 
CONTENTS IV 
LIST OF FIGURES XI 
LIST OF T A B L E S XIII 
ABBREVIATIONS X I V 
CHAPTER 1. GENERAL MATERIALS & METHODS 1 
1.1 Safety considerations 2 
1.2 Bacterial cultures 2 
1.3 Stock culture preparation and storage 2 
1.4 Identification and characterization of bacteria 2 
1.4.1 Gram staining 2 
1.4.2 Oxidase test 3 
1.4.3 Identification using biochemical profiles 3 
1.4.4 Identification using 16S rDNA gene sequencing 3 
1.5 Enumeration of bacterial cells 4 
1.5.1 Miles and Misra method 4 
1.5.2 Spread plate method 4 
1.6 Preparation of media 4 
1.6.1 Baumann broth (BB) 4 
1.6.2 Buffered peptone water (BPW) 5 
1.6.3 CHROMagarAcinetobacter medium 5 
1.6.4 Dimmer-Druggan agar (DDA) 5 
1.6.5 Enterobacteriaceae Enrichment broth (EE) 6 
I V 
1.6.6 Glycerol broth 6 
1.6.7 Leeds Acinetobacter medium (LAM) 6 
1.6.8 Modified M9 medium with casamino acids 6 
1.6.9 Saline solution 7 
1.6.10 Tryptic soy agar (TSA) 7 
1.6.11 Tryptic soy broth (TSB) 7 
1.6.12 Violet red bile glucose agar (VRBGA) 7 
CHAPTER 2. OVERVIEW ON ACINETOBACTER SPP 10 
2.1 Characteristics of Acinetobacter spp 11 
2.2 Current taxonomy and species identification 11 
2.3 Clinically important Acinetobacter species 14 
2.4 Natural habitats and transmission of Acinetobacter spp 14 
2.5 Virulence determinants 16 
2.5.1 Antibiotic resistance determinants 16 
2.5.2 Autoinducer molecules 19 
2.5.3 Capsule formation 20 
2.5.4 Extracellular enzymes 21 
2.5.5 Fimbnae/Pili 21 
2.5.6 Lipopolysaccharides (LPSs) 23 
2.5.7 Outer membrane protein A (OmpA) 23 
2.5.8 Siderophores 25 
2.6 Acinetobacter infections and risk factors 27 
AIMS & OBJECTIVES 30 
CHAPTER 3. DETECTION OF ACINETOBACTER IN PIF USING 
DIFFERENTIAL-SELECTIVE MEDIA 31 
3.1 INTRODUCTION 32 
3.2 M A T E R I A L S A N D M E T H O D S 35 
3.2.1 Preparation of the test media 35 
V 
3.2.2 Development of the D D A medium 35 
3.2.2.1 Formulation of the basal D D A medium 35 
3.2.2.2 Antibiotic susceptibility testing and selectivity of the basal D D A medium . 36 
3.2.2.3 Survey of powdered infant formula 37 
3.2.2.4 Optimization of the enrichment stage prior to the survey of PIF 39 
3.2.2.5 Survey procedure 39 
3.2.2.6 Evaluation and modification of the D D A medium 40 
3.2.2.7 Characterization of D D A and other selective Acinetobacter media 40 
3.2.2.7.1 Selectivity and sensitivity 41 
3.2.2.7.2 Percentage recovery (PR) 41 
3.2.2.7.3 Detection limit 41 
3.3 RESULTS 42 
3.3.1 Formulation of the basal D D A medium 42 
3.3.2 Antibiotic sensitivity testing 46 
3.3.3 Optimization of the enrichment stage 51 
3.3.4 Evaluation of the D D A medium 54 
3.3.5 Modification of the D D A medium (Second antibiotic sensitivity testing) 57 
3.3.6 Characterization of D D A and other selective Acinetobacter media 61 
3.4 DISCUSSION 66 
CHAPTER 4. L O N G - T E R M PERSISTENCE OF ACINETOBACTER IN 
DESICCATED INFANT F O R M U L A 73 
4.1 INTRODUCTION 74 
4.2 M A T E R I A L S A N D M E T H O D S 76 
4.2.1 Bacterial strains 76 
4.2.2 Capsule formation 76 
4.2.3 Preparation of cultures prior to the desiccation assay 76 
4.2.4 Desiccation procedure 77 
4.2.5 Reconstitution of the desiccated strains 77 
V I 
4.2.6 Determination of cell viability 78 
4.3 RESULTS 79 
4.3.1 Capsule formation 79 
4.3.2 Long-term desiccation survival of Acinetobacter strains 79 
4.3.3 Desiccation persistence of bacterial species belonging to the 
Enterobacteriaceae family 82 
4.4 DISCUSSION 84 
CHAPTER 5. BIOFILM FORMATION OF ACINETOBACTER INSIDE ENTERAL 
FEEDING TUBES 88 
5.1 INTRODUCTION 89 
5.2 M A T E R I A L S & M E T H O D S 92 
5.2.1 Bacterial cultures and growth media 92 
5.2.2 Determination of attachment and biofilm formation using the indirect 
impedance technique 92 
5.2.2.1 Preparation of potassium hydroxide agar 92 
5.2.2.2 Construction of calibration curves 92 
5.2.2.3 Biofilm setup 93 
5.2.2.4 Quantification of biofilm 94 
5.2.3 Statistical analysis 94 
5.3 RESULTS 95 
5.4 DISCUSSION 106 
CHAPTER 6. GASTROINTESTINAL SURVIVAL OF ACINETOBACTER 110 
6.1 INTRODUCTION I l l 
6.2 M A T E R I A L S & M E T H O D S 113 
6.2.1 Bacterial strains 113 
6.2.2 Inocula preparation 113 
6.2.3 Preparation of simulated gastrointestinal fluids and acidified infant formula 113 
6.2.3.1 Gastric fluid 113 
VII 
6.2.3.2 Small intestinal fluid 113 
6.2.3.3 Biliary fluid 114 
6.2.3.4 Acidified infant formula 114 
6.2.4 Acid, pepsin, small intestinal fluid, and bile salts tolerance assays 114 
6.3 RESULTS 116 
6.3.1 Acid tolerance 116 
6.3.2 Pepsin tolerance 120 
6.3.3 Tolerance to the small intestinal fluid 121 
6.3.4 Bile salts tolerance 122 
6.4 DISCUSSION 123 
CHAPTER 7. IN VITRO STUDIES OF ACINETOBACTER INFECTION MODELS 
129 
7.1 INTRODUCTION 130 
7.2 M A T E R I A L S & M E T H O D S 134 
7.2.1 Bacterial strains and growth conditions 134 
7.2.2 Caco-2 cells and storage conditions 134 
7.2.3 Caco-2 growth and infection media 134 
7.2.4 Caco-2 preparation and maintenance process 135 
7.2.5 Sub-culturing of mammalian cell line Caco-2 135 
7.2.6 Caco-2 cell count 135 
7.2.7 Seeding 24-well plates 136 
7.2.8 Preparation of inocula 137 
7.2.9 The association assay 137 
7.2.10 The gentamicin protection assay 138 
7.2.11 Preliminary experiments 138 
7.2.11.1 Determination of the bactericidal concentration of gentamicin 138 
7.2.11.2 Determination of bacterial viability in 0.5% Triton X-100 139 
VIII 
7.2.12 Effect of infection time course on the attachment and invasion levels of 
Acinetobacter 139 
7.2.13 Effect of different MOIs on the attachment and invasion levels of 
Acinetobacter 140 
7.2.14 Intracellular survival 140 
7.2.15 Cytotoxicity studies 141 
7.2.15.1 Preparation of M T T 141 
7.2.15.2 M T T viability assay 141 
7.2.16 Macrophage (U937) uptake and survival studies 142 
7.2.16.1 U937 cells and storage conditions 142 
7.2.16.2 U937 growth and infection media 142 
7.2.16.3 U937 subcultunng 142 
7.2.16.4 Preparation of P M A 143 
7.2.16.5 Bacterial strains and growth conditions 143 
7.2.16.6 Preparation of inocula 143 
7.2.16.7 Macrophage uptake and persistence assay 143 
7.3 RESULTS 145 
7.3.1 Determination of the bactericidal concentration of gentamicin 145 
7.3.2 Determination of bacterial viability in 0.5% Triton X-100 148 
7.3.3 Effect of the infection time course on the attachment and invasion levels.... 149 
7.3.4 Effect of different MOIs on the attachment levels of Acinetobacter 151 
7.3.5 Effect of different MOIs on the invasion levels of Acinetobacter 153 
7.3.6 Intracellular survival 155 
7.3.7 Cytotoxicity of Acinetobacter 156 
7.3.8 Persistence within U937 human macrophage cells 157 
7.4 DISCUSSION 159 
CHAPTER 8. DETECTION OF PHOSPHOLIPASE GENES: PRELIMINARY 
GENETIC ANALYSIS 166 
IX 
8.1 INTRODUCTION 167 
8.2 M A T E R I A L S & M E T H O D S 170 
8.2.1 Bacterial strains and culture preparation 170 
8.2.2 Isolation of genomic D N A 170 
8.2.3 Targeted genes and primer design 171 
8.2.4 Polymerase chain reaction (PCR) procedure 172 
8.3 RESULTS 173 
8.4 DISCUSSION 176 
CHAPTER 9. CONCLUSION 178 
REFERENCES 182 
X 
LIST OF FIGURES 
Figure 3.1 Percentage recovery of Acinetobacter strains in Baumann (BB), 
Enterobacteriaceae enrichment (EE), and modified M9 broths 52 
Figure 3.2 Recovery of Acinetobacter strains in M9 broth when incubated statically and 
on a rotary shaker 53 
Figure 3.3 Comparison of the percentage recovery on Acinetobacter agar media 65 
Figure 4.1 Survival oi Acinetobacter strains during the first twenty days of desiccation 80 
Figure 4.2 Survival of Acinetobacter strains during 24 months of desiccation 81 
Figure 4.3 Survival of E. cloaceae and E. hormaechei strains during the first twenty days 
of desiccation 82 
Figure 4.4 Survival of E. cloaceae and E. hormaechei strains during 24 months of 
desiccation 83 
Figure 5.1 Viable count of overnight cultures grown in casein- (Cow & Gate 1), whey-
(SMA 1), and soy-based (Cow & Gate Infasoy) infant formulas 96 
Figure 5.2 Doubling times of Acinetobacter cultures grown in casein- (Cow & Gate 1), 
whey- (SMA 1), and soy-based (Cow & Gate Infasoy) infant formulas 97 
Figure 5.3 Biofilm densities of Acinetobacter strains in casein-based infant formula (Cow 
& G a t e l ) 100 
Figure 5.4 Biofilm densities of Acinetobacter strains in whey-based infant formula (SMA 
1) 101 
Figure 5.5 Biofilm densities of Acinetobacter strains in soy-based infant formula (Cow & 
Gate Infasoy) 102 
Figure 5.6 Cell numbers of Acinetobacter strains in the residual casein-based infant 
formula (Cow & Gate 1) inside feeding tubes 103 
Figure 5.7 Cell numbers of Acinetobacter strains in the residual whey-based infant 
formula (SMA 1) inside feeding tubes 104 
Figure 5.8 Cell numbers of Acinetobacter strains in the residual soy-based infant formula 
(Cow & Gate Infasoy) inside feeding tubes 105 
Figure 6.1 Survival curves of Acinetobacter strains in infant formula at pH 4.5 117 
Figure 6.2 Survival curves of Acinetobacter strains in infant formula at pH 3.5 118 
Figure 6.3 Survival curves of Acinetobacter strains in infant formula at pH 2.5 119 
Figure 6.4 Survival curves of Acinetobacter strains in pepsin solution 120 
X I 
Figure 6.5 Survival curves oi Acinetobacter strains in small intestinal fluid 121 
Figure 6.6 Survival curves of Acinetobacter strains in 4% porcine bile solution 122 
Figure 7.1 Effect of 0.5% Triton X-100 on the viability of Acinetobacter strains 148 
Figure 7.2 Effect of infection time course on the attachment levels of Acinetobacter 
strains 150 
Figure 7.3 Effect of infection time course on the invasion levels of Acinetobacter strains. 151 
Figure 7.4 Effect of MOIs on the attachment levels of Acinetobacter strains 152 
Figure 7.5 Effect of MOIs on the invasion levels of Acinetobacter strains 154 
Figure 7.6 Levels of intracellular survival of Acinetobacter strains inside Caco-2 
epithelial cells 155 
Figure 7.7 Levels of Acinetobacter cytotoxicity 156 
Figure 7.8 Levels of Acinetobacter persistence within macrophages 158 
Figure 8.1 Detection of phospholipase A gene 174 
Figure 8.2 Detection of phospholipase C gene 174 
Figure 8.3 Detection of phospholipase D gene 175 
XII 
LIST OF TABLES 
Table 1.1 List of bacterial strains and their associated research studies 8 
Table 2.1 Delineation of Acinetobacter species 13 
Table 3.1 List of the antibiotics tested and their spectrum of activity 37 
Table 3.2 List of powdered infant formula products screened for the presence of 
Acinetobacter spp 38 
Table 3.3 Positive and negative recovery of Acinetobacter strains on D D A with and 
without the addition of 0.15g/l sodium deoxycholate 43 
Table 3.4 Positive and negative recovery of Acinetobacter strains on D D A containing 2 
and5g/lNaCl 44 
Table 3.5 Colony colour of Acinetobacter and other Gram-negative organisms cultured on 
D D A containing X-riboside and DHF-riboside 45 
Table 3.6 Antibiotic sensitivity of Acinetobacter spp. on the D D A medium 48 
Table 3.7 Sensitivity of Gram-positive organisms to aztreonam, ceftazidime, 
ciprofloxacin, norfloxacin, and temocillin on the D D A medium 49 
Table 3.8 Sensitivity of Acinetobacter and other Gram-negative and positive organisms to 
a range of lincomycin concentrations included in the D D A medium 50 
Table 3.9 Morphological and biochemical analysis of PIF isolates recovered on D D A 
(containing 1 Omg/1 lincomycin) and L A M 56 
Table 3.10 Gram-negative organisms recovered on selective media and biochemically 
identified during PIF screening 56 
Table 3.11 Activity of lincomycin against Gram-positive organisms recovered from PIF... 58 
Table 3.12 Activity of ceftazidime against Acinetobacter spp. and other Gram-negative 
species at different concentrations 59 
Table 3.13 Activity of aztreonam against Acinetobacter spp. and other Gram-negative 
species at different concentrations 60 
Table 3.14 Comparison of the selectivity of Acinetobacter agar media 63 
Table 3.15 Comparison of the sensitivity of Acinetobacter agar media 64 
Table 7.1 Sensitivity of Acinetobacter strains to gentamicin 146 
Table 7.2 In-situ gentamicin sensitivity testing of Acinetobacter strains 147 
Table 8.1 Details of the phospholipase genes selected for PCR analysis mAcinetobacter. 172 
Table 8.2 Detection of phospholipase genes in Acinetobacter strains 173 
XIII 
ABBREVIATIONS 
AIF 
A F L P 
A N O V A 
A R D R A 
ASP 
A T C C 
A T R 
B A A 
BB 
BIMP 
B P W 
C A C 
C C U G 
C F U 
C H D L 
COSHH 
DC 
D D A 
DHFR 
DMSO 
D N A 
D S M 
DT 
E A E C 
E D T A 
E E 
EFSA 
ESBL 
F H 
F A O 
FBS 
Apoptosis inducing factor 
Amplified fragment length polymorphism 
Analysis of variance 
Amplified 16S ribosomal D N A restriction analysis 
Acid shock protein 
American type culture collection 
Acid tolerance response 
Benzyl-arginine arylamidase 
Baumann broth 
Bacterial integral membrane proteins 
Buffered peptone water 
Codex Alimentarius Commission 
Culture collection of the University of Goteborg 
Colony forming unit 
Carbapenem-hydrolysing oxacillinase 
Control of substances hazardous to health 
Dendritic cell 
Druggan-Dimmer agar 
Dihydrofolate reductase 
Dimethyl sulfoxide 
Deoxyribonucleic acid 
Deutsche sammlung von mikroorganismen 
Doubling time 
Enteroaggregative Escherichia coli 
Ethylenediaminetetraacetic acid 
Enterobacteriaceae enrichment 
European Food Safety Authority 
Extended-spectrum P-lactamase 
Factor H 
Food and Agriculture Organisation 
Fetal bovine serum 
XIV 
F D A 
I A M C C 
ICU 
IF 
IROMP 
L A M 
LPS 
M A T E 
M B L 
M D R 
M E M 
MFS 
MIC 
MOI 
M P N 
M T T 
N A 
N C D O 
N C I M B 
N C T C 
N - A H L 
NHS 
N I C U 
N I P H 
NLS 
N T U C C 
OCC 
OD 
OmpA 
O M V 
PBS 
PBP 
PCR 
Food and Drug Administration 
Institute of Applied Microbiology culture collection 
Intensive care unit 
Infant formula 
Iron regulated outer membrane proteins 
Leeds Acinetobacter medium 
Lipopoly saccharide 
Multidrug and toxic compound extrusion 
Metallo-P-lactamase 
Multidrug resistance 
Minimum essential medium 
Major facilitator superfamily 
Minimum inhibitory concentration 
Multiplicity of infection 
Most probable number 
Methyl-thiazolyldiphenyl-tetrazolium 
Nutrient agar 
National collection of dairy organisms 
National collection of industrial and marine bacteria 
National collection of type cultures 
N-acylhomoserine lactones 
Normal human serum 
Neonatal intensive care unit 
National Institute of Public Health 
Nuclear localization signal 
Nottingham Trent University culture collection 
Oxoid culture collection 
Optical density 
Outer membrane protein A 
Outer membrane vesicle 
Phosphate buffered saline 
Penicillin-binding protein 
Polymerase chain reaction 
XV 
P H 
PIF 
P L A 
P L C 
P L D 
P M A 
PR 
Q M C 
RABIT 
R N D 
ROS 
SEIP 
SIRS 
SM-TSA 
T A E 
TSA 
TSB 
T T D 
V R B G A 
W H O 
Potential hydrogen 
Powdered infant formula 
Phospholipase A 
Phospholipase C 
Phospholipase D 
Phorbol 12-myristate 13-acetate 
Percentage recovery 
Queen's Medical Centre 
Rapid automated bacterial impedance technique 
Resistance-nodulation-cell Division 
Reactive oxygen species 
Service des Enterobactbries de l'lnstitut Pasteur 
Systematic inflammatory response syndrome 
Skimmed milk-tryptic soy agar 
Tris-acetate E D T A 
Tryptic soy agar 
Tryptic soy broth 
Time to detection 
Violet red bile glucose agar 
World Health Organization 
XVI 
CHAPTER 1. GENERAL MATERIALS & 
METHODS 
Chapter 1. General Materials & Methods 
1.1 Safety considerations 
The experiments were carried out in compliance with the Health and Safety Code of 
Practice for Microbiology containment level 2. Risks associated with all the materials and 
procedures described in this project were assessed according to the Control of Substances 
Hazardous to Health (COSHH) regulations. 
1.2 Bacterial cultures 
A l l the bacterial strains used in this project, their sources, and culture collection 
designations are listed in Table 1.1. The relevant research studies applied for these strains 
are also indicated. 
1.3 Stock culture preparation and storage 
A l l the strains were grown overnight on tryptic soy agar (TSA) and then mixed with 
Microbank™ cryobeads (Pro-LAB Diagnostics, PL. 170) for long-term storage at -70°C. 
Replicate stock cultures were also kept at -20°C in 4% glycerol broth. 
1.4 Identification and characterization of bacteria 
1.4.1 Gram staining 
Bacterial smears were prepared by emulsifying a portion of a colony in sterile distilled 
water on a dry clean slide. Smears were air dried, and then passed through a Bunsen 
burner flame. Heat-fixed smears were flooded with 1% crystal violet and left for 2x/2 min. 
Next, they were rinsed with tap water before they were flooded with 5% iodine and left 
for 2 min. Excess iodine was removed by rinsing with tap water. Decolorization step was 
then carried out using 50:50% ethanol:acetone, which was removed by tap water 
afterwards. Finally, the smears were counterstained with 2% safranin for 10 sec, then 
rinsed and blot dried with blotting paper. For visualization under the microscope, cells 
were covered with immersion oil and examined at the magnification of lOOOx. Gram-
positive bacterial cells appeared blue/purple, whereas the Gram-negative cells appeared 
pink/red. 
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1.4.2 Oxidase test 
This was performed in accordance with the manufacturer's instructions (Fluka Analytical, 
40560). Several bacterial colonies were smeared using a sterile loop on a paper saturated 
with alpha-naphthol and N,N-dimethyl-l,4-phenylene diamine. A positive oxidase 
reaction was determined by development of a purple colour in approximately 10 sec. 
Pseudomonas aeruginosa A T C C 15442 was used as a positive control. 
1.4.3 Identification using biochemical profiles 
API 20E (bioMeneux, 20120) and API 20NE kit (bioMeneux, 20050) were used to 
phenotypically identify presumptive Enterobacteriaceae as well as non-glucose 
fermentative isolates recovered on V R B G A respectively. Suspensions of overnight 
cultures in saline (Oxoid, BR0053G) were adjusted to 0.5 MacFarland standard then used 
to inoculate the standardized biochemical test strips. Inoculation, incubation, and 
interpretation were all carried out as according to the manufacturer's instructions. 
Identification profiles were obtained via Apiweb™ online database (bioMerieux SA, 
France). 
1.4.4 Identification using 16S rDNA gene sequencing 
FT A® Elute Micro Cards (Whatman International Ltd., WB120410) were used to send 
D N A samples of the bacteria to Accugenix Inc. (Newark, USA) for partial 16S rDNA 
gene sequencing. Colonies from overnight cultures on TSA plates were suspended in 
phosphate buffered saline (PBS). Forty microliter volumes of this suspension were 
dispensed onto F T A Elute Micro Cards, and then allowed to dry completely for at least 3h 
at room temperature before sealing. The cards were stored at room temperature prior to 
dispatch. 
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1.5 Enumeration of bacterial cells 
1.5.1 Miles and Misra method 
Bacterial cultures were serially diluted, then 20ul of the dilutions were placed on air dried 
TSA. This was done in triplicate and the average number of colonies between 3 and 30 
was calculated following incubation. This average was then multiplied by both 50 and the 
dilution factor in order to determine the number of colony forming units per ml of the 
original sample. 
1.5.2 Spread plate method 
Serially diluted cultures (0.1ml) were pipptted onto the surface of triplicate agar plates and 
spread using a sterile glass spreader. The samples were allowed to soak in and then 
incubated. Only the plates that had colonies between 30 and 300 colonies were selected 
for the calculation. The number of colony forming units per ml of the sample was 
averaged and finally divided by the relevant dilution factor. 
1.6 Preparation of media 
1.6.1 Baumann broth (BB) 
This medium was designed by Baumann (1968) for the enrichment of Acinetobacter 
isolates from water and soil. It contained 2g/l K N 0 3 (Sigma-Aldrich, P6083); 2g/l 
CH 3COONa (Sigma-Aldrich, S8750), and 0.2g/l MgS04 .7H20 (Sigma-Aldrich, 63138), 
which were added to 0.04M KH 2 P0 4 -Na 2 HP0 4 buffer (Sigma-Aldnch, P5655-S7907) (pH 
6.0), and 20ml/l Hutner's vitamin free mineral base. 
The mineral base was described by Cohen-Bazire et al. (1957) and consisted of 10g/l 
N(CH2COOH)3 (Sigma-Aldnch, N9877) which was dissolved in distilled water and 
neutralized with 7.3g of K O H (Sigma-Aldrich, 221473) before adding the remaining salts. 
These were 14.45g/l MgS04 .7H20, 3.34g/l CaCl2.2H20 (Sigma-Aldnch, C5080), 
9.25mg/l (NH4)6Mo7024.4H20 (Sigma-Aldnch, Al343), 99mg/l FeS04.7H20 (Sigma-
Aldnch, F8048), and was dissolved in 950ml distilled water and 50ml Metals "44". The 
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Metals "44" contained (per 100ml) 250mg Na 2 .EDTA (Sigma-Aldrich, E1644), l . l g 
ZnS04.7H20 (Sigma-Aldrich, 20635), 500mg FeS04.7H20, 154mg MnS04 .xH20 (Sigma-
Aldnch, 229784), 39.2mg CuS04.5H20 (Sigma-Aldnch, C8027), 24.8mg Co(N03)2.6H20 
(Sigma-Aldnch, 230357), and 17.7mg Na2B4O7.10H2O (Sigma-Aldnch, B9876). The 
components were dissolved in 100ml distilled water. 
1.6.2 Buffered peptone water (BPW) 
According to the manufacturer's instructions, 20g of B P W (Oxoid, CM509) was dissolved 
in llitre of distilled water, and sterilized at 121°C for 15 min in 9ml aliquots. It was then 
cooled to room temperature before use. 
1.6.3 CHROMagar Acinetobacter medium 
As per the instructions of CHROMagar (CHROMagar Microbiology, France), the medium 
was prepared as follows: 32.8g/l of the ready-made base (AC092 (B)) was suspended in 
distilled water. One millilitre of the liquid supplement (AC092 (S)) was then added to the 
base. Afterwards, the medium was heated and brought to boil while stirring regularly. 
When cooled to 55°C, the agar was dispensed into Petri dishes and allowed to set. Dry 
plates were then stored at 4°C for up to a week. Quality control strains comprised A. 
baumannii A T C C 19606 , which grew on the medium as red colonies, and E. faecalis 
N C I M B 775T as the positive and negative quality control strains respectively. The latter 
replaced Enterococcus faecalis ATCC® 29212 recommended by the medium provider, 
due to unavailability, but was correctly inhibited. 
1.6.4 Dimmer-Druggan agar (DDA) 
The medium contained 12 g/1 tryptone (LAB M , MC005), lg/1 yeast extract (LAB M , 
MC001), 5g/l soy peptone (LAB M , MC003), 0.5g/l ferric ammonium citrate (Sigma-
Aldnch, F5879), 0.4g/l DHF-nboside (Glycosynth, 50180), and 10 g/1 agar No. 2 (LAB 
M , MC006). These components were mixed with 1 litre of distilled water and autoclaved 
at 121°C for 15 mm. At 50-55°C, 20mg/l hncomycin (Sigma-Aldnch, 62143) and 2mg/l 
aztreonam (Sigma-Aldrich, A6848) were mixed with the medium (pH7) before dispensed 
into Petri dishes and allowed to solidify. 
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1.6.5 Enterobacteriaceae Enrichment broth (EE) 
The manufacturer's instructions were followed by adding 43.5g to 1 litre of distilled 
water. The medium (Oxoid, CM0317) was distributed in 250ml bottles which was then 
brought to boil and heated for 30 min until dissolved at 100°C. Once dissolved, it was 
cooled rapidly under flowing cold water before use. 
1.6.6 Glycerol broth 
Four percent glycerol broth was prepared as described by Gibson and Khoury (1986). 
Fourty millilitre of glycerol (Sigma-Aldrich, 49781) was mixed with 30g/l tryptone soya 
broth (Merck, 105459), 5g/l glucose (Merck, 346351), and 20g/l skimmed milk powder 
(Oxoid, LP0031). The volume was then made up to 1000ml with distilled water and 
sterilised by autoclaving at 115°C for 20 min. 
1.6.7 Leeds Acinetobacter medium (LAM) 
The medium was prepared as according to Jawad et al. (1994). The formula included 
10g/l bacteriological agar No. 2 (LAB M , MC006), 5g/l neutralized soy peptone (LAB M , 
MC003), 15g/l acid casein hydrolysate (Merck, 102245), 5g/l sodium chloride (Sigma-
Aldnch, S7653), 5g/l sucrose (Sigma-Aldnch, S7903), 5g/l D-(-)-fructose (Sigma-
Aldnch, F0127), lg/1 L-phenylalanine (Sigma-Aldnch, P2126), 5g/l D-mannitol (Sigma-
Aldnch, M4125), 0.02g/l phenol red (Sigma-Aldnch, P3532), and 0.4g/l ferric ammonium 
citrate (Sigma-Aldrich, F5879). The pH of the complete medium was 7. A l l the 
ingredients were dissolved in distilled water by heating, then autoclaved for 15 min at 
121°C. Once cooled to 50-55°C, 10mg/l vancomycin (Sigma-Aldnch, 861987), 50mg/l 
cephradine (Sigma-Aldrich, C8395), and 15mg/l cefsulodin (Sigma-Aldrich, C8145) were 
added to the medium and mixed before dispensing into Petri dishes. 
1.6.8 Modified M9 medium with casamino acids 
The medium was prepared by adding 6.0g/l Na 2 HP0 4 (Sigma-Aldrich, S7907), 5.0g/l 
casamino acids (Fisher-Scientific, BP1424), 3.0g/l K H 2 P 0 4 (Sigma-Aldnch, P5655), 
l,0g/l NH4C1 (Sigma-Aldnch, A0171), and 0.5g/l NaCl (Sigma-Aldnch, S7653) to 
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distilled water. In contrast to the original recipe, the 10ml of 20g/l glucose solution was 
not included. The volume was then made up to 997ml. The ingredients were mixed 
thoroughly and the pH adjusted to 6.0 instead of 7.0. The medium was autoclaved at 
121°C for 15 min at a pressure of 15 psi. The medium was left to cool before aseptically 
adding 1.0ml filter-sterilized solutions of lOmg/lOml thiamine.HC1 (Sigma-Aldrich, 
T4625), 246.5g/l MgS04 .7H20 (Sigma-Aldnch, 63138), and 14.7g/l CaCl2 (Sigma-
Aldrich, C5670). The medium was mixed thoroughly and distributed into baffled flasks. 
1.6.9 Saline solution 
Saline solution was used for diluting bacterial cultures and was prepared as Oxoid 
(BR0053) instructed. One sodium chloride tablet was dissolved in 500ml of distilled 
water. This 0.85% saline solution was then sterilised by autoclaving at 121°C for 15 min. 
1.6.10 Tryptic soy agar (TSA) 
According to Oxoid's instructions, 40 grams of TSA (CM0131) were suspended in 1 litre 
of distilled water and sterilised by autoclaving for 15 min at 121 °C. The medium was 
allowed to cool to around 60°C before dispensing into sterile petri dishes. 
1.6.11 Tryptic soy broth (TSB) 
Tryptic soy broth was prepared in accordance with the instructions of Merck (105459). 
Thirty grams of TSB was dissolved in 1 litre distilled water. Aliquots (10ml) of TSB were 
dispensed into Universal bottles, which were then autoclaved for 15 min at 121 °C. The 
broth was allowed to cool to room temperature before used. 
1.6.12 Violet red bile glucose agar (VRBGA) 
As per the manufacturer's instructions, 38.5g of V R B G A (Merck, 1.10275) was dissolved 
in 1 litre of distilled water. It was then brought to the boil to dissolve completely. Once 
dissolved, it was mixed, and then dispensed into Petri dishes. 
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T a b l e 1.1 L i s t of bacterial strains a n d their associated research studies. 
Species 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. calcoaceticus 
A. calcoaceticus 
A. calcoaceticus 
Acinetobacter gensp. 3 
Acinetobacter gensp. 3 
A. haemolyticus 
A.junii 
A. johnsonii 
A. Iwoffii 
A. radioresistens 
A. schindleri 
A. ursingii 
Bacillus cereus 
Bacillus sp. 
Bacillus sp. 
B. subtilis 
B. subtilis 
Strain 
number 
1095 
1096 
1098 
1099 
1102 
1109 
1110 
1111 
1112 
1113 
1114 
1115 
1116 
1117 
1118 
1119 
1120 
1121 
1122 
1123 
1124 
1125 
1126 
1127 
1183 
1440 
418 
1097 
1103 
415 
1182 
1337 
1335 
1336 
1338 
1340 
1339 
1334 
1170 
N33 
N94 
702 
1248 
Source/Culture collection 
designation 
QMC 
QMC 
QMC 
QMC 
N C T C 12156T 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
PIF 
A T C C 17978 
Food 
N C T C 7844 
N C T C 12983T 
Food 
PIF 
N C T C 10305T 
N C T C 10307T 
N C T C 10308T 
N C T C 5866T 
A T C C 43998T 
A T C C BAA-618T 
A T C C BAA-617T 
A T C C 11778 
PIF 
PIF 
N C I M B 10106 
N C I M B 10108 
Associated study 
1 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
2 
V 
V 
V 
V 
V 
V 
V 
V 
V 
3 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
4 
V 
V 
V 
V 
V 
V 
V 
V 
5 
v* 
v* 
v* 
V 
V 
v* 
v* 
V 
v* 
v* 
v* 
v* 
v* 
v* 
v* 
v* 
v* 
v* 
v* 
v* 
v* 
v* 
v* 
v* 
V 
V 
V 
V 
V 
V 
6 
V 
V 
V 
V 
V 
V 
V 
V 
V 
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Species 
Burkholderia cepacia 
Citrobacter freundii 
Citr. koseri 
Citr. koseri 
Citr. koseri 
Citr. koseri 
Citr. koseri 
Cronobacter sakazakii 
C sakazakii 
Enterobacter cloacae 
Ent. cloacae 
Ent. cloacae 
Ent. cloacae 
Ent. hormaechei 
Enterococcus faecalis 
Escherichia coli 
E. coli 
E. coli 
E. coli 
E. coli 
E. coli 
Klebsiella pneumoniae 
K. pneumoniae 
K. pneumoniae 
Lactococcus lactis 
Lactobacillus plantarum 
Pseudomonas aeruginosa 
P. aeruginosa 
P. aeruginosa 
P. luteola 
Salmonella Enteritidis 
Serratia liquefaciens 
S. marcescens 
S. marcescens 
S. marcescens 
Staphylococcus aureus 
Staph, aureus 
Staph, aureus 
Staph, aureus 
Staphylococcus sp. 
Staphylococcus sp. 
Staph, epidermidis 
Strain 
number 
627 
624 
48 
224 
225 
226 
826 
1 
2 
49 
50 
218 
597 
790 
1172 
100 
605 
571 
800 
1247 
1230 
68 
541 
1013 
1171 
574 
117 
401 
570 
133 
358 
579 
763 
834 
835 
1167 
1168 
152 
616 
N50 
N76 
671 
Source / Culture collection 
designation 
NCTC 10661 
NCTC 9750 
SMT319 
ATCC 27028 - OCC 270 
ATCC 25409 
ATCC 25410 - OCC 254 
ATCC 25408 
ATCC29544 -NCTC 11467 
ATCC 12868 
ATCC 13047 - NCTC 10005 
OCC 
ATCC 23355 - OCC 1062 
Textile surfactant solution 
Neonatal feeding tube 
NCIMB 775T 
NCIMB9517 
NCH 
ATCC 8196 
ATCC 43888 
NCTC 10418 
HB101 
NCDO 711 
NCIMB 10341 
Neonatal feeding tube 
NCIMB 6681 
NCIMB 6376 
NCTC 8602 
ATCC 15442 
NCTC 6749 
PIF 
NCTC 3046 
AES medium 
NCTC 1377 
OCC 217 
OCC 219 
NCTC 6571 
NCTC 4163 
NCTC 7447 
NCTC 10788 
PIF 
PIF 
NCTC 7944 
Associated study 
1 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
V 
2 
V 
V 
V 
3 4 5 
V 
V 
V 
6 
1 Development and evaluation of Acinetobacter medium for the detection of the organism in PIF, 2 Desiccation 
survival study, 3 Biofilm formation study, 4 Gastrointestinal survival study, 5 In vitro infection model studies, 6 
Genes detection study. ATCC American Type Culture collection, HB Hybrid Bacterium, NCDO National 
Collection of Dairy Organisms, NCIMB National Collection of Industrial and Marine Bacteria, NCTC National 
Collection of Type cultures, NCH Nottingham City Hospital, NTU Nottingham Trent University, OCC Oxoid 
Culture Collection, PIF Powdered Infant Formula, QMC Queen's Medical Centre, T Type strain, A/* strain was 
only included in the preliminary experiments. 
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2.1 Characteristics of Acinetobacter spp. 
Acinetobacter species are Gram-negative/variable, strictly aerobic, non-spore forming, 
non-motile, oxidase-negative, catalase-positive, and non-fermentative (Mahon et al, 
2011). Cells appear as short rods during the log phase and display a coccobacillary shape 
in the stationary phase (Allen and Hartman, 2010). Due to the morphological similarity, 
they are often confused with Achromobacter, Moraxella, and Neisseria (King et al, 
2009). However, Acinetobacter can be differentiated by its negative reaction of the 
oxidase test (de la Maza et al., 2004). The organism grows at 20°C to 37°C with the 
optimum growth temperature between 33°C and 35°C. Growth at 44°C has been recorded 
for A baumannii species (Bouvet and Grimont, 1986). Acinetobacter spp. are also known 
for their ability to utilise a variety of compounds as sources of carbon and energy, and to 
grow easily on general culture media (Allen and Hartman, 2010). Their smooth non-
pigmented colonies on these media may appear mucoid as they are generally encapsulated 
(Allen and Hartman, 2010). 
2.2 Current taxonomy and species identification 
The genus Acinetobacter belongs to the Moraxellaceae family within the 
Gammaproteobacteria of the Proteobacteria (Rossau et al., 1991), and currently comprises 
of thirty-six species (named and unnamed) (Table 2.1) delineated based on D N A - D N A 
hybridization, which is considered as the gold standard for species identification. The 
nomenclature of the unnamed genomic species (gensp.) was hindered by the lack of 
phenotypic identification criteria that could differentiate and assign them to a specific 
group (Gerner-Smidt, 1992; Gerner-Smidt et al, 1991). In addition, the small number of 
strains in these genomic species did not allow a generalisation to be made in terms of their 
phenotypic diversity. Another taxonomy issue for this organism is the close genomic 
relatedness of some species as represented by the A. calcoaceticus - A. baumannii (Acb) 
complex (Bouvet and Jeanjean, 1989). In addition to these two species, the complex 
includes gensp. 3, 13TU, as well as the DNA-hybridization groups labelled 'close to 
13TU' and 'between 1 and 3'. Acinetobacter gensp. 10 and 11 are also believed to be 
closely related (Bouvet and Jeanjean, 1989). Species belonging to this complex cannot all 
be accurately distinguished from each other (Gerner-Smidt et al, 1991). Commercial 
phenotypic systems such as API20 N E , and V I T E K 2, which are routinely used for 
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species identification of other bacteria in diagnostic laboratories, are unreliable for 
Acinetobacter in this respect (Bernards et al, 1995; Bernards et al, 1996; Horrevorts et 
al, 1995; Loubinoux et al, 2003). Although some species are correctly identified by 
these systems, others such as Acinetobacter gensp. 3 and 13TU, as well as A schindleri, 
and A ursingii can be misidentified (Dortet et al, 2006; Gerner-Smidt et al, 1991). This 
is partly due to the limited species database for Acinetobacter, and since the included 
biochemical tests are not tailored for acinetobacters considering their limited fermentation 
activities (Gerner-Smidt et al, 1991). 
Genotypically, a range of identification methods, based on the comparative analysis of 
D N A sequences and the analysis of D N A fragments separated electrophoretically, have 
been used. The D N A fragment based-identification techniques include tRNA intergenic 
spacer fingerprinting (Vaneechoutte et al, 2009), ribotyping (Gerner-Smidt, 1992), 
amplified fragment length polymorphism (AFLP ) (Nemec et al, 2010), and amplified 
16S ribosomal D N A restriction analysis (ARDRA) (Nemec et al, 2011). The last two 
methods have been extensively validated and hence widely recognized as reference 
procedures for species identification of this organism (Peleg et al, 2008). The second 
identification approach commonly applied involves the analysis of similarities between 
16S rDNA sequences where those lower than 98.7-99.0% are designated to different 
species (Janda and Abbott, 2007; Stackebrandt and Evers, 2006). Values above this 
threshold may or may not mean the organisms belong to the same species. D N A - D N A 
hybridization would then be used for confirmation in this case (Stackebrandt and Evers, 
2006). The above-mentioned methods are useful for species identification and suitable for 
reference laboratories (Peleg et al, 2008). However, they are laborious and non-practical 
for routine day-to-day diagnostic microbiology laboratories. 
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Table 2.1 Delineation of Acinetobacter species. 
Named species 
A. baumannii 
A. baylyi 
A. beijerinckii 
A. bereiinae 
A. bouvetii 
A. brisouii 
A. calcoaceticus 
A. gemeri 
A. grimontii 
A. guilbuiae 
A. gyllenbergii 
A. haemolyticus 
A.johnsonii 
A. junii 
A. Iwoffii 
A. nosocomialis 
A. parvus 
A. pittii 
A. radioresistens 
A. rudis 
A. schindleri 
A. soli 
A. tandoii 
A. tjernbergiae 
A. towneri 
A. ursingii" 
A. venetianus 
Genomic 
species 
2 
-
-
10 
-
-
1 
-
-
11 
-
4 
7 
5 
8,9 
13TU 
-
3 
12 
-
-
-
-
-
-
-
-
6 
13BJ, M T U 
14BJ 
15BJ 
16 
17 
15TU 
Between 1 and 3 
Close to 13TU 
Type strain 
ATCC19606T 
DSM 14961T 
NIPH 838T 
ATCC 17924T 
DSM149641 
DSM185161 
ATCC230551 
DSM 14967T 
DSM 14968T 
ATCC 11171T 
NIPH21501 
ATCC 17906T 
ATCC 17909T 
ATCC 17908T 
ACTC15309T 
NIPH21191 
NIPH 384T 
ATCC 19004T 
ATCC 43998T 
DSM240311 
NIPH 1034T 
JCM150621 
DSM 14970T 
DSM 14971T 
DSM149621 
NIPH 137T 
ATCC310121 
ATCC 17979 
ATCC 17905 
CCUG14816 
SEIP 23.78 
ATCC 17988 
SEIP Ac87.314 
LUH1090 
LUH1469 
L U H 1472 
Reference 
(Bouvet and Grimont, 1986; Tjemberg and Ursing, 1989) 
(Carre; a/., 2003) 
(Nemec e< a/, 2009) 
(Bouvet and Grimont, 1986; Nemec et al, 2010; Tjemberg and Ursing, 1989) 
(Carre; a/., 2003) 
(Anandhame(fl/.,2010) 
(Bouvet and Grimont, 1986; Tjemberg and Ursing, 1989) 
(Cm et al, 2003) 
(Cm et al, 2003) 
(Bouvet and Grimont, 1986; Nemec et al, 2010; Tjemberg and Ursing, 1989) 
(Nemec et al, 2009) 
(Bouvet and Grimont, 1986; Tjemberg and Ursing, 1989) 
(Bouvet and Grimont, 1986; Tjemberg and Ursing, 1989) 
(Bouvet and Grimont, 1986; Tjemberg and Ursing, 1989) 
(Bouvet and Grimont, 1986; Tjemberg and Ursing, 1989) 
(Nemec et al, 2011; Tjemberg and Ursing, 1989) 
(Nemec et al, 2003) 
(Bouvet and Grimont, 1986; Nemec et al, 2011; Tjemberg and Ursing 1989) 
(Bouvet and Grimont, 1986; Nishimura et al, 1988; Tjemberg and Ursing, 1989) 
(Vaz-Moreirae(a/.,2011) 
(Nemec et al, 2001) 
(Kim et al, 2008) 
(Carre; al, 2003) 
(Cm et al, 2003) 
(Cm et al, 2003) 
(Nemec et al, 2001; Nemec et al, 2008) 
(Vaneechoutte et al, 2009; Vaneechoutte et al, 1999) 
(Bouvet and Grimont, 1986; Tjemberg and Ursing, 1989) 
(Bouvet and Jeanjean, 1989; Tjemberg and Ursing, 1989) 
(Bouvet and Jeanjean, 1989) 
(Bouvet and Jeanjean, 1989) 
(Bouvet and Jeanjean, 1989) 
(Bouvet and Jeanjean, 1989) 
(Tjemberg and Ursing, 1989) 
(Gemer-Smidt and Tjemberg, 1993) 
(Gemer-Smidt and Tjemberg, 1993) 
The genus Acinetobacter is currently comprised o f 27 named and 9 unnamed species delineated based on D N A -
D N A hybridization. D N A - D N A hybridization groups were termed as genomic species and were assigned 
numbers i f species names were not originally given. The designated numbers o f genomospecies 13-15 described 
by two independent studies were extended wi th B J and T U to avoid confusion. " it has also been called A. 
septicus, - non-specified genomic species, A T C C American Type Culture Collection, C C U G Culture Collection; 
University o f Goteborg, D S M Deutsche Sammlung v o n Mikroorganismen, J C M Japan Collect ion o f 
Microorganisms, L U H Leiden University M e d i c a l Centre, N I P H National Institute o f Public Health, SEIP 
Service des Enterobacteries de l'lnstitut Pasteur, T type strain. 
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2.3 Clinically important Acinetobacter species 
The most commonly isolated Acinetobacter species from hospitals belong to the Acb 
complex, particularly A. baumannii (Turton et al, 2010). Other species including A. 
baylyi, A. beijerinckii, A. bereziniae, A. guillouiae, A. gyllenbergii, A. haemolyticus, A. 
johnsonii, A. junii, A. Iwoffii, A. nosocomialis (gensp. 13TU), A. parvus, A. pitti (gensp. 
3), A. radioresistens, A. schindleri, and A. ursingii have also been found in clinical 
specimens. However, they are less frequently encountered in association with hospital-
acquired infections (Chen et al, 2007b; Dortet et al, 2006; Gundi et al, 2009; Loubinoux 
et al, 2003; Nemec et al, 2011; Nemec et al, 2010; Turton et al, 2010; van den Broek et 
al, 2009). 
2.4 Natural habitats and transmission of Acinetobacter spp. 
Although Acinetobacter spp. are ubiquitously present in nature (water and soil) 
(Baumann, 1968), there is a misconception that the environment is the natural habitat of 
the entire Acinetobacter genus. A. ursingii and A. schindleri, for example, have only been 
isolated from clinical materials (Dortet et al, 2006; Nemec et al, 2001). The bacterium 
can also exist in humans as a commensal of the skin, throat, nose, ear, axilla, toe web, 
perineum, and groin (Berlau et al, 1999; Seifert et al, 1997). In fact, acinetobacters 
comprise part of the skin flora of healthy humans (Peleg et al, 2008; Wilson, 2005). A n 
epidemiological survey of the skin and mucosal membranes of non-hospitalised 
individuals revealed that 43% were colonised with Acinetobacter (Seifert et al, 1997). A. 
Iwoffii, A. johnsonii, A. junii, and Acinetobacter gensp. 3 were isolated from 58, 20, 10, 
and 6% of the samples respectively. In another study, an Acinetobacter carriage rate of 
44%) in healthy persons was also reported (Berlau et al, 1999). At 61%, A. Iwoffii was the 
most prevalent species followed by Acinetobacter gensp. 15BJ (12%). A. radioresistens 
and Acinetobacter gensp. 3 were recovered at 8 and 5% respectively (Berlau et al, 1999). 
Compared to the 43% colonisation of non-hospitalised individuals, that of patients in a 
regular ward was much higher (75%) (Seifert et al, 1997). Faecal carriage with A. 
johnsonii and Acinetobacter gensp. 11 has been previously detected in 25% of healthy 
humans (Dijkshoorn et al, 2005). A. baumannii was also found in 0.8% of the samples 
(Dijkshoorn et al, 2005). Another study reported 77% rectal colonization with A. 
baumannii, while that of the pharynxes or axillae was 75% (Ayats et al, 1997). 
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Although A. baumannii are occasionally found on the skin of healthy individuals (Jawad 
et al, 1998a), the skin carriage of this organism increases following hospitalization 
(Gerner-Smidt, 1994). Marchaim et al. (2007) investigated re-admitted cases with 
previous history of hospitalization and who had been colonised and/or infected with 
multidrug-resistant (MDR) A. baumannii. The isolation of this organism was traced back 
to 17.5 months on average since the patients were hospitalized. Approximately 55% of the 
recent carriers (<10 days) had more than one positive culture of M D R A. baumannii. Five 
of thirty patients with remote isolation history were also positive for the organism cultured 
from the pharynx and skin but not from other surveillance body sites (endotracheal 
aspirates, wounds, rectum, and nose). Isolates obtained from different sites in the same 
patient were identified as clonal in all cases except one (Marchaim et al, 2007). 
It has been suggested that hospitals are the primary reservoir for A. baumannii in 
particular (Zeana et al, 2003). The hands of the health-care personnel and contaminated 
surfaces have been identified as the sources of direct and indirect transmission of the 
organism in the clinical setting (Dijkshoorn et al, 2007; Go et al, 1994; Roberts et al, 
2001). Acinetobacter are believed to persist under desiccated conditions on inanimate 
hospital surfaces, generally, longer than other Gram-negative organisms such as 
Escherichia coli and other Enterobacteriaceae (Hirai, 1991; Jawad et al, 1996; Pettit and 
Lowbury, 1968; Wendt et al., 1997). The organism can be isolated from the surfaces of 
the components of patients' rooms (e.g. pillows and mattresses, and from dust inside 
dialysis machines and mechanical ventilators (Bernards et al, 2004; Mottar et al, 2006; 
Sherertz and Sullivan, 1985; Weernink et al, 1995). Almost all the medical devices have 
been considered a potential reservoir for Acinetobacter outbreaks. Common inanimate 
sources of cross-contamination includes blood pressure cuffs (Bureau-Chalot et al, 
2004), pressure transducers (Beck-Sague et al, 1990), temperature and oxygen probes 
(Snelling et al, 1996), humidifiers (Ebenezer et al, 2011; Schloesser et al, 1990), 
ventilator tubing (Cefai et al, 1990; Struelens et al, 1993), mouthpieces of ventilation 
masks (Stone and Das, 1986), resuscitation bags (Hartstein et al, 1988). Parenteral 
nutrition and intravenous fluids have also been identified as foci for Acinetobacter 
outbreaks (De Vegas et al, 2006; Ng et al, 1989). The prolonged survival on inanimate 
hospital surfaces combined with inefficient disinfecting procedures may enhance the 
existence of this organism in the hospital environment and the propensity for epidemic 
spread. In other words, contamination of these surfaces can serve as a dry vector for the 
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re-occurrence of outbreaks. The transmission of Acinetobacter between patients may also 
collectively contribute to the spread of acquired multidrug resistance and hence infections 
that are difficult to treat (D'Agata et al, 2000; Webster et al, 2000). 
2.5 Virulence determinants 
It is well established that Acinetobacter is an opportunistic organism that has the ability to 
be pathogenic and cause infections. The degree of pathogenicity (virulence) may vary 
between strains of the same species and depends on a combination of factors involving 
the bacterium, the host, and the interaction between them. The virulence of a bacterial 
strain is promoted by the virulence determinants and partly contributes to the outcomes of 
the infection associated. In the next part, an overview of the major virulence factors of 
Acinetobacter is given in terms of their relevance to the pathogenicity of the organism. 
These factors described in the literature are mainly reported in A. baumannii which has 
been the most extensively researched species compared to other Acinetobacter species 
due to its clinical significance as a multidrug resistant pathogen. However, this does not 
eliminate the potential pathogenicity or the virulence of the other species, nor reflects a 
sole interest of this research project on A baumannii. 
2.5.1 Antibiotic resistance determinants 
In comparison to other Acinetobacter species, A. baumannii has gained a wide reputation 
as a problematic nosocomial M D R pathogen. Resistance to all commonly used antibiotics 
against Gram-negative bacteria has become a frequent issue in clinical practice 
(Livermore et al, 2008; Morgan et al, 2009; Rossolini and Mantengoli, 2008). It has been 
proposed that the presence of M D R A. baumannii in a clinical sample indicates a potential 
outbreak-causing strain (Koeleman et al, 2001).The range of resistance mechanisms 
exhibited by this species has considerably limited the effective therapeutic options 
available for patients' treatment (Neonakis et al, 2011). Drug resistance of this organism 
is enhanced by its ability to acquire and integrate foreign genetic elements, such as 
integrons, transposons, and plasmids, from other bacteria in the same environment 
(Giamarellou et al, 2008; Vila and Pachon, 2008). Genes which are associated with 
multidrug resistance and believed to be acquired from other Gram-negative species have 
been found in a number of large genomic islands (AbaRl, R2, R3 and R5) in the genomes 
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of M D R isolates (Adams et al, 2008; Fournier et al, 2006; Iacono et al, 2008). Those 
resistant to three or more classes of drugs are regarded as multidrug resistant and have 
been increasingly reported worldwide (Doi et al, 2009; Fournier and Richet, 2006; Ko et 
al, 2007; Maviglia et al, 2009; Paterson, 2006; Zavascki et al, 2010). Collectively, the 
morbidity and mortality resulting from infections caused by such strains are on the 
increase (Paterson, 2006; Peleg et al, 2008; Rello et al, 1993; Zavascki et al, 2010). 
The spread of multidrug resistance has forced the use of antimicrobial agents that are not 
otherwise preferred as the first or optimal treatment option (Gordon and Wareham, 2010). 
Polymyxin B and E (colistin) for example should be infrequently used due to associated 
renal toxicity (Neonakis et al, 2011). However, these antibiotics have currently been 
resorted to in the absence of new alternative antibiotics (Neonakis et al, 2011). 
Alarmingly, resistance of A. baumannii to colistin which is considered to be the only 
antibacterial agent effective against M D R A. baumannii strains has also emerged 
(Fernandez-Reyes et al, 2009; Gales et al, 2006; Ko et al, 2007; Nation and L i , 2009; 
Souli et al, 2008). In addition, the emergence of non-susceptible A. baumannii isolates 
has compromised the use of carbapenems, which used to be the usual antibiotics of choice 
for this organism's infections (Bassetti et al, 2008; Maragakis and Perl, 2008; McDonald, 
2006; Vila and Pachon, 2008). 
The major mechanisms of resistance identified in A. baumannii include the production of 
the naturally occurring P-lactamase enzymes (chromosomal AmpC cephalosporinase and 
intrinsic oxacillinase OXA-51-like cluster) (Alsultan et al, 2009; Heritier et al, 2005; 
Koh et al, 2007; Peleg et al, 2008). AmpC cephalosporinases hydrolyse amino-
penicillins and cephalosporins but not ceftazidime when the associated gene is expressed 
at a basal level. Nevertheless, resistance to ceftazidime develops when a strong 
transcriptional promoter (the insertion element; ISAbal) is present upstream of the blaampC 
gene to modulate its expression (Corvee et al, 2003; Heritier et al, 2006; Segal et al, 
2004). In addition, the intrinsic oxacillinase enzymes strongly hydrolyse carbapenems 
under the overexpression of the bla0xA-5i-\ike gene containing the ISAbal element (Turton 
et al, 2006). 
As well as the intrinsic P-lactamases, A. baumannii may acquire clavulanic acid-inhibited 
class A P-lactamases (extended-spectrum P-lactamases; ESBLs), which can cause 
resistance to broad-spectrum cephalosporins (Bergogne-Berezin, 2010; Gordon and 
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Wareham, 2010). These enzymes include the C T X - M , GES, PER, SCO, SHV, T E M , and 
V E B families (Gordon and Wareham, 2010). A. baumannii may also acquire P-lactamases 
belonging to the class B (metallo-P-lactamases; MBLs) , or to the class D (oxacillinases) 
(Poirel and Nordmann, 2006). M B L s are active against all carbapenems and P-lactams, 
excluding aztreonam, while some oxacillinases (carbapenem-hydrolysing oxacillinases; 
CHDLs) may not always be effective on meropenem (Gordon and Wareham, 2010; Poirel 
and Nordmann, 2006). The production of oxacillinases is the commonest enzymatic 
mechanism of carbapenem resistance (Gordon and Wareham, 2010). These enzymes are 
particularly encoded by genes of the blaOXA-23, blaOXA-4o and &/a0xA-58-like lineage (Poirel 
and Nordmann, 2006). Resistance to penicillins can also be conferred by these 
oxacillinase enzymes (Heritier et al, 2005). Aminoglycoside resistance is found to be 
caused by aminoglycoside modifying enzymes (phosphotransferases, 
nucleotidyltransferases, and acetyltransferases) in A. baumannii (Seward et al., 1998). 
Other enzymes such as 16S rRNA methyltransferases also confer high resistance to this 
class of drugs (Doi et al, 2007; Y u et al, 2007). 
The intrinsic antimicrobial resistance of A. baumannii may be caused partly by the 
presence of relatively few porins in its outer membrane compared to other Gram-negative 
bacteria (Sato and Nakae, 1991). The lack of outer membrane proteins (OMPs), which 
perform as porins for the transport of substances across the outer membrane, decreases the 
permeability of the membrane and may accordingly enhance antimicrobial resistance. 0-
lactam resistance has been frequently associated with the absence of a 29 kDa protein, a 
33-36 kDa protein, and a 43 kDa protein from A. baumannii (del Mar Tomas et al, 2005; 
Dupont et al, 2005; Siroy et al). In addition, the colistin-resistant A. baumannii A T C C 
19606T has been found to down-regulate proteins such as OmpA in the presence of this 
antibiotic (Fernandez-Reyes et al, 2009). 
Removal of antimicrobial agents by active multidrug efflux systems represents a 
substantial contribution to antibiotic resistance (Gordon and Wareham, 2010). Narrow-
spectrum pumps of the major facilitator superfamily (MFS) are, for example, implicated 
in minocycline (TetB), tetracycline (TetA, TetE), and chloramphenicol (CmlA) resistance 
(Fournier et al, 2006; Huys et al, 2005). The resistance-nodulation-cell division (RND) 
type of pumps, namely AdeABC and AdelJK, has broad substrate specificity and has been 
identified in A. baumannii. The overexpression of AdeABC results in resistance to 
tetracyclines, erythromycin, chloramphenicol, P-lactams, and aminoglycosides (Marchand 
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et al, 2004). The AdelJK pump contributes with AdeABC to tigecycline resistance 
(Damier-Piolle et al, 2008). The overexpression of another efflux pump (AbeM), which 
belongs to the multidrug and toxic compound extrusion (MATE) family of transporters, 
has also been implicated in the resistance of A. baumannii to trimethoprim, 
chloramphenicol, erythromycin, kanamycin, gentamicin, and quinolones (Su et al, 2005). 
In addition, a M D R family of bacterial integral membrane proteins (BIMP) comprising an 
AbeS efflux system contributes to chloramphenicol, macrolides, and quinolones resistance 
(Srinivasan et al, 2009). Identified resistance against polymyxins in A. baumannii 
involves mutations in a two-component regulator (PmrAlB), which modifies lipid A in the 
lipopolysaccharide membrane (Adams et al, 2009). Mutations in D N A gyrase and 
topoisomerase IV have accounted for fluoroquinolone resistance (Vila et al, 1997). The 
production of a putative dihydrofolate reductase (DHFR) and a ribosomal protection 
protein, encoded by TetM, confer resistance to trimethoprim and tetracycline respectively 
(Mak et al, 2009; Ribera et al, 2003). P-lactam resistance due to downregulation of 
penicillin-binding proteins (PBPs) is another characterized mechanism for the antibiotic 
resistance of A. baumanii (Fernandez-Cuenca et al, 2003). Generally, several resistance 
mechanisms may exist in M D R isolates and act against the same class of antibiotics which 
can represent a difficulty in selecting suitable therapeutic agents (Gordon and Wareham, 
2010). 
2.5.2 Autoinducer molecules 
Most bacteria possess a major regulatory system that involves the production and response 
to signal molecules as a means of intercellular communication (Camilli and Bassler, 
2006). Gene expression, in such systems, is dependent on cell density and so it is known 
as quorum sensing. Depending on population density, small diffusible molecules such as 
N-acylhomoserine lactones (N-AHL/AHL) self-generate and consequently induce the 
expression of genes (Bassler, 2002; Fuqua et al, 1994). Several virulence genes, for 
example those responsible for toxin production, surface adhesion, and motility, are 
controlled by A H L s in Gram-negative pathogens (Antunes et al, 2010; Bosgelmez-Tinaz 
et al, 2005). This regulatory mechanism may also contribute to the auto-induction of 
several virulence traits in Acinetobacter. However, information regarding the quorum 
sensing signals modulating the physiology of Acinetobacter and its pathogenesis in 
humans is limited. 
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Both environmental and clinical Acinetobacter spp. isolates are able to produce one to five 
quorum sensing molecules for the activation of A H L biosensors (Bosgelmez-Tinaz et al, 
2005; Gonzalez et al, 2009; Gonzalez et al, 2001; Niu et al, 2008; Vallenet et al, 2008). 
Cell density-mediated communication has been found to control the surface twitching 
motility (Clemmer et al, 2011) and biofilm development of A. baumannii (Antunes et al, 
2011a; Gaddy and Actis, 2009b; Niu et al., 2008; Sarkar and Chakraborty, 2008). Sarkar 
and Chakraborty (2008) showed that inhibition of quorum sensing results in significant 
inhibition of cell growth and biofilm formation of A. junii strain BB1A. The quorum 
sensing pathway is mediated by the abal autoinducer synthase, which encodes for the 
A H L molecule, and is anticipated to be the only autoinducer synthase encoded by A. 
baumannii (Niu et al, 2008). The deletion mutation of this gene impairs the production of 
detectable A H L signals and consequently biofilm formation by A. baumannii strain M2. 
This is in agreement with the study by Gaddy and Actis (2009b), where inactivation of 
abal caused the biofilm of A. baumannii M 2 strain to be reduced by 30- 40% in 
comparison to the isogenic parental strain. Biofilm maturation was restored when the 
A H L was exogenously added to the abal mutant (Gaddy and Actis, 2009b). Antunes et al. 
(2011a) specified that this gene is required for biofilm maturation during the later stages 
of the development since there were no differences between the biofilm of the abaL.Km 
mutant and the wild type at 8h of development while variations were apparent after 16 and 
24 h. 
2.5.3 Capsule formation 
Although exopolysaccharide has generally been recognised as an important virulence 
factor in Gram-negative bacteria (Russo et al, 2010), little is known about its contribution 
to the pathogenesis of Acinetobacter. Vidal et al. (1996) noticed an amorphous matrix, 
surrounding A. baumaniii cells adhering to a glass coverslip, which resembled the 
exopolysaccharide exhibited by other biofilm-forming bacteria. Although adherence of 
clinical isolates of A. baumannii to rat bladder and tracheal tissues was observed to be 
independent of the exopolysaccharide (Ruiz et al, 1998; Sepulveda et al, 1998), the K l 
capsule is required for the survival of A. baumannii strain AB307-0294 in human serum 
and also for its optimal growth in human ascites fluid (Russo et al, 2010). Both the 
human serum and ascites fluid contain complement, which acts as a major defense 
mechanism against bacterial pathogens. The presence of the capsule prevents the 
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complement from accessing the bacterial cell wall and blocks the induction of the 
alternate complement activation pathway (Bergogne-Berezin et al, 2010). In addition, 
the capsule has been shown to be necessary for the existence of A. baumannii in a rat soft 
tissue infection model where the complete clearance of the capsule-negative mutants was 
a strong indication of the capsule's involvment in the protection of this organism (Russo 
et al, 2010). 
2.5.4 Extracellular enzymes 
Acinetobacter produces a range of extracellular enzymes that are believed to contribute to 
the virulence of the bacterium. The urease enzyme has been shown to assist A. Iwoffii 
strains in the colonization of the achlorhydric or hypochlohydric stomach and induce 
inflammation as a result (Rathinavelu et al, 2003). The ability to also cause damage to 
tissue lipids has been associated with the activity of esterases that hydrolyses the short-
chain fatty acids at the ester bond (Poh and Loh, 1985). Antunes et al (2011a) identified 
the presence of several haemoly sin-related genes and two phospholipase C genes in four 
A. baumannii strains whose genomes have been sequenced (SDF, A T C C 17978, ACICU, 
and A Y E ) . The P-haemolytic activity of these strains was demonstrated on 5.0% horse 
blood agar plates but not when sheep erythrocytes were used. The production of the 
enzyme phospholipase C, which has been reported to enhance the toxicity of A. 
baumannii to epithelial cells (Camarena et al, 2010), was also identified in all of the 
above mentioned strains (Antunes et al, 2011a). Another phospholipase enzyme 
(phospholipase D) has also been found to be important for the invasion of epithelial cells, 
and the pathogenesis of A. baumannii in a murine model of pneumonia, as well as 
resistance to 40% human serum (Jacobs et al, 2010). 
2.5.5 Fimbriae/Pili 
To establish an infection, bacteria have to first establish themselves by adhering to the 
mucosal surface of the host. This generally involves the interaction between bacterial 
surface structures called adhesins such as fimbriae or pili, and the surface of the host cell 
namely the complementary receptors. Sepulveda et al. (1998) identified fimbrial 
structures in A. baumannii strains which were able to adhere to rat bladder tissue. Thin 
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fimbrial-like extensions on the surface of A. baumannii that enabled the organism to 
firmly attach to the membrane surface of the human bronchial epithelial cells N C I - H 
(292) have also been observed by scanning electron microscopy (Lee et al, 2006). 
Electron microscopy also revealed the presence of both thick and thin fimbriae assemblies 
in A. calcoaceticus RAG-1 (Rosenberg et al, 1982). Deletion of the acuA gene encoding 
for the main protein involved in the production of the thin fimbriae caused Acinetobacter 
sp. strain BD413 to lose the fimbriae and consequently the attachment to erythrocytes and 
polystyrene (Gohl et al, 2006). 
Acinetobacter lacks flagellar-based motility to migrate and form biofilms. Instead, long 
filaments evenly spread around the cell surface are believed to be needed for the initiation 
and biofilm development on abiotic surfaces. These structures have been suggested to be 
type I pili utilised solely for surface adherence (Tomaras et al, 2003). Tomaras et al 
(2003) demonstrated the pili involvement by identifying an attachment-deficient mutant of 
A. baumannii A T C C 19606 which did not have appendages on the cell surface. A six-
gene operon (csuAIBABCDE), encoding a chaperone-usher system, was shown 
responsible for pili assembly/secretion and subsequent biofilm formation on plastic 
surfaces (Tomaras et al, 2003). This was subsequently confirmed where all the genes 
required for a csuAIBABCDE chaperone-usher pili assembly system were detected in A. 
baumannii A T C C 19606 as well as eight other clinical isolates forming biofilms on 
plastic (McQueary and Actis, 2011). Comparative genomic analysis of A. baumannii 
strains 17978 and A Y E showed the existence of operons similar to that described in the 
19606 type strain (Gaddy and Actis, 2009a; Smith et al, 2007; Vallenet et al, 2008). In 
addition, these two strains harbor three additional loci coding for secretion functions, 
which were possibly related to the assembly of pili and adhesion (Smith et al, 2007; 
Vallenet et al, 2008). Another study showed that the A. baumannii A C I C U strain also 
contains a locus coding for a putative chaperone-usher secretion system, but with a 
different number of genes. Their order appeared to differ from that identified in the 
19606 strain (Iacono et al, 2008). In comparison to the above strains, similar csu loci 
were absent from the genome of A. baumannii SDF and Acinetobacter baylyi ADP1 
(Vallenet et al, 2008). 
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2.5.6 Lipopolysaccharides (LPSs) 
The hydrophobic anchor domain (Lipid A) forming the core oligosaccharide structure of 
LPS, in the outer membrane of Gram-negative bacteria, is generally regarded as the most 
inflammatory/toxic part of LPS (Luke et al, 2010). In some cases of A. baumannii 
infections, severe systemic inflammatory reactions can be triggered and result in 
symptoms such as systemic inflammatory response syndrome (SIRS) and septic shock 
(Aguirre-Avalos et al, 2010; Asati et al, 2011; Leung et al, 2006). It has been proposed 
that LPS (endotoxin) might be associated with the exaggerated host response and 
consequently the fulminant course of a disease (Leung et al, 2006). Erridge et al (2007) 
concluded that endotoxins derived from one clinical isolate of Acinetobacter gensp. 9 and 
five of A. baumannii were highly potent in stimulating the innate immune response in 
human monocytic cells through TLR2 and TLR4 inflammatory signalling which may 
correlate with the pathology of Acinetobacter infections. 
In addition to the initiation of over-inflammatory reactions, LPS has been shown to be 
involved in the resistance of Acinetobacter to the lytic impact of complement in human 
serum. According to Garcia et al (2000), 9 of 16 clinical A. baumannii isolates showing 
resistance to normal human serum were rendered susceptible to serum when the 
production of LPS was reduced by prior ethylene diamine tetraacetic acid (EDTA) 
treatment. Protection against normal human serum has been critically associated with the 
expression of full-length LPS on the surface of A. baumannii 307-0294 in vitro (Luke et 
al, 2010). In addition, its contribution to the organism's survival in a rat soft tissue 
infection model in vivo was recognized by mutagenesis (Luke et al, 2010). The gene 
encoding for the glycosyltransferase involved in LPS core biosynthesis in A. baumannii is 
believed to be highly conserved among clinical isolates (Luke et al, 2010). 
2.5.7 Outer membrane protein A (OmpA) 
OmpA is believed to be the most abundant protein on the cell surface of A. baumannii and 
the most potent cytotoxic molecule in this bacterium (Jin et al, 2011). It does not only act 
as a major transmembrane porin facilitating the transport or permeability of small 
molecules such as antibiotics across the membrane but also plays a multi-factorial role in 
the pathogenesis of this organism (Jyothisri et al, 1999; Lee et al, 2007a; Vashist and 
23 
Chapter 2. Overview on Acinetobacter spp. 
Rajeswari, 2006). It is essential for the adherence of A. baumannii A T C C 19606T to 
human alveolar epithelial cells (A549) and Candida albicans filaments (Gaddy et al, 
2009b). It is also believed to be a major contributor to the invasion of epithelial cells 
according to the significantly less invasion (95.0%) observed with the OmpA-mutant as 
opposed to wild-type bacteria (Choi et al, 2008c). Gaddy et al. (2009b) on the other hand 
suggested that OmpA is not essential for the attachment of Acinetobacter to abiotic 
surfaces and partially contributes to the development of robust biofilms on plastic. 
Analysis of electron microscopy images following OmpA inactivation showed clear 
alterations of the A. baumannii 19606 cell wall, possibly due to the destabilization of the 
outer membrane. According to Gaddy et al. (2009b), the exact role played by this surface 
protein in the attachment and biofilm formation on abiotic surfaces is, however, unclear. 
In addition to its major role in the direct binding of A. baumannii to the host epithelial 
cells, OmpA also imposes cytotoxic effects on these targeted cells. Induction of host cell 
apoptosis has been shown to be OmpA-dependent where its deletion mutant lacked the 
ability to cause the same impact (Jin et al., 2011). According to Jin et al. (2011), the 
induction of host cell death by OmpA is mediated by the delivery of this protein via outer 
membrane vesicles (OMVs) to host cells. The mechanism of the OmpA-mediated 
apoptosis in the early stage of A. baumannii A T C C 19606 infection can be initiated 
through entering the mitochondria and nuclei of the invaded cells (Choi et al, 2008b; 
Choi et al, 2005). Localisation of the OmpA (Omp 38) in the mitochondria of human 
laryngeal cells (HEp-2) leads to mitochondrial disintegration, which subsequently induces 
the release of the apoptosis inducing factor (AIF) and cytochrome c. The release of these 
proapoptotic molecules mediates AIF-dependent and caspase-dependent apoptosis. The 
caspase cascades and the translocation of apoptosis-inducing factors to the nuclei 
eventually result in host cell death (Choi et al, 2005). Besides the effect of OmpA on the 
viability of the host cells through mitochondrial targeting, cell death can occur through 
nuclear damage (Choi et al, 2008b). In vitro, this surface protein was found to directly 
bind to eukaryotic cells, translocate to the nuclei, and consequently induce their death 
mediated by the carried monopartite nuclear localization signal (NLS). The N L S 
sequences are believed to be conserved in the Omp As of the Acb complex (Choi et al, 
2008b). Recombinant OmpA (rOmpA), secreted in vitro, displayed a DNAse I-like 
enzymatic activity that degrades chromosomal D N A when translocated into the nuclei of 
host cells (Choi et al, 2008a). In vivo, embryonic death of the frog Xenopus laevis, due to 
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inability to develop normal embryogenesis, was seen following the injection of the 
nucleus of frog embryos with this surface protein (Choi et al, 2008a). The disruption of 
the mucosal lining as a consequence of the death of the epithelial cells may ultimately 
allow the access of the bacterium or its products to the deep tissues (Choi et al, 2005). A 
study conducted by Choi et al. (2008c) showed that the wild type A. baumannii A T C C 
19606T strain produced severe lung pathology in a murine pneumonia model and was 
capable of disseminating into the bloodstream in a high bacterial load, which was rarely 
detected with the OmpA-deficient mutant. 
One of the common diseases caused by A. baumannii is bacteraemia. A key part of the 
innate immune defense against such pathogens in the blood is known to be the 
complement system (Kim et al, 2009). OmpA has been shown to be important in 
enabling A. baumannii to evade the direct complement-mediated killing. A. baumannii 
isolates obtained from bacteraemic patients appeared to be resistant to 40% normal human 
sera (NHS) (Kim et al, 2009). Their mechanism of evading the complement-mediated 
killing (lysis) was through the surface acquisition of factor H (FH), necessary for the 
activation of this defense pathway. Factor H interacted with the OmpA (Omp 38) as well 
as those with molecular sizes of 32, and 24 kDa. OmpA proved particularly important in 
acquiring the complement regulator F H as shown by the high sensitivity of the OmpA-
negative mutant to NHS compared to the wild type strain (Kim et al, 2009). Furthermore, 
OmpA can induce apoptosis and necrosis of dendritic cells (DCs) by targeting the 
mitochondria and consequently triggering the production of reactive oxygen species 
(ROS) (Lee et al, 2010). The death of these cells may impair T cell biology and hence 
affect adaptive immune responses against A baumannii (Lee et al, 2010). 
2.5.8 Siderophores 
Secretion of the high affinity iron-chelators (siderophores) and their specific cell surface 
receptor (iron regulated outer membrane proteins; IROMPs), provide bacterial pathogens 
with chelated iron essential for their living in otherwise iron-limited conditions such as 
those within the host during the infection process. They are hence considered as major 
virulence factors in the pathogenicity of organisms (Eijkelkamp et al, 2011). Infections 
caused by Acinetobacter are indicative of the existence of mechanisms of acquiring iron 
from their environment. Septicemic patients, due to A. calcoaceticus, were found to have 
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a specific antibody response to IROMPs in their convalescent sera (Smith and Alpar, 
1991). Several studies have also reported the production of siderophores in A. 
calcoaceticus (Nudel et al, 2001; Smith and Alpar, 1991; Smith et al, 1990) and A. 
haemolyticus A T C C 17906 (Okujo et al, 1994). Likewise, A. baumannii strains have the 
ability to survive and grow under iron-deficient conditions by secreting siderophores, 
which may in turn enhance their chances of colonizing the human host (Actis et al, 1993; 
Echemque et al, 1992; Eijkelkamp et al, 2011; Goel and Kapil, 2001; Goel et al, 1998). 
So far, three gene clusters for siderophore biosynthesis have been identified in A. 
baumannii. The first siderophore characterized was in A. baumannii A T C C 19606T and 
was named acinetobactin (Yamamoto et al, 1994). A. baumannii A T C C 19606T and four 
of twelve other strains from the same species were found to produce this novel 
siderophore comprising both the hydroxamate and catechol functional groups (Yamamoto 
et al, 1994). The biosynthesis and transport of the acinetobactin is believed to be 
associated with a cluster of 18 genes found in this organism (Mihara et al, 2004). Iron 
acquisition proteins with siderophore receptors were expressed in the outer membrane of 
A. baumannii A T C C 19606T when cultured under iron-chelated conditions (Nwugo et al, 
2011). Some of these proteins differ from the acinetobactin receptor protein indicating the 
presence of different siderophore utilization pathways in addition to the acinetobactin-
mediated system as a means of acquiring iron. The acinetobactin gene cluster has been 
found in all the currently sequenced A. baumannii strains, namely AB307-294, AB0057, 
A Y E , ACICU, and A T C C 17978 but not in the non-clinical SDF isolate (Adams et al, 
2008; Antunes et al, 201 lb; Iacono et al, 2008; Smith et al, 2007; Vallenet et al, 2008). 
The non-human isolate SDF was found to have significantly lower capacity to resist iron 
starvation than the clinical A. baumannii isolates (Antunes et al, 201 la). In addition, SDF 
was the only strain not to show an iron-chelating activity when grown in an iron-depleted 
environment as opposed to all the clinical isolates (Antunes et al, 201 la). Recent genome 
analysis of A. baumannii SDF, A Y E , A T C C 17978, ACICU, A T C C 19606T, as well as 
another 50 genotypically diverse clinical isolates of the same species have revealed the 
coding potential for the utilization/expression of two siderophores other than the 
siderophore acinetobactin (Antunes et al, 2011a), which support previous reports 
suggesting the production of more than one siderophore by this species (Dorsey et al, 
2003; Dorsey et al, 2004; Mihara et al, 2004; Zimbler et al, 2009). The two 
siderophores include one conserved in all A. baumannii strains currently sequenced apart 
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from the A. baumannii SDF, as well as another siderophore found only in A T C C 17978 
(Antunes et al, 2011b) and whose cluster has previously been identified (Zimbler et al., 
2009). This is in agreement with another study indicating that iron-uptake systems found 
in A. baumannii can vary between different clinical isolates (Dorsey et al., 2003). The fact 
that several iron-uptake systems are widely distributed among diverse A. baumannii 
clinical isolates underline the importance of these systems and their potential role in the 
pathogenicity of this bacterium. 
2.6 Acinetobacter infections and risk factors 
The various virulence factors described above offer some explanation to the clinical 
relevance of Acinetobacter in response to hospitals reports, which have named the 
organism as the cause of a wide spectrum of hospital-acquired infections such as 
endocarditis, Keratitis or dophthalmitis, meningitis, skin and wound infections, urinary 
tract infections, nosocomial and community-acquired pneumonia, and blood stream 
infections (Garnacho-Montero et al., 2005; Gaynes and Edwards, 2005; Levy et al, 2005; 
Metan et al, 2007; Rizos et al, 2007; Wisphnghoff et al, 2004). Those caused by A. 
baumannii represent about 10% of all nosocomial infections (Dijkshoorn et al, 2007; 
Joly-Guillou, 2005; Peleg et al, 2008). According to the voluntary surveillance scheme 
adopted by the Health Protection Agency (2011), the total number oi Acinetobacter spp. 
bacteraemia reports, in England, Wales, and Northern Ireland, was 1139 in 2006 and 779 
in 2010. The attributable mortality rate of Acinetobacter blood stream infections is 
reported to be 7.8% (Blot et al, 2003), while Lee et al. (2007b) described a higher 
percentage (21.8%) associated with M D R A. baumannii. With respect to A. baumannii 
overall infections, a systematic review of cohort and matched case-control studies 
revealed that attributable mortalities ranged from 10% to 43% in intensive care units 
(Falagas et al, 2006). 
According to Fournier and Richet (2006), the majority of Acinetobacter infections occur 
in critically-ill patients treated in ICUs. Infections associated with this organism in these 
settings are mostly severe and septic shock can be incurred as a result (Taccone et al, 
2006). The risk of mortality to these patients has been shown to be 4-fold greater than 
uninfected patients (Garcia-Garmendia et al, 2001). They are particularly vulnerable as 
they are likely to be immunocompromised due to advanced age, prolonged stays in 
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intensive care units, prior antibiotic therapy, need for mechanical ventilation or invasive 
devices, severe underlying diseases, surgery or arterial and venous annulations, or cord 
blood transplantation (Bergogne-Berezin and Towner, 1996; Jung et al, 2010; Saavedra et 
al., 2002; Torres et al., 1990). Risk factors predisposing Acinetobacter infections also 
include low birth weight (< 2500g), as defined by the World Health Organization (World 
Health Organization W H O , 2011), and prematurity (gestation age < 37 week). According 
to the national statistics on births in England and Wales, the number of live births in 2009 
was 706,248; of those 7.2% had a low birthweight (< 2,500 grams) and 1.2% had a very 
low birthweight (< 1,500 grams) (Office for National Statistics, 2009). 
Acinetobacter is known to be one of the organisms that cause severe infections in neonatal 
intensive care units (NICUs). Outbreaks of pneumonia, skin infections, urine infections, 
bacteraemia, septicaemia, and meningitis, due to this bacterium, have been reported 
worldwide (Anyebuno and Newman, 1995; Bernards et al, 1997; Chan et al, 2007; de 
Beaufort et al, 1999; Horrevorts et al, 1995; Mader et al, 2010; McDonald et al, 1998; 
Mishra et al, 1998; Morgan and Hart, 1982; Oto et al, 1991; Pillay et al, 1999; Saleem 
et al, 2010; Schloesser et al, 1990; Siegman-Igra et al, 1993; Simmonds et al, 2009; 
Touati et al, 2009; Vivanco and Figueroa, 1991; von Dolinger de Brito et al, 2005). In 
these reports, outbreaks of blood stream infections have been described to last from 1 day 
to 30 months, involving up to 53 neonates in a single outbreak. Although A. baumannii 
has been isolated, the causative agents were not limited to this species and included A. 
calcoaceticus, A. junii, A. ursingii, Acinetobacter gensp. 14, Acinetobacter gensp. 3, as 
well as Acinetobacter whose species identities were not specified. Of note is that some of 
the isolates obtained showed multidrug-resistance (Pillay et al, 1999; Simmonds et al, 
2009; von Dolinger de Brito et al, 2005). While successful treatment was achieved with 
some cases, others failed. A retrospective investigation recorded 47% crude mortality of 
neonatal Acinetobacter sp. infections during a five-year period (Saleem et al, 2010). 
Seventy percent of the neonates died within 4 days of obtaining positive Acinetobacter 
cultures. Furthermore, Pillay et al. (1999) described 22%) attributable mortality during a 
16-day outbreak of M D R Acinetobacter spp. infections in 9 pre-term neonates. These 
neonates were presented with clinical symptoms of sepsis, pneumonia, disseminated 
intravascular coagulopathy, and abdominal distension. Contaminated catheters and suction 
bottles were presumed to be the source of the outbreak. Mishra et al. (1998) 
retrospectively described an outbreak that occurred over five months and involved 53 
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septicemia cases including full-term neonates. Three neonates had meningitis 
complications while five experienced necrotising enterocolitis. Bleeding manifestations 
were observed in six additional cases. The overall mortality was 13.9%. 
Neonates in ICUs often require supporting medical devices and antibiotic treatment 
(Westerbeek et al, 2006). The intensive care treatment combined with their immature 
immune system may render them highly vulnerable for colonisation and possibly 
subsequent infections when exposed to opportunistic organisms such as Acinetobacter. 
This could be particularly alarming considering that common antibiotics may not be 
effective against the M D R strains. The exposure of these neonates to this bacterium is 
often through the respiratory route, or skin at the insertion site of an intravenous line, 
catheter, or surgery. Another possible risk of acquiring Acinetobacter is through ingestion. 
Although it has not been highlighted before, the potential risks of this exposure deserves a 
great deal of understanding and assessment. These may not only be local gastrointestinal 
infections but also systematic infections where other organs and tissue might be involved 
especially i f the bacterium has the potential ability to translocate from the immature 
gastrointestinal system of the neonate. In their meeting in 2006, F A O - W H O called for 
research on sources and vehicles, including PIF, of infections by organisms of concern to 
neonatal health and among them was Acinetobacter. In response to this call, the aim 
defined in the next section was set for this project. 
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AIMS & OBJECTIVES 
The overall aim of this research project was to characterise the risk factors of neonatal 
exposure to Acinetobacter spp. through the administration of infant formula via the 
nasogastric tract. This was achieved according to the following objectives: 
1- Develop a new chromogenic-selective Acinetobacter medium. 
2- Screen powdered infant formula for Acinetobacter contamination using the developed 
medium and other selective media. 
3- Examine the long-term persistence of Acinetobacter desiccated in infant formula. 
4- Investigate biofilm formation of Acinetobacter inside enteral (nasogastric) feeding 
tubes using practices similar to those applied in the healthcare and inspect the 
contamination magnitude of subsequent fresh enteral feeds. 
5- Examine the effect of different physiological elements of the gastrointestinal system on 
the viability of Acinetobacter. 
6- Characterise the pathogenicity of Acinetobacter and its attributes. 
7- Screen for selected virulence genes in Acinetobacter. 
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3.1 INTRODUCTION 
Although Acinetobacter has previously been isolated from dehydrated infant formula 
(Cawthorn et al, 2008; Chap et al, 2009; Miled et al, 2010), its prevalence in PIF has not 
been examined before. The U.S. Food and Drug Administration (Food and Drug 
Administration FDA) method, adopted in 2002 for screening PIF, was designed to detect 
of Cronobacter sakazakii and is not specific to Acinetobacter. The method principally 
involved the resuscitation of the sub-lethally injured bacteria followed by an enrichment 
stage, the detection on agar media, and eventually biochemical testing. In this mixed 
culture environment of the PIF, the predominant microflora may outgrow the minorities 
that are present in smaller numbers during the resuscitation and enrichment steps. This 
may consequently decrease the chances of picking the fewer colonies recovered on the 
agar plates leading to a false negative result. Therefore, the detection of Acinetobacter 
whether in PIF, in the manufacturing, or clinical setting, from mixed microbial 
populations requires an isolation method which is both specific and sensitive. 
Selective/differential media in this respect are of great use as they offer additional 
simplicity, specificity and quick identification over the solely selective media. 
A differential/selective medium for the isolation of Acinetobacter was first described by 
Mandel et al. (1964). The medium consisted of soy peptone, lactose, pancreatic digest of 
casein, bile salts, sodium chloride, maltose, agar, and bromocresol purple as a pH 
indicator. In (1983), Holton modified Mandel's medium by substituting desiccated ox bile 
for bile salts. Acinetobacter spp. were distinguished by their pink colonies with mauve 
background on both Mandel and Holton's media. Two years later, MacFaddin (1985) 
replaced the maltose in Mandel's agar with sucrose, and removed the bromocresol purple 
and lactose. In addition, mannitol, fructose, phenol red, and phenylalanine were added. 
Cefsulodin, ampicillin, and vancomycin were also incorporated into the medium as the 
antibacterial agents. Colonies with pale lavender colour and yellow background were 
regarded as potential Acinetobacter. This medium was named Herellea agar (MacFaddin, 
1985). Another selective Acinetobacter medium was designed by Flint in (1993) and was 
based on the addition of di-ammonuim hydrogen orthophosphate as an inorganic source of 
nitrogen, and ethanol as a carbon source. The selective agents were ethanol, bile salts, 
cycloheximide and tetracycline. A differential selective medium, similar to that of Holton, 
was then developed and known as Leeds Acinetobacter medium (LAM) (Jawad et al, 
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1994). L A M contained agar, neutralized soy peptone, acid casein hydrolysate, sodium 
chloride, sucrose, D-(-)-fructose, L-phenyalanine, D-mannitol, and ferric ammonium 
citrate. Instead of inhibitory bile salts, three antibiotics (cefsoludin, vancomycin, and 
cephradine) were included. The differential indicator was phenol red which changes to 
mauve when the pink Acinetobacter colonies grow and produce highly alkaline end-
products. According to Jawad, et al. (1994), L A M was more selective than Herellea and 
Holton's agar media that were either poorly selective or too inhibitory. 
The most recent medium available for the detection of Acinetobacter spp. is CHROMagar 
Acinetobacter . It is also the first chromogenic medium, specific for this organism, on the 
market. It is designed to permit the growth and the differentiation of Acinetobacter spp. 
from other Gram-negative bacteria (CHROMagar Microbiology, 2008). Some 
Enterobacteriaceae may grow and produce blue to metallic blue colonies while some other 
non-fermenters such as Stenotrophomonas spp. and Pseudomonas spp. appear red 
pigmented similar to Acinetobacter. The medium contains mineral salts, yeast extract and 
peptone, as well as a non-specified chromogen. A liquid supplement containing growth 
and regulation factors is also added. The components of this supplement have not been 
reported. Another different selective mixture can also be added i f M D R - A baumannii is 
the target strain (CHROMagar Microbiology, 2008). 
With chromogenic media, the detection and differentiation of organisms is based on the 
presence of characteristic enzyme activities shown by these organisms (Manafi, 1996, & 
2000; Manafi and Kneifel, 1990; Manafi and Kremsmaier, 2001; Orenga et al, 2009). 
Principally, synthetic enzymatic substrates are incorporated into the media and the 
hydrolysis of these substrates by specific enzymes results in color changes of the bacterial 
colonies that are positive for this activity. 5-bromo-4-chloro-3-indolyl-b-D-ribofuranoside 
(x-riboside) is a novel chromogenic substrate synthesized for the differentiation and 
identification of Gram-negative bacteria and evaluated by Butterworth et al. (2004). 
Hydrolysis of this substrate in air, by the P-ribosidase enzyme, results in blue-green 
complexes that are intense and do not diffuse in the medium. Another novel chromogen 
named DHF-riboside (3',4'-dihydroxyflavone-4'-P-D-ribofuranoside) can also be used for 
the detection of P-ribosidase through the formation of black colonies. 
Based on the application of chromogens (Butterworth et al, 2004) and also on antibiotic 
sensitivity testing, a chromogenic-selective Acinetobacter medium named Druggan-
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Dimmer Agar (DDA) was developed in collaboration with Dr Patrick Druggan (Oxoid 
Thermofisher, UK). It was aimed primarily for investigating the prevalence of 
Acinetobacter spp. in PIF especially with the limited choice of specialised agar for this 
organism. However, it could be potentially applied for clinical and environmental 
sampling for a robust and quick presumptive identification of the bacterium. A modified 
enrichment broth was also designed to encourage the recovery and growth of 
Acinetobacter spp. during the survey of 63 PIF products collected from 17 different 
countries. Isolates were cultured on both the D D A and L A M media for comparison. These 
agar media were also characterized and compared to the new CFIROMagar Acinetobacter 
medium, which had not been introduced to the market prior to the survey starting. 
34 
Chapter 3. Detection of Acinetobacter in PIF Using Differential-Selective Media 
3.2 MATERIALS AND METHODS 
3.2.1 Preparation of the test media 
Description of the media used in this study is detailed in Chapter 1. 
3.2.2 Development of the DDA medium 
The final formula of the D D A medium described in Chapter 1 was developed according 
to the following stages: 
Stage 1: Formulation of the basal D D A medium. 
Stage 2: Antibiotic sensitivity testing to choose a selective antimicrobial agent for the 
medium. 
Stage 3: Evaluation of the D D A medium during a survey of 63 PIF products. 
Stage 4: Modification of the D D A medium following further antibiotic sensitivity testing. 
Stage 5: Characterization of the D D A medium in comparison to other Acinetobacter 
media. 
3.2.2.1 Formulation of the basal DDA medium 
The basal D D A medium was designed by Patrick Druggan (Oxoid Thermofisher, UK) and 
consisted of 12g/l tryptone, lg/1 yeast extract, 5g/l soy peptone, 0.15g/l sodium 
deoxycholate, and agar 10g/l. The agar plates were then streaked with thirty-five 
Acinetobacter strains to check their recovery on the medium. 
During preliminary studies, the positive and negative recovery oi Acinetobacter strains on 
the basal D D A medium was examined in the presence of 0.15g/l sodium deoxycholate to 
inhibit Gram-positive bacteria. In order to enhance the growth of some strains, sodium 
chloride (NaCl) was also added at 1 and 5g/l. Before selecting a suitable chromogen, the 
appearance of one Pseudomonas aeruginosa, four Enterobacteriaceae, and sixteen 
Acinetobacter strains on D D A containing X-riboside (O.lg/1), and DHF-riboside (0.4g/l) 
was separately observed. The latter substrate was combined with 0.5g/l ferric ammonium 
citrate. 
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3.2.2.2 Antibiotic susceptibility testing and selectivity of the basal DDA medium 
To select an appropriate selective antibacterial agent for the D D A medium, the antibiotic 
sensitivity of a number ofAcinetobacter and non-Acinetobacter strains, on the basal D D A 
medium, was tested in accordance with the British Society for Antimicrobial 
Chemotherapy guidelines using the agar dilution method (BSAC, 2001). The antibiotics 
employed and their spectrum of activity are shown in Table 3.1. Antibiotic solutions 
were prepared in the appropriate solvents and stored at -20°C for a maximum of 5 days 
before use. Temocillin was prepared and added to the agar medium on the same day. Once 
the D D A medium was sterilized, it was allowed to cool to 50°C before adding the 
antibiotics. Antibiotic susceptibility tests were performed in duplicate/triplicate. Growth 
on antibiotic-free TSA and D D A media was also included. The surface of the agar plates 
was dried before inoculation. Overnight cultures (150ul) of the test strains in TSB were 
dispensed into a microtitre tray. A replicator was used to inoculate around 2ul of the 
bacterial suspensions onto TSA and D D A plates. The inocula were then allowed to be 
absorbed into the agar before incubation for 24h at 30°C and 37°C, for Acinetobacter and 
the Enterobacteriaceae respectively. Other organisms were also incubated at suitable 
temperatures. The control strain was Escherichia coli N C T C 10418. 
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Table 3.1 List of the antibiotics tested and their spectrum of activity. 
Antibiotic 
Aztreonam 
Cefotaxime 
Cefsulodin 
Ceftazidime 
Ciprofloxacin 
Enoxacin 
Lincomycin 
Lomefloxacin 
Netilmicin 
Norfloxacin 
Pipemidic acid 
Temocillin 
Vancomycin 
Target organisms 
Gram negatives 
Gram-positives and Gram-negatives 
Gram-positives and Gram-negatives 
Gram-positives and Gram-negatives 
Gram-positives and Gram-negatives 
Gram-positives and Gram-negatives 
Gram-positives 
Gram-positives and Gram-negatives 
aerobic Gram-negatives 
Gram-positives and Gram-negatives 
Gram-positives and Gram-negatives 
Gram-positives and Gram-negatives 
Gram-positives 
3.2.2.3 Survey of powdered infant formula 
A total number of 63 PIF products (Table 3.2), aimed at neonates from birth to the age of 
6 months, were collected from 17 different countries, and were screened for 
contamination with Acinetobacter using the procedure described in section 3.2.2.9. 
Briefly, each PIF sample was analysed by reconstituting 25g of the powder in 225ml 
BPW, followed by the enhancement of bacterial growth in an appropriate enrichment 
broth medium. Enriched cultures were then inoculated onto D D A and L A M for a 
comparative assessment. 
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Table 3.2 List of powdered infant formula products screened for the presence ofAcinetobacter 
spp. 
Product number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
56 
57 
58 
59 
60 
61 
62 
63 
PIF product 
N E S T L E N A N 1 
U L K E R H E R O B A B Y 1 
M I L U P A C O N F O R M I L 1 
N U T R I C I A B E B E L A C 1 
S A H H A I N F A N T F O R M U L A 1 
S A H H A P R E M A 1 
S A H H A C O M F O R T 
N E S T L E NIDINA C O N F O R T 1 
P U L E V A PEQUES 1 
H E R O B A B Y INICIA 
H E R O S U N A R 
N U T R I C I A N U T R I L O N 
SNOW B R A N D , STEP 1 
A N M U M I N F A C A R E R U M U S A N B A Y I 
F R I S O L A C 1 GOLD 
D U L A C M A X I - Q I N F A N T F O R M U L A 
N E S T L E L A C T O G E N 1 
N U T R I C I A B E B E L A C I N F A N T F O R M U L A 
E N F A L A C A + I N F A N T F O R M U L A M I L K STEP 1 
D U M E X M A M E X GOLD I N F A N T F O R M U L A STEP 1 
N E S T L E N A N 1 I N F A N T F O R M U L A 
S I M I L A C N E O S U R E I Q 
D U T C H L A D Y I N F A N T F O R M U L A STEP 1 
M Y B O Y E L D O L Z A N 1 
N E S T L E GUIGOZ 1 
B E B E L A C 1 
O R G A N I C I N F A N T F O R M U L A 
NUSEIN G O A T M I L K I N F A N T F O R M U L A 
I N F A N T F O R M U L A CHOICE 
E M E R A L D P R E M I U M 
SCIENCE 1 
G O A T M I L K I N F A N T F O R M U L A 
B A B Y SCIENCE Q T 
P R E M I U M 1 
P R E M I U M 2 
P R E M I U M F O R M U L A X O 
G O A T M I L K B A S E D O R G A N I C I N F A N T F O R M U L A 
E M E R A L D 
M O J U N G 
SU1 
SCIENCE 2 
IQ 
E X T R A SELECTION 
S U 2 
SUPER P R E M I U M 
P R E M I U M 
M I L U P A A P T A M I L 1 P R E M I U M 
N E S T L E N A N 1 H A . P R E M I U M 
N E S T L E NIDINA 1 H A . 
N E O L A T T E 1 
A B B O T T ISOMIL 1 
A B B O T T S I M I L A C ® A D V A N C E 
N E S T L E N A N H A . 1 
P R O M I L GOLD ( F O L L O W - O N F O R M U L A ) 
B E B E L A C 1 
C A L L I I A 1 
N U T R I B E N 
A B B O T T ISOMIL 1 
F R I S O L A C 1 GOLD 
A P T A M I L 1 
M O D I L A C E X P E R T H A 
L A C T U M 1 
Country of manufacture 
Germany 
Germany 
Germany 
Germany 
Jordan 
Jordan 
Jordan 
Germany 
Spain 
Spain 
Czech Republic 
Czech Republic 
Japan 
New Zealand 
Holland 
New Zealand 
Philippines 
New Zealand 
Thailand 
New Zealand 
Holland 
Spain 
Holland 
Holland 
Switzerland 
Holland 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Portugal 
Portugal 
Portugal 
Italy 
Holland 
Ireland 
Switzerland 
Ireland 
Holland 
France 
France 
Holland 
Holland 
Turkey 
France 
Turkey 
The PIF products were designed for neonates from birth to the age of 6 months and were collected from 17 
different countries to investigate the presence ofAcinetobacter. 
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3.2.2.4 Optimization of the enrichment stage prior to the survey of PIF 
In order to evaluate the prevalence of Acinetobacter in PIF, an enrichment broth was 
required. Preliminary experiments were conducted to choose an efficient enrichment broth 
to promote the growth of Acinetobacter present in PIF following their resuscitation stage 
in buffered peptone water (BPW). The growth of Acinetobacter spp. in Enterobacteriaceae 
enrichment (EE) broth, modified M9, and Baumann broth (BB) (Baumann, 1968) was 
evaluated. First, viable counts of overnight cultures in B P W were determined by the Miles 
& Misra method. One millilitre of the overnight cultures was then transferred to the 
enrichment broths before incubation for 18h at 30°C. Next, the plate count (Miles & 
Misra) was performed and the percentage recovery in each broth was then calculated in 
relation to BPW. This procedure was performed once. 
The next step was optimizing the incubation conditions in terms of aeration. To do so, 
overnight cultures of 13 Acinetobacter strains were inoculated (1:10) into the chosen 
enrichment broth (M9), which was then incubated statically and in a rotary shaker (280 
rpm) at 30°C for 18h. Cell counts were subsequently determined by Miles & Misra, and 
the percentage recovery of the strains with/without vigorous aeration was obtained 
comparatively to the viable counts in B P W (conducted once). 
3.2.2.5 Survey procedure 
To ensure aseptic handling of the PIF samples, the surface of weighing boats was 
disinfected with 70% (v/v) ethanol and then dried. A spatula was also flame sterilized and 
allowed to cool before 25g of each sample was added to 225ml of sterile BPW. Samples 
were then incubated overnight at 30°C. The following day, an aliquot (0.1 ml) of these 
reconstituted samples was transferred into 9.9ml of the modified M9 broth in baffled 
flasks, which were next then incubated overnight at 30°C in a rotary shaker at 280 rpm. 
Following the 24h incubation of the M9 broths in a rotary shaker, 0.1ml was streaked on 
D D A and L A M media. The plates were incubated at 30°C for 48h. Growth on the two 
media was then recorded and the colour of colonies noted. Presumptive 
Enterobacteriaceae strains appeared black on D D A plates, whereas presumptive 
Acinetobacter and Gram-positive strains were non-pigmented on this medium 
(Butterworth et al, 2004). A l l the isolates were next subcultured on TSA for 24h at 30°C. 
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Once the isolates from PIF were grown on TSA plates, the morphological appearance was 
observed and compared with control Acinetobacter strains grown on TSA. In addition, 
they were provisionally identified under the microscope using Gram staining. Since 
Acinetobacter can be Gram-variable, all Gram-positive coccobacilli and Gram-negative 
rod shaped isolates were further identified. Additionally, all the Gram-negatives were 
tested for the oxidase reaction. Subsequently, the oxidase-negative isolates were plated on 
V R B G A , which is semi-selective for Enterobacteriaceae. Although the growth of non-
enteric and Gram-positive organisms is normally inhibited due to the presence of bile salts 
and crystal violet, some Acinetobacter strains can form small colonies (2mm in diameter) 
on this medium. Once presumptive Enterobacteriaceae or Acinetobacter spp. were 
identified, API 20E biochemical profiles (bioMerieux Ltd., UK) were used for primary 
identification. The isolates that did not grow on V R B G A were considered as non-enteric. 
Therefore, the appropriate API kit to use was API 20NE for Gram-negative non-
Enterobacteriaceae (oxidase-negative) strains including Acinetobacter spp. For further 
confirmation of the identification, isolates of interest (Gram-negatives including 
Acinetobacter) were sent to Accugenix Inc. (Newark, USA) for partial 16S rDNA gene 
sequencing. 
3.2.2.6 Evaluation and modification of the DDA medium 
The performance of D D A medium, following the addition of 10mg/l lincomycin, was 
evaluated in comparison to L A M during the survey of PIF products. In light of the results, 
the selectivity of the D D A medium was further optimized by increasing the concentration 
of lincomycin to 20mg/l lincomycin and incorporating aztreonam (2mg/l) into the 
medium. 
3.2.2.7 Characterization of DDA and other selective Acinetobacter media 
This part of the study was composed of a comparative assessment of DDA, CHROMagar 
Acinetobacter, and L A M in terms of selectivity, sensitivity, percentage recovery (PR) and 
the detection limit. 
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3.2.2.7.1 Selectivity and sensitivity 
Bacterial cultures were grown in TSB for 18h (stationary phase) at 30 or 37°C, as 
appropriate. Their turbidity was then adjusted to McFarland Standard 0.5 (~ 1.5xl08 
cfu/ml) before being diluted to 105 cfu/ml in sterile saline. Inocula were simple streaked 
onto the three test media and the control (TSA) using a sterile lOul loop. Plates were 
incubated at 37°C for 24h. Based on presence or absence, the selectivity of the media was 
expressed as the percentage of the negative recovery of non-Acinetobacter strains. In 
terms of sensitivity, the percentage of the positive number of Acinetobacter that grew was 
recorded. 
3.2.2.7.2 Percentage recovery (PR) 
Percentage recovery was analysed by performing the Miles and Misra plate count method 
on all media plus TSA. TSA was used as a non-selective control medium. Recoveries 
<50% were deemed a failure for the selective medium. 
PR= Viable count on selective agar X 100 
Viable count on TSA 
3.2.2.7.3 Detection limit 
The detection limit was assessed by the lowest number of Acinetobacter each medium 
could detect. Three Acinetobacter strains (1096, 415, and 418) were grown overnight (18) 
at 37°C in sterile ready-to-feed formula (Cow & Gate 1). The next day, fresh Cow & Gate 
1 was spiked with 1000, 100, 10, 1, 0.1 cfu/ml of Acinetobacter cultures. Using the spread 
plate method, the viable counts were determined by aseptically spreading 0.1ml of the 
spiked ready to feed formula on the test media. The plates were incubated at 37°C for 24h 
before enumeration. 
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3.3 RESULTS 
3.3.1 Formulation of the basal DDA medium 
The basal D D A medium containing tryptone, yeast extract, soy peptone, sodium 
deoxycholate, and agar was initially evaluated for the recovery of thirty-five 
Acinetobacter strains (Table 3.3). The majority (94.3%) of strains were able to grow. 
Exceptions were two type strains; A. radioresistens (ATCC 43998T) and A calcoaceticus 
(NCTC 12983T). However, the removal of sodium deoxycholate, which was originally 
incorporated into the medium to inhibit the growth of Gram-positive bacteria, allowed the 
recovery of the two sensitive strains (Table 3.3). The addition of 2 and 5g/l NaCl into the 
medium did not enhance the growth of these two strains as they remained inhibited (Table 
3.4). Sodium deoxycholate was consequently excluded from the basal medium. 
The colour exhibited by the colonies of Acinetobacter in comparison to other Gram-
negative bacteria was assessed in the presence of the chromogen X-riboside and DHF-
riboside. One P. aeruginosa, four strains from the family Enterobacteriaceae, and 16 
Acinetobacter strains were streaked onto the D D A medium. Any pigmentation was 
recorded and checked with the descriptions reported by Butterworth et al, (2004). 
Colonies of those from the Enterobacteriaceae showed blue-green pigmentation in the 
presence of the X-riboside substrate. Conversely, Acinetobacter and Pseudomonas were 
non-pigmented (Table 3.5). This non-pigmentation was also observed with Acinetobacter 
when DHF-riboside was added. The remaining non-Acinetobacter strains appeared black 
on the medium (Table 3.5). 
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Table 3.3 Positive and negative recovery ofAcinetobacter strains on DDA with and without the 
addition of 0.15g/l sodium deoxycholate. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
Species 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
A. calcoaceticus 
A. calcoaceticus 
A. calcoaceticus 
Acinetobacter gensp. 3 
A. haemolyticus 
A 
A. junii 
. johnsonii 
A. Iwoffii 
A. radioresistens 
A schindleri 
A. ursingii 
Strain 
number 
1095 
1096 
1098 
1099 
1102 
1109 
1110 
1111 
1112 
1113 
1114 
1115 
1116 
1117 
1118 
1119 
1120 
1121 
1122 
1123 
1124 
1125 
1126 
1127 
418 
1097 
1103 
415 
1337 
1335 
1336 
1338 
1340 
1339 
1334 
DDA 
with SD* 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
— 
+++ 
+++ 
+++ 
+++ 
+++ 
— 
+++ 
+++ 
medium 
without SD 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
Sodium deoxycholate (0.15g/l) was originally incorporated into the basal DDA medium to inhibit the growth of 
Gram-positive bacteria. The majority (94.3%) of strains were able to grow in its presence, while 100.0% was 
achieved following its removal. * Sodium deoxycholate, +++ triplicate positive recovery, — triplicate negative 
recovery. 
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Table 3.4 Positive and negative recovery ofAcinetobacter strains on DDA containing 2 and 5g/l 
NaCl. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
Species 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
Acinetobacter gensp. 3 
A. calcoaceticus 
A. calcoaceticus 
A. calcoaceticus 
A. haemolyticus 
A 
A. junii 
. johnsonii 
A. Iwoffii 
A. radioresistens 
A. schindleri 
A. ursingii 
Strain 
number 
1095 
1096 
1098 
1099 
1102 
1109 
1110 
1111 
1112 
1113 
1114 
1115 
1116 
1117 
1118 
1119 
1120 
1121 
1122 
1123 
1124 
1125 
1126 
1127 
415 
418 
1097 
1103 
1337 
1335 
1336 
1338 
1340 
1339 
1334 
DDA(+ 
2g/l 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
— 
+++ 
+++ 
+++ 
+++ 
— 
+++ 
+++ 
NaCl) 
5g/l 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
— 
+++ 
+++ 
+++ 
+++ 
— 
+++ 
+++ 
Sodium chloride (2 and 5g/l) was included in the basal DDA medium (containing sodium deoxycholate) to 
enhance the growth of the sensitive strains. However, these strains remained inhibited. +++ triplicate positive 
recovery, — triplicate negative recovery. 
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Table 3.5 Colony colour of Acinetobacter and other Gram-negative organisms cultured on DDA 
containing X-riboside and DHF-riboside. 
Strain 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. calcoaceticus 
A. calcoaceticus 
A. calcoaceticus 
Acinetobacter gensp. 3 
A. haemolyticus 
A. johnsonii 
A. junii 
A. Iwoffii 
A. radioresistens 
A. schindleri 
A. ursingii 
Enterobacter cloacae 
Escherichia coli 
Klebsiella pneumoniae 
Pseudomonas aeruginosa 
Serratia liquefaciens 
Strain 
number 
1098 
1099 
1102 
1095 
1096 
418 
1097 
1103 
415 
1337 
1336 
1335 
1338 
1340 
1339 
1334 
597 
605 
1013 
1169 
579 
Colony colour 
with X-riboside 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Blue-green 
Blue-green 
Blue-green 
Off-white 
Blue-green 
on DDA medium 
with DHF-riboside 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Off-white 
Black 
Black 
Black 
Black 
Black 
The chromogens X - and DHF-riboside were compared to enable better differentiation of Acinetobacter from 
other Gram-negative bacteria. All Acinetobacter strains exhibited non-pigmented colonies compared to the other 
Gram-negative bacteria in the presence of these substrates. Differentiation between the P. aeruginosa 1169 and 
Acinetobacter strains was achieved with DHF-riboside based on the black pigmentation produced by the former 
organism. 
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3.3.2 Antibiotic sensitivity testing 
Acinetobacter strains were tested for antibiotic sensitivity at concentrations thought to be 
required for minimum inhibition. The antibiotics and the susceptibilty results are 
presented in Table 3.6. In general, all A. baumannii strains tended to have similar 
antibiotic resistance trends which were greater than those of non-A baumannii strains. 
Acinetobacter gensp. 3 (415) was sensitive to 16.7% (2/12) of the antibiotics tested, while 
A. calcoaceticus 418 showed 41.7% (5/12) sensitivity. Similar to the food isolate 418, the 
clinical A. calcoaceticus 1097 was susceptible to the same antibiotics except 0.5mg/l 
Netilmicin. Seventeen of the twenty-four A. baumanii isolates, including the type strain 
(1102), showed resistance to 100.0%) (12/12) of the antibiotics included. The only 
sensitivity shown by the remaining A. baumanii strains (7/25) was to 256mg/l 
vancomycin. The type cultures of A. haemolyticus, A. Iwoffii, and A. schindleri showed 
particular sensitivity and were inhibited by 58.3% (7/12), 75.0% (9/12), and 91.6 % 
(11/12) of the antibiotics respectively (Table 3.6). A. schindleri was the only strain whose 
recovery was affected by the presence of aztreonam (4mg/l) in D D A medium (Table 3.6). 
Antibiotics (aztreonam, ceftazidime, ciprofloxacin, norfloxacin, and temocillin) which 
resulted in a maximum inhibition of 3 Acinetobacter strains and known for their activity 
against Gram-positive bacteria were further tested against a sample of these organisms 
(Table 3.7). Temocillin inhibited 5 of the 6 Gram-positive bacteria while none were 
inhibited by ceftazidime. In contrast, the presence of 0.5mg/l norfloxacin prevented the 
growth of Bacillus cereus, Enterococcus faecalis, and Lactobacillus plantarum which was 
the only Gram-positive strain to be also sensitive to ciprofloxacin (0.05mg/l). Apart from 
the temocillin, none of the antibiotics mentioned above showed high selectivity against 
the examined Gram-positive organisms (Table 3.7). However, due to the unstability of 
temocillin (Dr. Patrick Druggan, personal communication), it was deemed appropriate to 
investigate another choice of antibiotics. Subsequently, a range of lincomycin 
concentrations from 10mg/l to 260mg/l was next tested against 7 Gram-positive strains as 
well as 34 acinetobacters to ensure both high sensitivity and selectivity of the medium 
under development (Table 3.8). At 10mg/l lincomycin, there was a 100%) recovery of the 
34 Acinetobacter strains with a 100% inhibition of the 7 Gram-positive strains. The 
increase of the antibiotic concentration to 20mg/l prevented the growth of A. 
radioresistens. At 60mg/l A. Iwqfii was also unable to grow. Therefore, lincomycin 
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(10mg/l) was incorporated into the preliminary formula of the D D A as the selective agent 
against Gram-positive bacteria. The medium was then evaluated during a survey of PIF 
products for the presence ofAcinetobacter spp. 
The PIF analysis was an opportunity to assess the differentiation characteristics of the 
D D A as a chromogenic medium using not only Gram-negative strains from culture 
collections as described earlier but also natural PIF isolates for an in-use comparison. In 
addition, uninhibited Gram-negative isolates that might be found in PIF could be 
clinically significant and important to report. For these reasons, no antibiotics against the 
non-Acinetobacter Gram-negative organisms were added to the D D A medium at this 
stage. 
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Table 3.6 Antibiotic sensitivity of Acinetobacter spp. on the DDA medium. 
Species 
Strain 
number 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
A. 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
A. calcoaceticus 
A. calcoaceticus 
inett obacter gensp. 3 
A. haemolyticus 
A 
A. 
. johnsonii 
A. junii 
A. Iwoffii 
schindleri 
A. ursingii 
1095 
1096 
1098 
1099 
1102 
1109 
1110 
1111 
1112 
1113 
1114 
1115 
1116 
1117 
1118 
1119 
1120 
1121 
1122 
1123 
1124 
1125 
1126 
1127 
418 
1097 
415 
1337 
1336 
1335 
1338 
1339 
1334 
Control me dium Aztr. Cefo. Cefe. Cefta. Cipr. Eno. Lorn. Net. Nor. Pip. Tern. Van. 
T S A D D A 4mg/l 2mg/l 64mg/l lmg/1 0.05mg/l 2mg/l 0.25mg/l 0.5mg/l 0.5mg/l 64mg/l 100mg/l 256mg/l 
To examine the antibiotic sensitivity of a number of Acinetobacter strains, the agar dilution method was used. TSA and DDA media which did not contain the antibiotics were included as controls. A. baumannii, including the type 
strain 1102 (12156T), showed greater antibiotic resistance compared to other species. Resistance ranging between 91.7% (11/12) and 100.0 % was shown by A. baumannii strains. The only sensitivity shown was at 356mg/l 
vancomycin with 29.2% (7/24) of the A. baumanii strains being inhibited. A. haemolyticus, A. Iwoffii, and A. schindleri showed particular sensitivity and were inhibited by 58.3%) (7/12), 75.0%) (9/12), and 91.6 %> (11/12) of the 
antibiotics respectively. A. schindleri was the only strain whose recovery was affected by the presence of aztreonam (4mg/l). The food (418) and the clinical (1097) isolates of A. calcoaceticus exhibited similar susceptibilities. 
Aztreonam, ceftazidime, ciprofloxacin, norfloxacin, and temocillin had the least inhibitory effect on Acinetobacter (< 3 strains inhibited). They were, therefore, considered as potential selective agents for the DDA medium. Azt 
Aztreonam, Cefo Cefotaxime, Cefs Cefsulodin, Ceft Ceftazidime, Cipr Ciprofloxacin, Eno Enoxacin, Lorn Lomefioxacin, Net Netilmicin, Norfloxacin, Nor Norfloxacin, Pip Pipemidic acid, Tern Temocillin, Van Vancomycin, 
+++ triplicate positive recovery, — triplicate negative recovery, ++- duplicate positive recovery with the relevant strain counted as resistant, — duplicate negative recovery. 
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Table 3.7 Sensitivity of Gram-positive organisms to aztreonam, ceftazidime, ciprofloxacin, norfloxacin, and temocillin on the DDA 
medium. 
Species 
Strain Control medium 
number 
Aztr. Ceft. Cipr. Nor. Tem. 
TSA DDA 4mg/l lmg/1 0.05mg/l 0.5mg/l 100mg/l 
Bacillus cereus 1170 
Enterococcus faecalis WII 
Lactococcus lactis 1171 
Lactobacillus plantarum 51A 
Staphylococcus aureus 1167 
Staphylococcus aureus 1168 
Due to the minimised sensitivity of Acinetobacter to these five antibiotics (as shown earlier), their inhibitory effect was further tested against a set of Gram-
positive bacteria. Two S. aureus strains were used, due to availability. Temocillin proved to be the most selective against the tested Gram-positive organisms 
compared to the other antibiotics at the specified concentrations. Azt Aztreonam, Ceft Ceftazidime, Cipr Ciprofloxacin, Nor Norfloxacin, Tem Temocillin, +++ 
triplicate positive recovery, — triplicate negative recovery. 
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Table 3.8 Sensitivity of Acinetobacter and other Gram-negative and positive organisms to a range of lincomycin concentrations included in 
the DDA medium. 
Species Strain 
numbe r 
Control medium Lincomycin 
10mg/l 20mg/l 40mg/l 60mg/l 80mg/l 100mg/l 120mg/l 140mg/l 160mg/l 180mg/l 200mg/l 220mg/l 240mg/l 260mg/l 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
baumanni 
A. calcoacetic 
A. calcoacetic 
A. calcoacetic 
Acinetobacter gei 
A. 
A 
haemolytici 
. johnsonii 
A. junii 
A. Iwoffii 
A. ursingii 
A. radioresiste 
L 
B. cereus 
B. subtilis 
E.faecalis 
L.lactis 
plantarutr 
S. aureus 
S. aureus 
1095 
1096 
1098 
1099 
1102 
1109 
1110 
1111 
1112 
1113 
1114 
1115 
1116 
1117 
1118 
1119 
1120 
1121 
1122 
1123 
1124 
1125 
1126 
1127 
us 418 
us 1097 
us 1103 
isp. 3 415 
is 1337 
1336 
1335 
1338 
1334 
ns 1340 
1170 
1248 
1172 
1171 
574 
1167 
1168 
At 10mg/l lincomycin, there was 100% recovery of the Acmetobacter strains and 100% inhibition of the Gram-positive strains. The increase of the antibiotic 
concentration to 20mg/l (MIC) prevented the growth of A. radioresistence. At 60mg/l, A. Iwofii was also unable to grow. ++ duplicate positive recovery, ~ 
duplicate negative recovery. 
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3.3.3 Optimization of the enrichment stage 
The main purpose of the survey was to screen PIF products for the presence of Acinetobacter. 
Each PIF sample was analysed by reconstituting 25g of the powder in 225ml BPW, followed 
by the enhancement of bacterial growth in an appropriate enrichment broth medium. 
Enriched cultures were then inoculated onto D D A and L A M medium for a comparative 
assessment. Morphological and biochemical tests were applied for presumptive identification 
of the isolates. 
To select a suitable broth for the enrichment stage of the survey, the recovery of 
Acinetobacter in EE, modified M9, and BB was evaluated. The results are presented in 
Figure 3.1. Percentage recoveries (PRs) were higher in M9, with 10 strains, and generally 
significant (p < 0.05). The lowest PRs exhibited in BB and E E broth were 44.6 and 52.3 % 
respectively, while that recorded with M9 was 79.9%. Ten of the 13 tested strains (76.9%) 
showed higher recovery when grown in M9 compared to E E broth. Furthermore, higher 
numbers were also detected with all of the strains in M9 in contrast to BB. Viable counts 
increased from the original inocula size with 5 of the strains (A. calcoaceticus 418, A. 
baumannii 1102, A ursingii 1334, A. johnsonii 1336, and A haemolyticus 1337) cultivated in 
M9 (PR > 100.0%). This growth was not recorded in BB or in E E broth. 
Since the majority of strains showed enhanced recovery in M9 in comparison to the other two 
broths, it was selected as the enrichment broth for the survey of PIF. The next step was 
optimizing the incubation conditions during the enrichment stage. Acinetobacter cultures in 
M9 were incubated statically and on a rotary shaker at 30°C for 18h. The PRs were 
determined relatively to B P W and compared (Figure 3.2). The vigorous shaking (280 rpm) 
proved a significant (p < 0.05) enrichment factor for the strains tested. Eleven strains (84.6%) 
had a PR > 100.0%) when the air circulation increased during incubation. The only reduction 
was shown with A haemolyticus 1337. However, it was not significantly different (p > 0.05). 
Therefore, the shaking method was appropriate for the incubation of overnight cultures 
during the enrichment in M9 broth. 
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Figure 3.1 Percentage recovery of Acinetobacter strains in Baumann (BB), Enterobacteriaceae 
enrichment (EE), and modified M 9 broths. 
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To select an appropriate broth for the enrichment stage of the PIF survey, Baumann (BB), Enterobacteriaceae 
enrichment (EE), and modified M 9 broths were compared based on the number of bacterial cells recovered. Viable 
counts were determined in each medium using the Miles & Misra method and percentage recoveries were calculated 
in relation to the viable count in the pre-enrichment medium (BPW). The percentages in BB and E E were both 
significantly lower than in M 9 . The lowest PRs exhibited in BB and E E broths were 44.6 and 52.3 % respectively, 
while that recorded with M 9 was 79.9%. Viable counts increased from the original inocula size with 5 of the strains 
cultivated in M 9 (PR>100.0%). This growth was not recorded in BB or in E E broth. Strain 415 is Acinetobacter 
gensp. 3; 418 and 1097 are A calcoaceticus; 1095 to 1127 are A baumannii; 1334 is A ursingii; 1335 is A. junii; 
1336 is A. johnsonii; 1337 is A haemolyticus and 1339 is A schindleri. 
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Figure 3.2 Recovery of Acinetobacter strains in M 9 broth when incubated statically and on a rotary 
shaker. 
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To optimize the incubation condition so that the recovery of Acinetobacter isolates, from PIF, would be enhanced, 
bacterial cultures in M 9 were incubated statically and on a rotary shaker. Viable counts of overnight cultures were 
determined using the Miles & Misra method and the percentage of bacterial cells recovered was calculated in relation 
to the original inoculum. The percentage recoveries under each condition were then compared. Strain 415 is 
Acinetobacter gensp. 3; 418 and 1097 are A calcoaceticus; 1095 to 1127 are A baumannii; 1334 is A ursingii; 1335 
is A. junii; 1336 is A. johnsonii; 1337 is A haemolyticus and 1339 is A schindleri. 
53 
Chapter 3. Detection of Acinetobacter in PIF Using Differential-Selective Media 
3.3.4 Evaluation of the DDA medium 
The developed medium was assessed in terms of selectivity and sensitivity during the survey 
of PIF. The results were used to optimize the D D A medium during the course of the study. 
The number of isolates (acinetobacters and non-acinetobacters) recovered, and their 
percentages were calculated and compared between the D D A and L A M (Table 3.9). 
The D D A medium at this stage was designed to prevent the growth of Gram-positive 
bacteria. This is while allowing the differentiation mostly between fermentative and non-
fermentative Gram-negative organisms based on the latter's pigmented appearance on the 
medium. Presumptive Enterobacteriaceae were also able to grow on V R B G A medium and 
ferment Glucose. Non-fermentative Gram-negative/variable coccobacilli that were oxidase-
negative were proposed as Acinetobacter. The identity of the Gram-positives, on the other 
hand, was beyond the scope of this study and therefore was not investigated further. 
Although 10mg/l lincomycin was incorporated into the D D A medium, 69.5% (57/82) of the 
total number of isolates detected on D D A was Gram positive organisms (Table 3.9) which 
indicated the low levels of selectivity of the medium. In contrast, it was apparent that L A M 
was highly selective by showing no recovery of the Gram-positives detected on the D D A 
medium. These presumptively included Bacillus spp., Staphylococcus spp., and Enterococcus 
spp. based on their appearance under the microscope. From the four isolates that grew on 
L A M , one was a Gram-variable rod (presumptively Bacillus spp. according to the 
microscopic examination). 
With respect to sensitivity, from 63 PIF products, only 1 was positive for Acinetobacter and 
was identified as A. haemolyticus using API 20NE. One A. haemolyticus (as identified using 
API 20NE), was detected on D D A but not L A M . This isolate was a Gram-variable 
coccobacillus and also colourless on DDA. 
Despite the absence of a selective agent against Gram-positive bacteria (non-acinetobacters), 
only one Gram-negative cocobacillus/short rod isolate was found in PIF. It produced 
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pigmented colonies on D D A medium and was identified as Enterobacter amnigenus group2 
using API 20E. Another twenty one Gram-negative rod isolates did not produce acceptable 
profiles by API 20NE, but were designated as Lysinibacillus spp. by partial 16S rDNA 
sequencing. 
The most isolated Gram-negative organism was Pseudomonas luteola (8 isolates from 8 
different PIF products). A l l of which grew on D D A medium only. Isolates which were Gram-
negative rods and positive for glucose fermentation on V R B G A were regarded as 
presumptive Enterobacteriaceae. The only Enterobacteriaceae recovered on D D A was 
identified as Enterobacter amnigenus group2 using API 20E. The recovery of this organism 
was also detected on L A M . Enterobacter cloacae and Klebsiella pneumoniae were each 
isolated from L A M and not DDA. Only 43.5% (10/23) of the Gram-negative isolates and 
75.0% (3/4) of the Gram-variable organisms, recovered on D D A and L A M respectively, were 
acceptably identified by API biochemical profiling (Table 3.10). The remaining isolates had 
either unacceptable or low discrimination profiles when the same test was applied. It is of 
note that 6 isolates which also appeared as Gram-negative rods were identified as 99.9% 
Burkholderia cepacia by API20NE but were in fact Lysinibacillus fusiformis, Bacillus 
amyloliquefaciens/atrophaeus/mojavensis/subtilis and Enterococcus casseliflavus based on 
16S rDNA sequence-based identification. A Lysinibacillus boronitolerans was also 
misidentified asMyroides spp. with an ID percentage of 93.1%> by the same API biochemical 
test. 
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Table 3.9 Morphological and biochemical analysis of PIF isolates recovered on D D A (containing 
10mg/l lincomycin) and L A M . 
Gram variable 
Gram reaction 
Gram positive 
Gram negative 
Morphology 
cocci 
rods 
rods 
coccobacilli/short rods* 
Oxidase 
-
22/0 
3/0 
(-/+) Isolation 
D D A 
10 
47 
21 
1 
medium 
L A M 
0 
0 
1 
2 
Total 
10 
47 
22 
3 
cocci 
rods 3/0 
coccobacilli/short rods* 1/0 
Total numbers of isolates (%) 82 (95.3) 4 (4.7) 86 
Despite the incorporation of 10mg/l lincomycin, 69.5% (57/82) of the total number of isolates on D D A was Gram-
positive organisms. These organisms were completely inhibited o n L A M . Only 40.0% (10/25) and 75.0% (3/4) of the 
total Gram-negative and Gram-variable isolates recovered on D D A and L A M respectively were acceptably identified 
by API biochemical profiling as indicated in Table 2.10. The remaining isolates had either unacceptable or low 
discrimination profiles when the same test was applied. * Presumptive acinetobacters, (-/+) Negative and positive 
oxidase reactions, D D A Druggan-Dimmer agar, L A M Leeds Acinetobacter medium. 
Table 3.10 Gram-negative organisms recovered on selective media and biochemically identified 
during PIF screening. 
PIF product 
ULKER HERO BABY 1 
NESTLE NAN H.A. 1 
MLUPA CONFORML 1 
SUPER PREMIUM 
BEBELAC 1 
GOAT MILK BASED ORGANIC INFANT FORMULA 
NESTLE NAN H.A. 1 
NESTLE MDMA 1 H.A. 
NESTLE MDMA C0M0RT 1 
MOJUNG 
SCIENCE 2 
SNOW BRAND, STEP 1 
Bacterial species (ID %) 
Acinetobacter haemolyticus (92.7%) * 
Enterobacter amnigenus group 2 (84.6%) ** 
Enterobacter cloacae (99.4%) ** 
Klebsiella pneumonia spp. pneumonia (97.6%) ** 
Pseudomonas luteola (99.0, 99.1%) * 
P. luteola (97.2%)* 
P. luteola (99.9%) * 
P. luteola (99.7%)* 
P. luteola (99.9%)* 
P. luteola (99.1%)* 
P. luteola (99.7%)* 
P. luteola (99.9%)* 
API profile 
0010141 
3205553 
3305563 
5215773 
1577740 
1475741 
0777541 
1577771 
1777741 
0477541 
1577771 
0777541 
DDA 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Isolation mi 
LAM 
+ 
+ 
+ 
dia 
VRBGA 
+ " 
+ " 
+ " 
Organisms listed in this table are the only Gram-negative isolates that gave valid profiles using API tests. V R B G A 
medium was used to presumptively identify organisms from the Enterobacteriaceae before using the appropriate API 
kit (API 20E). API 20NE was used for the non-Enteric bacteria. * API 20NE identification, ** API 20E 
identification, + positive recovery,a red/pink colonies. 
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3.3.5 Modification of the DDA medium (Second antibiotic sensitivity testing) 
The low levels of selectivity of the D D A medium against the Gram-positive isolates found in 
PIF showed the need for further optimization of this medium. Therefore, the growth of some 
of these randomly selected PIF isolates was tested at different lincomycin concentrations 
(Table 3.11). A 100.0% inhibition was observed at all concentrations including the 10mg/l 
originally incorporated into the medium prior to the survey. Nevertheless, the lincomycin 
concentration was increased from 10mg/l to 20mg/l for a possibly more effective dose against 
Gram-positives. 
To enhance the specificity of the medium, another set of antibiotics (ceftazidime and 
aztreonam) was tested against Gram-negative bacteria other than Acinetobacter spp., and the 
minimum inhibitory concentration (MIC) was determined (Tables 3.12 & 3.13). These 
antibiotics caused the least inhibition of Acinetobacter (0.0% and 3.0%> (1/33) at 4mg/l and 
lmg/1 respectively) as previously shown in Table 3.6, and therefore were selected for further 
testing. 
When ceftazidime was used, the only Acinetobacter undetected on D D A medium was A. 
radioresistens (1340) (Table 3.12). Of the 6 non-Acinetobacter strains tested, only 2 
(Klebsiella pneumoniae 1013, and Escherichia coli 1247) were inhibited. Therefore, it was 
not considered as the best option with regard to increasing the selectivity of the medium. 
However, in the presence of aztreonam (lmg/1), 4 non-Acinetobacter strains showed inability 
to grow (Table 3.13). These strains were 1 Enterbacter cloacae, 2 Escherichia coli, and 1 
Klebsiella pneumoniae. At this MIC, 2 Acinetobacter type strains {A. calcoaceticus 1103 and 
A. radioresistens 1340) were not also recovered. The increase of the concentration to 4mg/l 
caused A. schindleri to also be inhibited. Pseudomonas aeruginosa, Pseudomonas luteola, 
and Serratia liquefaciens remained resistant. The 2 latter strains did not appear to be affected 
by any of the aztreonam concentrations. Conversely, Pseudomonas aeruginosa became 
sensitive at a higher concentration of this antibiotic (8mg/l). However, this was also 
accompanied with an inhibition of another Acinetobacter strain (A. haemolyticus) indicating 
an overall negative recovery of 25.0% (4/16). Zero inhibition of Acinetobacter could not be 
achieved. It was hence decided to select the maximum concentration (2mg/l) of aztreonam 
that would inhibit the least possible number of Acinetobacter strains on D D A medium. This is 
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while maintaining the highest levels o f selectivity against non-Acinetobacter Gram-negatives. 
In summary, 2mg/l aztreonam and 20mg/l lincomycin were both used in the final formula of 
the D D A medium, which were to be characterised in the following experiments. 
Table 3.11 Activity of lincomycin against Gram-positive organisms recovered from PIF. 
Species 
Strain Control medium Lincomycin 
number TSA DDA 10mg/l 20mg/l 40mg/l 60mg/l 80mg/l lOOmg/i 120mg/l 
Bacillus sp. 33 
Bacillus sp. 94 
Staphylococcus sp. 50 
Staphylococcus sp. 76 
The number o f Gram-positive bacteria detected o n the D D A medium during the P I F survey indicated the l o w levels 
o f selectivity o f this medium. Therefore, the sensitivity o f some o f these randomly selected P I F isolates was tested to 
choose an effective l i ncomyc in concentration. Complete inhibi t ion (100.0%) o f a l l the isolates was observed at a l l 
concentrations inc luding that originally used i n the medium prior to the survey. 
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Table 3.12 Activity of ceftazidime against Acinetobacter spp. and other Gram-negative species at 
different concentrations. 
Species 
Strain 
number 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A. 
A. 
A. 
Acinel 
A. 
/ 
A.r 
A 
Enter 
Esc 
Klebs 
Pseud 01 
Serra 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
calcoaceticus 
calcoaceticus 
calcoaceticus 
obacter gensp. 3 
haemolyticus 
. johnsonii 
A. junii 
A. Iwoffii 
adioresistens 
. schindleri 
A. ursingii 
obacter cloacae 
herichia coli 
iell pneumoniae 
nonas aeruginosa 
P. luteola 
tia liquefaciens 
1095 
1096 
1098 
1099 
1102 
1109 
1110 
1111 
1112 
1113 
1114 
1115 
1116 
1117 
1118 
1119 
1120 
1121 
1122 
1123 
1124 
1125 
1126 
1127 
418 
1097 
1103 
415 
1337 
1336 
1335 
1338 
1340 
1339 
1334 
49 
1247 
1013 
1169 
133 
579 
Control medium Ceftazidime 
TSA PDA lmg/1 2mg/l 4mg/l 6mg/l 8mg/l 10mg/l 12mg/l 16mg/l 
To enhance the specificity of the medium, susceptibilities of Acinetobacter and non-Acinetobacter strains to 
aztreonam were tested and the minimum inhibitory concentrations were determined on the D D A medium. Results 
showed that 2 Acinetobacter strains and 4 non-acinetobacters were unable to recover at the lowest tested 
concentration of aztreonam (lmg/1). The increase of the concentration to 8mg/l inhibited 5 of the 7 non-
Acinetobacter strains while the total number of unrecoverable acinetobacters rose to 4. ++ duplicate positive 
recovery, ~ duplicate negative recovery. 
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Table 3.13 Activity of aztreonam against Acinetobacter spp. and other Gram-negative species at 
different concentrations. 
Species 
A. baumannii 
k. baumnnii 
k. baumnnii 
k. baumnnii 
k. baumnnii 
k. calcoaceticus 
k. calcoaceticus 
k. calcoaceticus 
kcinetobacter gensp. 3 
A. haemolyticus 
Ajohnsonii 
k.junii 
k. Iwoffii 
k. radioresistens 
k. schindleri 
k. ursingii 
Enterobacter cloacae 
Escherichia coli 
Escherichia coli 
Klebsiella pneumoniae 
Pseudomonas aeruginosa 
P. luteola 
Serratia liquefaciens 
Strain 
number 
1095 
1096 
1098 
1099 
1102 
418 
1097 
1103 
415 
1337 
1336 
1335 
1338 
1340 
1339 
1334 
49 
605 
1247 
1013 
1169 
133 
579 
Control medium 
TSA 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
DDA 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
lmg/l 
H 
H 
H 
H 
H 
H 
H 
-
H 
H 
H 
H 
H 
-
H 
H 
-
-
-
-
H 
H 
H 
2mg/l 
H 
H 
H 
H 
H 
H 
H 
--
H 
H 
H 
H 
H 
--
H 
H 
-
--
--
~ 
H 
H 
H 
4mg/l 
H 
H 
H 
H 
H 
H 
H 
-
H 
H 
H 
H 
H 
-
-
H 
-
-
-
-
H 
H 
H 
6mg/l 
H 
H 
H 
H 
H 
H 
H 
--
H 
H 
H 
H 
H 
--
~ 
H 
-
--
--
~ 
H 
H 
H 
Aztreonam 
8mg/l 
H 
H 
H 
H 
H 
H 
H 
-
H 
-
H 
H 
H 
-
-
H 
-
-
-
-
-
H 
H 
10mg/l 
H 
H 
H 
H 
H 
H 
H 
--
H 
~ 
H 
H 
H 
--
~ 
H 
-
--
--
~ 
--
H 
H 
12mg/l 
H 
H 
H 
H 
H 
H 
H 
-
H 
-
H 
H 
H 
-
-
H 
-
-
-
-
-
H 
H 
14mg/l 
H 
H 
H 
H 
H 
H 
H 
-
H 
-
H 
H 
H 
-
-
H 
-
-
-
-
-
H 
H 
16mg/l 
H 
H 
H 
H 
H 
H 
H 
-
H 
-
H 
H 
H 
-
-
H 
-
-
-
-
-
H 
H 
Ceftazidime was tested against Acinetobacter and non-Acinetobacter strains and the minimum inhibitory 
concentration was determined. A. radioresistens (ATCC 43998T) was the only Acinetobacter strain to be undetected 
in the presence of 4mg/l ceftazidime. However, this concentration did not prove effective against 4 of the 6 non-
Acinetobacter strains. ++ duplicate positive recovery, ~ duplicate negative recovery. 
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3.3.6 Characterization of DDA and other selective Acinetobacter media 
Following the optimization of D D A medium in light of the survey results, a second 
comparative investigation of the selective Acinetobacter media was conducted and involved 
DDA, L A M , as well as CHROMagar Acinetobacter. The latter was newly introduced to the 
market as the first chromogenic agar for Acinetobacter. Thus it was of particular interest to 
examine its effectiveness in relation to the other above-mentioned media. A total number of 
67 strains including Acinetobacter and non-Acinetobacter species were used to examine the 
media in terms of the percentage recovery (PR), selectivity, sensitivity, and detection limit. 
Based on presence and absence, the selectivity of the media was expressed as the percentage 
of the negative recovery of non-Acinetobacter strains. CHROMagar was the most selective 
medium inhibiting 96.9% (n = 31) of the total 32 tested strains (Table 3.14). The only strain 
recovered on this medium was Burkholderia cepacia which was also detected on D D A and 
L A M . The latter, on the other hand, showed the least selectivity at 65.6% (n=2\). Amongst 
the bacteria that grew on L A M but not on CHROMagar or D D A were Serratia marcescens, 
Escherichia coli, and Klebsiella pneumoniae. In contrast to CHROMagar and L A M , 
Pseudomonas aeruginosa was not inhibited on DDA. D D A was 12.5% lower on selectivity 
than CHROMagar but was more efficient than L A M with 84.4% (n = 27) growth inhibition 
of non-Acinetobacter spp. 
In terms of sensitivity, which was determined by the percentage of the positive growth of 
Acinetobacter, D D A was the best (94.3%) with 33 out of the 35 strains recovered, followed 
by CHROMagar inhibiting four strains (88.6%) (Table 3.15). L A M showed the least 
sensitivity performance as eight strains failed to grow (77.1%). A. calcoaceticus and A. 
radioresistens were distinctively the only strains to be inhibited on the three media mentioned 
above. 
PRs were analysed by performing the Miles & Misra plate count method on all media plus 
TSA. TSA was used as a control given that a 100.0%) of Acinetobacter recovers on this all-
purpose medium. Applying the One way-analysis of variance (ANOVA), the /'-value (0.09) 
showed no significant difference between the PR on the three selective media. The minimum 
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PR on CHROMagar, DDA, and L A M was 80.3, 88.1, and 90.4% respectively (Figure 3.3). 
Twelve of thirty-three recovered strains (36.4%>) were counted in higher numbers (PR > 
100.0%)) on D D A relative to the control TSA. The increase in viable counts of these strains 
was averaged at 4.1% (0.3 log10 cfu/ml). On CHROMagar, 29.0% (9/31) of the strains 
showed a total average of 2.8% growth increase (0.2 logio cfu/ml) in comparison to TSA. 
L A M encouraged the bacterial growth of 14.8% (4/27) of the strains by 2.7%) in average (0.2 
logio cfu/ml). 
The detection limit was assessed by the lowest number of Acinetobacter colonies each 
medium can detect. The culture media of interest were inoculated with 0.1, 1, 10, 100, 1000 
cfu/ml of overnight cultures of Acinetobacter. The viable counts were determined by the 
spread plate method. TSA had a detection limit of 1-10 cfu/ml. That of L A M was 10 cfu/ml, 
while CHROMagar and D D A media were detecting bacterial cells at 10-100 cfu/ml. 
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Table 3.14 Comparison of the selectivity of Acinetobacter agar media. 
Species Strain 
number 
Selectivity 
TSA CHROMagar DDA L A M 
Bacillus subtilis 
B. cereus 
Burkholderia cepacia 
Citrobacter freundii 
Citr. koseri 
Citr. koseri 
Citr. koseri 
Citr. koseri 
Cronobacter sakazakii 
C. sakazakii 
Enterococcus cloacae 
E. cloacae 
Enterococcus faecalis 
Escherichia coli 
E. coli 
E. coli 
E. coli 
Klebsiella pneumoniae 
K. pneumoniae 
K. pneumoniae 
Lactococcus lactis 
Pseudomonas aeruginosa 
P. aeruginosa 
P. aeruginosa 
Serratia marcescens 
S. marcescens 
S. marcescens 
Staphylococcus aureus 
S. aureus 
S. aureus 
S. aureus 
S. epidermidis 
702 
1170 
627 
624 
224 
225 
226 
826 
1 
2 
49 
218 
1172 
100 
540 
571 
800 
68 
541 
1013 
1171 
117 
401 
570 
763 
834 
835 
152 
616 
1167 
1168 
671 
Based on presence and absence, the selectivity of the media was expressed as the percentage of the negative recovery 
of non-Acinetobacter strains. CHROMagar was the most selective medium inhibiting 96.9% (« = 31) of the total 32 
tested strains. The only strain recovered on this medium was Burkholderia cepacia which was also detected on DDA 
and L A M . L A M showed the least selectivity at 65.6% (n = 21). DDA was 12.5% lower on selectivity than 
CHROMagar but was more efficient than L A M with 84.4% growth inhibition of non-Acinetobacter spp. +++ 
triplicate positive recovery, — triplicate negative recovery. 
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Table 3.15 Comparison of the sensitivity of Acinetobacter agar media. 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A. 
A. 
A. 
Acinet 
A. 
A 
Ar 
A 
Species 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
baumannii 
calcoaceticus 
calcoaceticus 
calcoaceticus 
obacter gensp. 3 
haemolyticus 
. johnsonii 
A. junii 
A. Iwoffii 
adioresistens 
. schindleri 
A. ursingii 
Strain 
number 
1095 
1096 
1098 
1099 
1102 
1109 
1110 
1111 
1112 
1113 
1114 
1115 
1116 
1117 
1118 
1119 
1120 
1121 
1122 
1123 
1124 
1125 
1126 
1127 
418 
1097 
1103 
415 
1337 
1336 
1335 
1338 
1340 
1339 
1334 
TSA 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
Sens 
CHROMagar 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
— 
+++ 
— 
+++ 
+++ 
— 
— 
+++ 
+++ 
itivity 
DDA 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
— 
+++ 
+++ 
+++ 
+++ 
+++ 
— 
+++ 
+++ 
L A M 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
— 
+++ 
— 
— 
— 
— 
— 
— 
— 
Sensitivity of the media was defined as the percentage of the positive growth of Acinetobacter. DDA came first 
(94.3%) with 33 out of the 35 strains recovered, followed by CHROMagar inhibiting 4 strains (88.6%). L A M 
showed the least sensitivity performance as 8 strains failed to grow (77.1%). A. calacoaceticus and A radioresistens 
were the only strains to be inhibited on the 3 above-mentioned media. +++ triplicate positive recovery, — triplicate 
negative recovery. 
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Figure 3.3 Comparison of the percentage recovery on Acinetobacter agar media. 
Percentage recovery (PR) was analysed by performing the Miles and Misra plate count method on all media plus TSA. TSA was used as a non-selective control 
medium with a 100.0% recovery of Acinetobacter. The proportion of the viable counts on each medium relative to that of TSA was calculated and expressed as a 
percentage. These percentages were then compared. The minimum PR on CHROMagar, D D A , and L A M was 80.3, 88.1, and 90.4% respectively. Twelve of 33 
recovered strains (36.4%) were counted in higher numbers (PR>100.0%) relative to the control TSA. The increase was averaged at 4.1%. On CHROMagar, 
29.0% (9/31) of the strains showed a total average of 2.8% increase in recovery in comparison to TSA. L A M encouraged the bacterial growth of 14.8% (4/27) of 
the strains by 2.7% in average. A15 Acinetobacter gensp. 3; 418 and 1097 A calcoaceticus; 1095 to 1121 A. baumannii; 1334 A ursingii, 1335 A. junii, 1336 A 
johnsonii, 1337 A haemolyticus, 1338 A hvoffii, 1339 A schindleri. 
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3.4 DISCUSSION 
The use of chromogenic agars for the differentiation of Acinetobacter has not been widely 
applied. The differentiation of the organism on L A M is based on the utilization of complex 
nitrogenous resources and the consequent release of ammonium ions. The base of the 
medium becomes alkaline (pH 8-9) and changes from dark orange to mauve as a result 
(Jawad et al, 1994). DDA, on the other hand, exploits the presence of DHF-riboside to 
distinguish between Gram-negative bacteria according to their positive or negative hydrolysis 
of this substrate. D D A medium made use of the incapability of Acinetobacter to produce this 
enzyme for the purpose of presumptively differentiating and identifying the organism. This is 
particularly efficient i f other P-ribosidase negative organisms are inhibited. According to 
Butterworth et al, (2004), other Gram-negative bacteria showing no activity with DHF-
riboside included Yersinia enterocolitica, Yersinia pseudotuberculosis, Yersinia kristensenii, 
Proteus mirabilis, Proteus penneri, Vibrio parahaemolyticus, Vibrio cholerae, Ralstonia 
spp., and Pandoraea spp. whose colonies also appeared non-pigmented. Without any 
selective agents, the Gram-negative organisms mentioned above would all produce non-
pigmented colonies on the medium along with Gram-positive bacteria. Therefore, it was 
important to test different selective agents to achieve the maximum inhibition possible of 
non-Acinetobacter spp. One of the agents tested against Gram-positives was sodium 
deoxycholate. Generally, Gram-positive organisms are more sensitive to bile salts than the 
Gram-negatives due to the absence of the outer membrane as a protective barrier (Gunn, 
2000). However, when sodium deoxycholate was incorporated into the medium at 0.15g/l, A. 
calcoaceticus N C T C 12983T and A radioresistens A T C C 43998T were unable to grow. This 
might be due to some membrane alteration as designated type strains usually undergo 
intensive studies and repeated subculturing, which can generate mutations and lead to some 
changes in their characteristics. 
Susceptibility data of this study demonstrated the resistance, amongst all of the tested A. 
baumannii strains, to at least 11 of the 12 antibiotics used. These strains were clinical in 
origin. In contrast, A genomospecies 3, and A. calcoaceticus (418, 1097, and 1103) as well as 
the A. haemolyticus, A. johnsonii, A. junii, A. Iwoffii, A. radioresistens, A. schindleri, and A. 
ursingii varied in their sensitivity. The levels of resistance may explain why A. baumannii is 
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able to maintain its existence and be frequently isolated from the clinical setting compared to 
other species of Acinetobacter. Of note is that the food/cheese isolates, Acinetobacter gensp. 
3 (415) and A. calcoaceticus (418), were resistant to 83.3 and 58.3% of the antibiotics 
respectively. Food isolates are generally less exposed to antibiotics as opposed to the clinical 
ones which are, consequently, more prone to developing antibiotic resistance due to the 
extensive use of suboptimal antimicrobial agents. However, as stated by the World Health 
Organization (World Health Organization W H O , 2001) the emergence of increased levels of 
antibiotic resistance of micro-organisms found in food produced from animal sources is 
anticipated to rise as a result of inappropriate use of antibiotics. Giving antibiotics to 
livestock or adding them to animal-feed may give rise to this resistance. Moreover, it has 
been suggested that probiotics may serve as likely reservoirs for antibiotic resistance genes 
(von Wright, 2005; European Food Safety Authority-The panel on additives and products or 
substances used in animal, 2008). 
As well as its potential use for diagnostic or screening purposes in laboratories, industry, and 
hospitals, the D D A medium was initially aimed for the analysis of PIF. Therefore, the 
medium was formulated for the general detection ofAcinetobacter species and not merely for 
the commonly isolated M D R - A baumannii isolates. Achieving both high selectivity against 
non-acinetobacters and 100% recovery of Acinetobacter spp. was not possible. In this case, 
the species and their frequent isolation and importance as nosocomial pathogens needed to be 
considered before choosing the final selective agents for the medium. The final formulation 
of the medium included 20mg/l lincomycin and 2mg/l aztreonam. The type strains A. 
calcoaceticus N C T C 12983T and A. radioresistens A T C C 43998T were both inhibited as a 
result. Nevertheless, this was not of particular concern since type strains do not necessary 
represent their species owing to their atypical behaviour as previously observed by Caubilla-
Barron and Forsythe (2007). This was also indicated by the positive recovery of both the food 
(418) and the clinical (1097) isolates of A. calcoaceticus on D D A in contrast to their type 
strain (NCTC 12983T). 
For a comprehensive and robust validation of selective/differential culture media in general, 
it is necessary not only to use culture collection strains but also natural samples containing 
competitive microflora that are relevant to the application of the medium. The usefulness of 
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D D A medium was assessed by analysing 63 PIF samples. The number of Gram-positive 
bacteria recovered on D D A showed its reduced selectivity compared to L A M . However, this 
lower level of selectivity is caused by the low selectivity of the broth used for the enrichment 
stage and not an indication of the effectiveness of the medium. Gram-positives including 
Bacillus spp., and Staphylococcus spp. were sensitive to 10mg/l lincomycin when tested prior 
to the survey of PIF. However, these organisms, as a part of the natural inhabitants of PIF, 
were able to grow on D D A medium containing the same concentration of lincomycin as 
mentioned above. Pure cultures of some of these PIF isolates were examined in the presence 
of lincomycin and they were in fact sensitive. The resistance of these isolates, inoculated 
directly from the enrichment broth, can be due to the large number of bacterial cells that 
might exist in clumps and hence be protected or at least less affected by the antibiotics in the 
medium. The bacterial concentration used for lincomycin susceptibility testing was 
~105cfu/ml and so it can be assumed that the amount of these Gram-positive cells may be 
much greater than the number above. 
Despite the ability of some non-Acinetobacter strains cultured on D D A medium to grow, they 
were not mistaken with the target organism. Enterobacter cloacae, Pseudomonas aeruginosa, 
and Burkholderia cepacia were easily distinguished from Acinetobacter spp. by their 
coloured appearance. The positive oxidase reaction would then differ the latter organisms (P. 
aeruginosa and B. cepacia) from the Enterobacteriacae in general. However, the 
differentiation between these two bacteria would require further characterization. 
Biochemical tests such as benzyl-arginine arylamidase (BAA) can be applied for this purpose 
since P. aeruginosa possesses the B A A activity which is otherwise lacking in Burkholderia 
cepacia (Laffineur et al, 2002). P. aeruginosa can be a significant contaminant of wet 
environmental sources but as far as the detection of desiccated organisms in PIF, the 
proportion of Pseudomonas spp. is unlikely to be significant (Druggan and Iversen, 2009). 
With regard to Burkholderia cepacia, its presence in PIF has not been reported. While the P. 
aeruginosa strains obtained from culture collections were negative for their recovery on 
CHROMagar in this study, scant growth of red colonies was observed with 2 clinical isolates 
(limipenem sensitive and 1 resistant) examined by Akers et al. (2010). Four out of 6 
Staphylococcus aureus, 2 Enterococcus faecalis, and 1 Enterobacter cloacae were also able 
to grow on the same medium and produced a red to red-orange colour (Akers et al, 2010). 
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The growth of organisms with similar colony color as Acinetobacter means that it is more 
likely to have a mi si dentifi cation and report a false positive result if additional tests were not 
performed. This can be of particular concern with respect to infection control, 
appropriateness of treatment, and unnecessary exposure to antibiotics. Akers et al. (2010) 
also inspected the growth of clinical isolates of Citrobacter freundii, Escherichia coli, 
Enterobacter cloacae, Klebsiella pneumoniae, and Serratia marcescens. Apart from one 
Escherichia coli A T C C 25922 and Citrobacter freundii, all of these strains were recovered on 
CHROMagar. In comparison, strains from the same species were examined in our study and 
showed negative recovery on the same medium. This observation of strain variations 
highlighted the need to use larger numbers of clinical isolates of each species, in order to 
properly validate whether the current formula of the D D A medium is suitable for future 
applications in the hospital setting. 
Using 105 cfu/ml inocula, CHROMagar proved to be 12.5% and 31.3% more selective for 
Acinetobacter than DDA, and L A M respectively. The latter was too selective in that the 
recovery of eight Acinetobacter species (A. calcoaceticus, A. haemolyticus, A. johnsonii, A. 
junii, A. Iwoffli, A. radioresistens, and A. schindleri, A. ursingii) was affected. Despite its 
lower selectivity compared to CHROMagar, D D A medium was the most sensitive medium 
with 94.3% of the Acinetobacter strains showing positive recovery. CHROMagar came 
second at 88.6%, followed by L A M (77.1%). Seventy-five percent sensitivity of the prior 
medium was previously reported by Akers et al. (2010) when eight mixed cultures containing 
the calcoaceticus-A. baumannii complex were inoculated into CHROMagar at 104 cfu/ml. 
Earlier during the PIF screening, better sensitivity of D D A over L A M was also demonstrated 
whereby one A. haemolyticus was only isolated on D D A but not L A M . When the medium 
was inoculated with sterile pre-made infant formula artificially spiked with 0.1, 10, 100, and 
1000 cfu/ml, the lowest number of bacterial cells detected was 10 cfu/ml on CHROMagar, 
DDA, and L A M . The lower the detection limit the better it is for the isolation of 
Acinetobacter from a sample specifically if the organism is present in low numbers, 
otherwise, a false negative might be obtained. The opposite correlation applies to the low 
percentage recovery on a medium and the sensitivity. In other words, the lower the 
percentage recovery of an organism on an isolation medium the lower the sensitivity of that 
medium will be. For this reason, PRs on the media were determined and compared and 
69 
Chapter 3. Detection of Acinetobacter in PIF Using Differential-Selective Media 
recoveries below 50.0% were regarded as a failure for the evaluated media. However, all 
strains showed PRs greater than 80.0% on CHROMagar, DDA, and L A M . D D A presented 
the highest percentage (36.4%) of strains whose PR was greater than 100.0%). However, 
generally there was no significant difference between the levels of recovery on these three 
media. 
The D D A medium described here showed promising results for its applicability as a selective 
and a differential medium in laboratories, industry, hospitals where the presence of 
Acinetobacter is investigated. A l l acinetobacters tested were abundantly recovered 
(PR>80.0%>) on this medium, which was also highly sensitive and showed good selectivity. 
The latter can be further improved with the incorporation of an antimicrobial agent against 
Pseudomonas spp. Moreover, D D A is simple and quick to prepare as it is composed of few, 
uncomplicated, and inexpensive ingredients. The only costly part is the chromogenic 
substrate. However, this could be justified by the pronounced advantages of better specificity 
offered by chromogenic media. A 100%) accuracy of isolation and presumptive identification 
is seldom achieved as false negatives and false positives may occur in any selective medium 
(Greenhalgh, 1997). Incorporating a differential agent into a selective medium can increase 
the accuracy and reliability of the presumptive identification. Consequently, it would reduce 
the need for complementary testing (biochemical or morphological), culture media, and time 
spent on the analysis of samples containing mixed populations of bacteria, that are generally 
insignificant to the case scenario or the screening purpose. 
With regards to the species specificity of the DDA, the medium was not designed for the 
selective recovery of M D R - A baumannii and therefore cannot be applied for clinical 
diagnosis or screening for this particular strain in the hospital without conducting 
confirmatory identification and susceptibility testing. As mentioned before, the medium as it 
stands was designed for PIF sampling where the prevalence of all species of Acinetobacter is 
of interest. Future practical research applications of the medium may include clinical, 
environmental, and food screening of general Acinetobacter species. 
This research study had another goal, which was investigating the PIF for Acinetobacter 
contamination. The procedure required the inoculation of recovered cells into an enrichment 
broth to enhance the growth of the target organism in relation to competitive microflora 
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present in the same sample. Although M9 broth increased the growth of Acinetobacter as 
shown in the preliminary experiments, it was apparent that the broth was not effective in 
terms of inhibiting the recovery of Gram-positive organisms. These organisms were 
consequently isolated abundantly on the D D A medium despite the presence of 20mg/l 
lincomycin. The idea of the modified M9 broth was to enhance the recovery of Acinetobacter 
spp. and at the same time avoid the reduction in sensitivity, or in other words avoid the 
inhibition of some Acinetobacter strains. This was believed to be achieved by making the 
broth more suitable for the target organism and less so for others without incorporating a 
selective agent. Therefore, the glucose was omitted from the original formula of the medium 
so that Acinetobacter have an advantage over organisms that require this nutrient for their 
growth. 
The pH of the medium was also reduced to 6.0 to selectively enhance the recovery of 
Acinetobacter as observed by Baumann (1968). However, PIF samples contain mixed 
bacterial populations. Consequently, predominant bacteria, mainly Gram-positives, can 
outgrow the organisms that are present in smaller proportions, i f they are not inhibited in the 
enrichment stage. In the survey here, Bacillus spp. presented the majority of the isolates 
detected from PIF. Their frequent isolation from PIF is not uncommon (Anderton, 1986; 
Cnelly et al, 1994; Reyes et al, 2007; Rommus et al, 2006; Rueckert et al, 2005). 
Endospore-formation enables them to withstand extreme conditions during manufacturing 
which would otherwise limit the growth of many Gram-negative organisms in particular 
(Atrih and Foster, 2001; Setlow, 2006). Genera from the Bacillaceae family can also produce 
antibiotics such as colistin and polymyxin which are active against both Gram-negative and 
positive organisms (He et al, 2007; Katz and Demain, 1977). Such antibiotics are used as 
selective agents in isolation media for Gram-positive bacteria found in water and food 
(Bisson and Cabelli, 1979; Handford, 1974; Holbrook and Anderson, 1980). The above-
mentioned factors may have lowerd the sensitivity of the enrichment broth (M9) and 
therefore it is possible that some Acinetobacter in the samples were missed. 
Overall, Pseudomonas luteola was the most prevalent Gram-negative organism isolated in 
this study and was found in 12.7% (8/63 products) of PIF products. In contrast to 
Pseudomonas aeruginosa, this species is oxidase negative. Although the organism was 
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colourless on D D A medium, it had a distinctive morphological appearance that differentiates 
it from Acinetobacter. P. luteola has been associated with nosocomial infections such as 
endocarditis, peritonitis, cellulitis, septicaemia, and bacteraemia (Casaltae/a/., 2005; Connor 
et al, 1987; Dalamaga et al, 2004; Freney et al, 1988; Rastogi and Sperber, 1998). 
However, PIF contamination with this organism has not been previously reported. 
From the Enterobacteriaceae, K. pneumoniae, E. cloacae, and E. amnigenus were also 
detected in different PIF products. Infections caused by E. amnigenus have been occasionally 
reported (Capdevila et al, 1998; Korah et al, 2007) but were not associated with neonates or 
PIF. On the other hand, epidemiological link between contaminated feeds and new-borns 
colonized with multi-resistant K. pneumoniae has been found (Vieira et al, 1999). 
Overgrowth of this organism in the gut has been observed following treatment with broad-
spectrum antibiotics. The organism has the potency to acquire and/or develop antibiotic 
resistance which can serve as a reservoir for antibiotic resistance genes (Sirot et al, 1991). 
The presence of E. cloacae in PIF has also been previously reported by Chap et al. (2009), 
and Iversen and Forsythe (2004). Similar to Acinetobacter spp., this species along with K. 
pneumoniae were classified by F A O - W H O (2004) (2006), according to their potential risks 
to neonates, as category B whereby causality is plausible but not yet demonstrated. 
Only one Acinetobacter isolate was isolated. It was identified as A. haemolyticus using API 
20NE. According to the surveillance programme of bacteraemia resistance, A. haemolyticus 
was implicated in 24 and 21 of the total Acinetobacter 1246 and 984 bacteraemia cases in the 
U K and Ireland between 2007 and 2008 respectively. However, there was no specific data 
available regarding the rates of neonatal infections caused by this species. 
The detection of one Acinetobacter isolate may or may not accurately reflect the organism's 
actual occurrence in the PIF products included in this study. No conclusion can be drawn in 
this respect unless an efficient screening method, which is both highly sensitive and selective, 
is established. Nevertheless, the occasional isolation of Acinetobacter by no means minimises 
the importance of this organism as a potential agent of neonatal infections. This should be 
evaluated in terms of clinical impact of such infections on feeding rather than frequent 
occurrences in PIF. 
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Chapter 4. Long-Term Persistence of Acinetobacter in Desiccated Infant Formula 
4.1 INTRODUCTION 
Infant formulas are designed to provide the nutritional requirements of growing infants. To 
ensure they are suitable for their consumption, the Codex Alimentarius Commission (CAC), 
established by the W H O and F A O , developed a global safety, quality, and compositional 
standard for infant formula which was first adopted in 1981 and revised in 2007 (CAC, 
2007). However, despite the 'good manufacturing practices' regulations, bacterial 
contamination of PIF remains an issue since sterilization cannot be achieved during 
production. Consequently a variety of Gram-positive and Gram-negative micro-organisms 
(Edelson-Mammel et al, 2005; Iversen and Forsythe, 2004) including Acinetobacter spp. 
may contaminate the product (Cawthorn et al, 2008; Marino et al, 2007; Miled et al, 2010). 
Although no epidemiological link between Acinetobacter infections in neonates and 
contaminated PIF has been established, the organism was included in the F A O - W H O (2006) 
list of organisms of plausible concern for neonatal health due to powdered formula. A. 
baumannii/calcoaceticus were classified under category B representing 'plausible causality, 
but not yet demonstrated' according to their potential risk of causing neonatal illnesses. 
In addition to the isolation of Acinetobacter from the inanimate surfaces in hospitals, 
Acinetobacter has been experimentally shown to survive desiccation for up to ten months 
(Getchell-White et al, 1989; Jawad et al, 1996; Jawad et al, 1998b; Wagenvoort and 
Joosten, 2002; Wendt et al, 1997). These studies were conducted using suspensions of 
Acinetobacter in distilled water and/or bovine serum albumin, or phosphate-buffered saline. 
Infant formula has been used to study the desiccation persistence of various 
Enterobacteriaceae including Cronobacter sakazakii (a major neonatal pathogen found in 
PIF) (Bar-Oz et al, 2001; Caubilla-Barron and Forsythe, 2007; Lai, 2001). However, the 
persistence during desiccated storage in this carrier medium has not been previously 
investigated for Acinetobacter'. The documented presence in PIF may be indicative of the risk 
of neonatal exposure to Acinetobacter infections through the consumption of a reconstituted 
PIF intrinsically contaminated with this organism. This study, therefore, quantitively 
examines the ability of Acinetobcter strains to maintain their viability in dehydrated infant 
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formula over a storage period consistent with the shelf-life of the commercial PIF products (2 
years). 
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4.2 MATERIALS AND METHODS 
4.2.1 Bacterial strains 
A total number of nine Acinetobacter strains were evaluated for their desiccation survival in 
infant formula. Acinetobacter strains were obtained from clinical (n = 7) and environmental 
in = 2) sources. For comparison, species of such as Enterobacter cloacae (n = 2) and 
Enterobacter hormaechei (n = 1) from the Enterobacteriacaeae family were also included. 
Bacterial species, their sources and culture collection designation are presented in Chapter 1. 
4.2.2 Capsule formation 
A l l strains included in this study were examined by microscopy for the presence of the 
capsule, using the India ink stain, prior to the desiccation experiment. A loopful of sterile 
distilled water was placed on a clean and dry slide. A small amount of one colony from TSA 
plates was emulsified in the water, and was then mixed with a drop of India ink and covered 
with a clean coverslip. A small drop of immersion oil was added before viewing under the 
microscope at the magnification of lOOOx. 
4.2.3 Preparation of cultures prior to the desiccation assay 
Cultivation of Acinetobacter for desiccation studies required some method development. 
Acinetobacter strains were grown on milk agar consisting of 3.0g of bacteriological agar No. 
3, and 0.4g of ammonium sulphate. Both were dissolved in 40ml of distilled water. After that, 
the agar was autoclaved at 121°C for 15 min. Meanwhile, 200ml ready to use sterile liquid 
infant formula (Cow & Gate Premium 1) was kept in the 55°C incubator to be added 
aseptically to the agar and mixed. Milk agar was then poured and allowed to set before 
inoculation. The medium, however, based on plate counts did not support sufficient bacterial 
growth required for the desiccation assay. A n alternative method evaluated included growing 
the strains in 25ml sterile liquid infant formula, centrifugation at 500xg for 5 min and re-
suspension of the pellet in 2ml of infant formula. This method also proved to be an 
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inadequate method for obtaining ~10 Acinetobacter cfu/ml. In the final procedure, sufficient 
growth was obtained when skimmed milk-tryptic soy agar (SM-TSA) was used. It was 
prepared by adding 200ml TSA to 50ml of sterilised 10% skimmed milk (w/v) (LAB M , 
MC027). The skimmed milk was autoclaved separately from the TSA for 5 min at 121 C, 
while the TSA was autoclaved for 15 min at 121 °C. They were then mixed together 
aseptically, poured into Petri dishes, allowed to set, and then inoculated. Each strain was 
streaked onto five SM-TSA plates. The plates were incubated for 48h at 37°C. 
4.2.4 Desiccation procedure 
The desiccation assay applied followed the same procedure as previously described by 
Caubilla-Barron and Forsythe (2007). Bacterial cultures (48h incubation period) were 
harvested from the five plates using a sterilized spatula. The cells were dispensed in 7ml of 
liquid infant formula (Cow & Gate premium 1) and vortexed. A n aliquot (0.5ml) of each 
bacterial suspension (cell density 108-1010 cfu/ml) was then transferred into 4.5ml of sterile 
liquid infant formula and serially diluted up to 10"8 cfu/ml. Next, 12.5ul of the undiluted 
bacterial suspension, and the multiple decimal dilutions, as well as un-inoculated liquid infant 
formula (Cow and Gate premium 1) were transferred into 40 of 96-microtitre trays giving a 
total of 480 trays for the 12 desiccated strains. Two plates containing 16 replicates per 
dilution were assigned for each sampling point. Plate counts were performed using the Miles 
and Misra method on TSA and incubated at 30°C for 24h to determine the initial 
concentration of the bacterial suspension before desiccation. To air-dry these suspensions, the 
96-well plates were left open overnight (18h) in a class two cabinet. The plates were then 
sealed and stored away from light at room temperature (21°C). 
4.2.5 Reconstitution of the desiccated strains 
At 20 timed intervals, bacterial cells desiccated in two 96-microtitre trays were rehydrated 
with 200ul of sterile liquid infant formula (Cow and Gate Premium 1), and then incubated for 
48h at 37°C. Reconstitution time points were 18h, 3, 7, 14, and 20 days, then every two 
months for up 24 month. 
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4.2.6 Determination of cell viability 
Following the 48-hour incubation of the reconstituted cells, a replicator was used to 
aseptically inoculate two TSA plates with aliquots from each rehydrated well. The TSA 
plates were incubated overnight at 37°C. Next, the plates were checked for the presence or 
absence of growth of the sixteen replicates per dilution. The number of positive wells were 
entered into the B A M - M P N Excel software (Food and Drug Administration, 2006) to 
determine the viability of each strain at each time point based on the estimation of the most 
probable number (MPN) that caused these positive results per millilitre of the original 
sample. Survival curves of bacterial cells were generated by plotting the viable count (log10 
cfu/ml) against the time points in order to compare desiccation survival trends of all the 
strains tested. The recovery of the strains tested was followed for a maximum period of 24 
months or until the bacteria became undetectable. 
78 
Chapter 4. Long-Term Persistence of Acinetobacter in Desiccated Infant Formula 
4.3 RESULTS 
4.3.1 Capsule formation 
India ink staining showed that all the Acinetobacter strains were capsulated. These capsules 
were negative stained and appeared as clear areas surrounding bacterial cells. 
4.3.2 Long-term desiccation survival of Acinetobacter strains 
The first 18h of desiccation in infant formula caused the viability of all Acinetobacter strains 
to decrease by 2.4-3.5 logio cfu/ml (Figure 4.1). However, the reduction observed over the 
next 19 days ranged between 0.0 and 0.98 logio cfu/ml (Figure 4.1). Thereafter, the viable 
cells of strains 1095, 1096, 1098, and 1099 (A. baumannii) as well as 1097 (A. calcoaceticus) 
did not appear to be reduced for 5 months before starting to consistently decline (Figure 4.2). 
Bacterial counts were at the order of 103-104 cfu/ml (3.1-3.7 logio cfu/ml decrease) when a 
plateau was reached by 12 months of desiccation. The food isolates (415, and 418) exhibited 
similar desiccation survival trends to those of the clinical strains (Figure 4.2). However, the 
decrease in viability was apparent after 3 months of desiccation. Unlike that of the clinical 
strains (12 months), the decline in the recovery of strain 415 and 418 continued only for up to 
8 months until the persistence phase was reached. At this time point (8 months), the number 
of detected cells was 1.6xl03 cfu/ml (total log decrease = 3.5 and 3.7 for strain 418 and 415 
respectively). Overall, 7 out of the 9 desiccated strains were resistant to long-term desiccation 
in infant formula and remained detectable for the whole duration of the study (24 months) 
(Figure 4.2). On the other hand, the type strains A. baumannii 1102 (NCTC 12156T) and A 
calcoaceticus 1103 (NCTC 12983 ) both exhibited a reduced desiccation tolerance compared 
to the other strains. The initial drop in viable count (2.4 and 3.1 logio cfu/ml respectively) was 
followed by a lag phase which lasted 3 months at the order of 105 cfu/ml. After which, strains 
1103 and 1102 continued to lose their viability until they were no longer detectable by 6, and 
9 months respectively (total reduction = 3.1 and 3.3 logio cfu/ml). 
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Figure 4.1 Survival of Acinetobacter strains during the first twenty days of desiccation. 
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The figure shows an intial decrease in viability (2.4 and 3.5 log10 cfu/ml) as a result of overnight desiccation stress. 
The reduction observed by 20 days ranged between 0.0 and 0.98 logio cfu/ml. The number of viable cells recovering 
after reconstitution was calculated based on the MPN estimation of the number of cells showing growth in each well. 
Visible growth was seen when at least one bacterial cell was present in the sample. Strain 415 is Acinetobacter 
gensp. 3; 418 and 1097 are A calcoaceticus; 1095, 1096, 1098, and 1099 are A baumannii. Strains 1102 and 1103 
are A baumannii NCTC 12156T and A.calcoaceticus NCTC 12983T respectively.* Type strain. Error bars represent 
95% confidence intervals. 
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Figure 4.2 Survival ofAcinetobacter strains during 24 months of desiccation. 
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The figure shows three distinctive survival trends that separated the test strains into three groups. The food isolates 
(415 and 418), and the clinical isolates (1095, 1096, 1097, 1098, and 1099) both maintained their viability for 24 
months in desiccated infant formula. However, the clinical isolates incurred lower viability loss than the food isolates 
particularly after 3 months of desiccation stress. The type strains 1103 and 1102 proved to be the most sensitive and 
were undetectable by 6 and 9 months respectively. Strain 415 is Acinetobacter gensp. 3; 418 and 1097 are A. 
calcoaceticus; 1095, 1096, 1098, and 1099 are A baumannii. Strains 1102 and 1103 are A baumannii N C T C 12156T 
and A. calcoaceticus N C T C 12983T respectively.* Type strain. Error bars represent 95% confidence intervals. 
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4.3.3 Desiccation persistence of bacterial species belonging to the Enterobacteriaceae 
family 
Exposure ofE. cloacae 50 and 597, and E. hormaechei 790 to desiccation generated an initial 
4.2, 4.3, and 3.4 logio cfu/ml decrease in viability, while that monitored during the next 19 
days was 0.1, 0.4, and 0.0 logio cfu/ml respectively (Figure 4.3). Afterwards, the cell count 
continued to decrease until no detection was achieved (Figure 4.4). Strain 790 was the 
longest to persist under desiccated stress and remained recoverable until the last sampling 
point (17 months) (5.8 logio cfu/ml decrease). On the other hand, strain 597 was the first of 
the Enterobacteriaceae to become undetectable by 10 months of desiccation, followed by 
strain 50 which was no longer recoverable at 12 months. The total loss of these strains was 
determined at 6.4 and 6.2 logio cfu/ml respectively. 
Figure 4.3 Survival of K cloaceae and E. hormaechei strains during the first twenty days of 
desiccation. 
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Overnight desiccation in infant formula caused the viability of strains 50, 597, and 790 to initially decrease by 4.2, 
4.3, and 3.4 logio cfu/ml, while the loss of 0.1, 0.4, and 0.0 logio cfu/ml was detected during the next 19 days 
respectively. Strains 50 and 597 are E. cloacae; 790 is E. hormaechei. Error bars represent 95% confidence intervals. 
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Figure 4.4 Survival of E. cloaceae and K hormaechei strains during 24 months of desiccation. 
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A l l the strains presented in the figure showed consistent reduction in viability after two months of desiccated storage 
in infant formula. E. hormaechei 790 appeared to persist longer than E. cloacae 50 and 597. The total loss of these 
strains was determined at 5.8, 6.2 and 6.4 logio cfu/ml respectively. Error bars represent 95% confidence intervals. 
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4.4 DISCUSSION 
This desiccation survival study was designed to resemble the conditions present in PIF. The 
proposed period for monitoring the persistence was 2 years corresponding to the shelf-life of 
commercially available PIF products. Bacterial cultures were suspended in ready-to-use 
sterile infant formula so that the bacteria of interest were exposed to similar nutritional 
components to those in PIF. Commercially available PIF could not be used due to non-
sterility and skimmed milk powder does not have similar nutritious content of PIF. Hence, 
both were not deemed suitable for the purpose of the study. 
This study aimed to also optimise the recovery of injured bacterial cells after reconstitution. 
The incubation temperature and period, as well as the temperature of the water used for 
reconstitution were not intended to replicate the feed preparation and storage conditions in 
the hospital. The reason for this was to start the study with a high bacterial concentration in 
order to avoid a quick possible loss of detection of the persistent cells that could have 
otherwise been monitored over a longer period. 
To produce powdered infant formula, the liquid in the milk suspension is evaporated by 
exposing it to enough heat for a very short period of time that the material dries almost 
instantaneously. The equipment commonly employed for this procedure in the food industry 
is the spray dryer. For research purposes, laboratory scale spray dryers can be employed. 
However, this method could not be feasibly applied to this study due to its high cost, and the 
impracticality when multiple organisms are involved. In contrast, the procedure used in this 
desiccation study is more practical and reproducible in any laboratory. 
The biphasic survival curves observed in Figures 4.2 could be due to the presence of mixed 
populations in which a small proportion is more resistant. Desiccation stress imposed on the 
microbial cells may have generated desiccation-resistant mutants in part of the population 
that survived the non-lethal selective pressure, which was illustrated by the decline in viable 
cells followed by the stationary period. A n example of these survival changes was described 
elsewhere (Ramos et al., 2001) in which a large proportion of the E. coli population exposed 
to carbon starvation died after a few days, and survivors were nourished on what was released 
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from the dead cells. Eventually, the resistant mutants outnumbered the sensitive cells and 
remained viable for years (Ramos et al, 2001). 
Based on the comparison of the survival curves (Figure 4.2), the desiccated Acinetobacter 
strains were divided into 3 groups. Strains in the first category were considered the most 
sensitive to desiccation, and included type strains A. calcoaceticus N C T C 12983T and A. 
baumannWHCTC 12156T. The food isolates A. calcoaceticus (415), and Acinetobacter gensp. 
3 (418) formed the second cluster. The final group consisted of the clinical isolates; A. 
baumannii 1095, 1096, 1097, 1098, and 1099. Although the food and the clinical isolates all 
recovered after 2 years of storage, the latter group seemed to have a smaller proportion of the 
more sensitive cells in its populations, while the food isolates appeared to contain a larger 
proportion of these cells. This was suggested by the sharper declining of the second group. 
However, overall the organism is clearly able to successfully adapt to the prolonged 
desiccation stress, regardless of the source of isolation. The higher sensitivity of the type 
strains of A. baumannii and A. calcoaceticus compared to the remaining strains is not unusual 
and is in agreement with previous studies that monitored the desiccation persistence of 
species of the Enterobacteriaceae family (Caubilla-Barron and Forsythe, 2007; Jawad et al., 
1998a; Wendt et al, 1997). Although the A baumannii type strain did not survive as long as 
the other strains, it persisted for longer than reported in other studies when desiccated in 
distilled water (Jawad et al., 1998b; Wendt et al, 1997), which may indicate the protective 
role of the nutritional content of infant formula. Milk-based infant formula products contain 
milk fat, proteins, and lactose. These compositions are believed to provide some degree of 
protection to desiccated Acinetobacter strains through their protective osmotic effects 
(Gardiner et al, 2000; Lian et al, 2002). A previous observation by (Wang et al, 2004b) 
showed that the percentage recovery of spray-dried bifidobacteria increased from 16% and 
82.6% when dried with 10%) skimmed milk compared to gum arabic, gelatin, and soluble 
starch. Another factor contributing to the protection of bacterial cells against desiccation is 
believed to be the presence of the capsule by retaining water molecules, and hence 
prolonging the time taken by these cells to dry (Ophir and Gutnick, 1994; Roberson and 
Firestone, 1992). A l l the Acinetobacter strains tested in this study appeared to be capsulated 
and these capsules may have consequently enhanced their persistence under desiccated 
conditions. 
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It is apparent in this study that Enterobacteriacae strains (E. cloacae and E. hormaechei) 
reported to cause neonatal infections were more sensitive to desiccation than the 
Acinetobacter strains. E. cloacae, which is commonly found in PIF, was no longer 
recoverable by 10 and 12 months. Caubilla-Barron and Forsythe (2007) reported an 8 months 
survival period for E. cloacae when the same desiccation procedure was applied. The 
survival variation between strains within the same species is not exceptional. For instance, 
desiccation persistence of 10 Cronobacter sakazakii strains was described to be ranging from 
12 to 30 months (Caubilla-Barron and Forsythe, 2007). Different repair mechanisms adopted 
by different strains within the same species may attribute to these strain-dependent responses 
to dehydration. Of interest is that Acinetobacter strains studied here survived for longer than 
some Cronobacter sakazakii strains that were no longer detectable after 20 months (Caubilla-
Barron and Forsythe, 2007). C. sakazakii has been well known for its implication in life-
threatening neonatal infections such as meningitis and necrotizing enterocolitis in association 
with contaminated PIF (Bar-Oz et al., 2001; Lai, 2001). This observation highlights the 
virulence potential of Acinetobacter and also the possible relevance between the consumption 
of a feed containing Acinetobacter and the risk of neonatal infections. 
The ingested dose of Acinetobacter cells required for the initiation of a neonatal infection is 
not known. However, it is reasonable to propose that it could be relatively low given the state 
of the immune system and the deficiency in the competing gut flora of the neonate. High 
recovery of Acinetobacter from reconstituted PIF given to infants at a hospital in Cape Town 
has been reported (Marino et al, 2007). Eighty-two samples were analysed pre-incubation at 
different temperatures, while ninety-two samples were examined post-incubation. Pre-
incubated samples were found to contain 31 Acinetobacter isolates, 12 Bacillus isolates, and 
6 mixed cultures of Bacillus and Acinetobacter. When PIF was left to stand for 6h at 30°C, 
the detectable bacterial contamination in PIF increased from 8/34 to 18/34 samples. Overall, 
20/82 and 25/92 samples showed heavy contamination (> 104 cfu/ml) pre- and post-
incubation, respectively (Marino et al, 2007). The ingestion of this number of bacterial cells 
in a contaminated feed could potentially expose the neonates to a high risk of consequent 
infections. According to the Codex Alimentarius Commission (2008), pathogenic organisms 
in PIF should not be considered safe at any level since illnesses resulting from the 
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administration of contaminated PIF do not require a large number of pathogens, as even small 
numbers can colonize the neonate. 
In summary, this work is the longest reported desiccation persistence study to involve 
Acinetobacter and the first to be conducted in infant formula. The findings demonstrated the 
considerable ability of this organism to maintain its viability during long-term desiccation in 
infant formula and to efficiently recover after reconstitution. This recovery and subsequent 
proliferation, if allowed to happen, can be considered as a risk factor to the health of the 
neonate receiving the contaminated feed in the ICU. This risk would be greater i f bacterial 
cells were provided with an environment where they could establish themselves and increase 
in numbers. Such environment could be the enteral tubes, which are placed inside the 
nasogastric tract of the neonate and used for feeding. The next study investigated the biofilm 
formation inside enteral feeding tubes and the potential hazard associated with it for the 
neonate. 
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5.1 INTRODUCTION 
One of the predisposing factors for Acinetobacter infections is the use of invasive devices 
(Bergogne-Berezin and Towner, 1996; Dima et al, 2007; Jerassy et al., 2006; 
Thongpiyapoom et al., 2004; Wang et al., 2004a). On one hand, these devices are an essential 
part of medical care but on the other hand they serve as a source of acquisition and 
transmission of micro-organisms. Acinetobacter spp. is known for its ability to attach and 
form biofilms on abiotic surfaces such as glass and plastic (Loehfelm et al, 2008; Tomaras et 
al, 2003; Vidal et al, 1997; Vidal et al, 1996). Such a trait facilitates the colonization and 
survival of pathogens not only in the hospital environment but also in medical devices 
(Donlan and Costerton, 2002) where biofilms have been associated with severe clinical 
manifestations including bacteraemia, meningitis, and lower respiratory infections (Chen et 
al, 2007a; Rodnguez-Bano et al, 2008). 
Biofilms are likely to develop at the point where the medical device is inserted or on its 
surface as a result of local colonization, hematogenous spread from a distant site, or infusion 
of contaminated material (Crnich and Maki, 2002; Raad and Bodey, 1992). Enteral feeding is 
a standard practice used for nutritional provision to patients who have a functional 
gastrointestinal system but cannot ingest food orally (Matlow et al, 2003; Roberts, 2007). In 
contrast to parenteral feeding, enteral nutrition is generally associated with fewer 
complications (Kirby et al, 1995), as well as being cost effective (Tucker and Miguel, 1996), 
and helping to maintain the structure and the function of the gastrointestinal system (Abou-
Assi et al, 2002; Kalfarentzos et al, 1997; Gupta et al, 2003). However, bacterial 
contamination of the enteral formula is one of the recognized disadvantages of this method of 
nutritional support. Studies have previously identified enteral tubes as a reservoir for 
microbial contamination (Matlow et al, 2003; Mehall et al, 2002a; Roy et al, 2005). The 
acquisition of antimicrobial-resistant organisms such as vancomycin-resistant Enterococcus 
(Matlow et al, 2003; Mehall et al, 2002a; Weinstein et al, 1996), methicillin-resistant 
Staphylococcus aureus (MRSA) (Mehall et al, 2002a), and carriers of extended-spectrum 
beta lactamases {Escherichia coli and Klebsiella spp.) (Wiener et al, 1999) is not unusual via 
this route. Epidemiological and microbiological links between enteral feeding and feeding 
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intolerance, abdominal distention, aspiration pneumonia, diarrhoea, necrotizing enterocolitis, 
and even systemic infections such as sepsis caused by bacterial contamination have been 
found (Anderson et al., 1984; Anderton, 1993; Freedland et al., 1989; Wagner et al., 1994). 
Ingestion of enteral feeds contaminated with Acinetobacter spp. can also potentially serve as 
a risk factor for neonatal infections (FAO-WHO, 2006). Powdered infant formula can be 
intrinsically contaminated (Cawthorn et al, 2008; Marino et al, 2007; Miled et al, 2010) 
where this organism is likely to survive owing to its desiccation resistance capacity (as shown 
in the previous chapter). Alternatively, the prepared feed can be contaminated during 
preparation by the carer, environment, or the equipment. The presence of the organism in 
nasogastric feeding tubes collected from hospitalized patients has been previously reported. 
Desport et al (2004) described that Acinetobacter was one of the most common contaminants 
of the enteral feeding lines administered to 14-89 years patients. In addition, Okuma et 
al. (2000) determined high contamination levels of A. baumannii (10 cfu/ml) from a 
nasogastric feeding formula sample given to a 62 year-old female patient. Contact with the 
abiotic surface of an enteral feeding tube could subsequently lead to attachment and biofilm 
formation. 
The World Health Organization (WHO, 2007) have recommended using water at 70 °C or 
above to reconstitute PIF followed by the consumption of the feed within 2 hours of 
preparation. Avoiding the ambient temperature storage of the reconstituted feed in order to 
minimize the risks of neonatal infections was also recommended. This recommendation is not 
followed in all countries, such as USA, and is impractical when preparing small volumes of 
feed and fortifying breast milk. This proposition also did not take into account the time for 
which the enteral feeding tubes are at body temperature inside the nasogastric tract of the 
neonate, which can be for more than 48h (Hurrell et al, 2009a; Hurrell et al, 2009b; Mehall 
et al, 2002b). During this time, bacterial biofilm formation occurs and can act as loci for 
repeated microbial contamination of subsequent feeds entering the neonate stomach and 
intestines (Hurrell et al, 2009b; Mehall et al, 2002b). As the biofilm ages the cells begin to 
disperse in the form of clumps which may protect the cells from the stomach acidity owing to 
the presence of bacterial capsular material. Consequently, bacterial biofilm formation may 
pose a risk to neonatal health once the bacterial cells could evade the detrimental effects of 
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the acidity and transit into the intestinal tract (Kim et al, 2006). The complications resulting 
from this are significant in premature neonates due to the increased permeability of mucosa, 
immaturity of the immune system, and the undeveloped microflora of the gut (Greenough, 
1996; Mehall et al, 2002b). In addition, neonates in ICUs often require antibiotic treatment 
(Westerbeek et al, 2006) which, combined with the intrinsic susceptibility of the neonate, 
may render them highly vulnerable for potential infections when exposed to organisms such 
as Acinetobacter. These infections may not only be local gastrointestinal infections, but also 
systematic infections following translocation from the immature gastrointestinal system. This 
could be particularly serious considering that common antibiotics may not be effective 
against multidrug-resistant Acinetobacter strains. 
Although the isolation of Acinetobacter spp. from enteral feeding samples has been 
documented, the potential risk of exposure to neonatal Acinetobacter infections through 
enteral feeding required further elucidation. This was achieved by investigating the 
contamination of both the fresh enteral feeds administered to neonates and the lumen of the 
tubes due to biofilm formation. These investigations were conducted using practices similar 
to those applied in the healthcare setting, and based on applying the indirect Rapid 
Automated Bacterial Impedance Technique (RABIT) (Owens et al, 1989; Silley and 
Forsythe, 1996). Quantification of biofilm cells through this technique relied on measuring 
the decrease in the conductivity of the growth medium consequently to the production of 
carbon dioxide, which resulted from the metabolic activities of the organism present. 
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5.2 MATERIALS & METHODS 
5.2.1 Bacterial cultures and growth media 
Whey (Cow & Gatel), casein (SMA1), and soy-based (Cow & Gate infasoy) infant formula 
were used to grow eleven Acinetobacter cultures for 18-20h (stationary phase) at 37°C. The 
test strains, their sources and designated culture collection numbers are presented in Chapter 
1. A l l the strains were part of the preceding study (Chapter 4) except for three strains (1440, 
1182, andl 183) which were newly included here due to their later availability in the research 
culture collection. 
5.2.2 Determination of attachment and biofilm formation using the indirect impedance 
technique 
5.2.2.1 Preparation of potassium hydroxide agar 
The K O H agar was prepared as indicated by Dezenclos et al. (1994). Ten grams per litre of 
K O H (Sigma-Al drich, 221473) was dissolved in distilled water. Twenty grams per litre of 
bacteriological agar No. 2 (LAB M , MC006) was also prepared in distilled water and 
autoclaved for 15min at 121 °C. Equal volumes of the K O H solution and the agar were then 
mixed and kept at 60°C for 3h before used for the indirect impedance method described next. 
5.2.2.2 Construction of calibration curves 
Acinetobacter cultures grown in casein, whey, and soy-based infant formula for 18-20h at 
37°C were serially diluted to 10"7 cfu/ml. Sterile two-by-half tubes containing 2ml of the 
required infant formula type were inoculated, in duplicate, with 0.1ml of the dilutions. Two 
tubes containing un-inoculated infant formula were also included as negative controls. These 
test tubes were then placed inside specific electrode assembly tubes containing 0.75ml K O H 
agar, which was previously prepared and allowed to set across the electrodes. Neoprene 
rubber bungs were used to seal the tubes before loading into the Rapid Automated Bacterial 
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Impedance equipment (Don Whitley Scientific Ltd., UK). This equipment is composed of 
heating blocks into which the electrode assembly tubes are inserted. It also has a heating 
system for different incubation temperatures (± 0.001) in addition to a computer control 
system. Specific manufacturer's software designed to detect the conductivity was used. The 
metabolism of bacterial cells, present in the sample, would result in the production of C0 2 . 
The K O H agar would in turn absorb the released C 0 2 and lead to a reduction in conductivity. 
The detection criterion was set at - l l u S change monitored at 6 min intervals. The detection 
time was defined as the time at which three repeated decreases in conductivity, which were 
equal or larger than - l l u S , occurred. The values of time to detection (TTD) for all the 
bacterial dilutions in infant formula, incubated in the RABIT instrument at 37C for 24h, were 
plotted against the viability (logio cfu/ml) of the inoculum. The regression equations derived 
from these plots were used to calculate the doubling time of the test organisms. 
5.2.2.3 Biofilm setup 
Acinetobacter cultures grown in infant formula for 24 hours at 37°C were diluted to 104-105 
cfu/ml in sterile casein, whey, and soy-based infant formula before inoculation into 40 cm 
sterile polyvinylchloride enteral feeding tubes (Unomedical Ltd., UK) . These tubes were 
placed aseptically in sterile bottles and then incubated at 37 C. Two hours later, air was 
pushed gently through the tubes using a sterile syringe. The lumen liquid was retained for a 
viable count of the detached cells using the Miles and Misra plate count method. Four 2 cm 
lengths were cut from the feeding tubes, resulting in two duplicate samples. Within 10 min of 
preparation, the four pieces were transferred to two sterile two-by-half tubes each containing 
2ml sterile infant formulas. The tubes were then placed inside the impedance electrode 
assembly tubes containing 0.75ml K O H agar across the electrodes, and sealed with rubber 
bungs. These were then connected to the RABIT equipment. The remaining portion of the 
tubes had fresh sterile infant formula flushed into them before placing back in the 37 C 
incubator until the next time point. The procedure was repeated at 2h intervals for up to 10, 
24, and 48h. Each strain was tested for biofilm formation in duplicate. The same procedure 
was repeated three times with different types of infant formula and the results were 
compared. 
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5.2.2.4 Quantification of biofilm 
The tubes containing the test samples were connected to the RABIT equipment for 48h at 
37°C. The reduction in conductivity was detected and reported by the relevant computer 
software. Bacterial cells in the biofilm were calculated using the following formula: 
Bacterial concentration (logio cfu/2cm) = c + (m x TTD) 
Where c is the intercept, m is the slpoe, and T T D is the time to detection. These c and m 
values were derived from the calibration curves established in the same media for each test 
strain. 
5.2.3 Statistical analysis 
The data were statistically analysed in terms significant differences using the Student t-test. 
.P-values lower than 0.05 indicated significantly different results. In addition, those lower 
than 0.01 and 0.001 were considered highly significant, and very highly significant 
respectively. To examine the relationship between two datasets, the Standard correlation test 
(Pearson product-moment correlation) was applied. The measure of correlation (r) ranging 
from -1 to 1 shows the strength of the negative or positive correlation. The closer the r value 
to the zero the weaker the correlation is. 
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5.3 RESULTS 
Eleven Acinetobacter strains were evaluated for their time-course biofilm formation on 
enteral feeding tubes. Seven of which were clinical, and the remaining four were from food 
(2/4) and PIF samples (2/4). Viable counts of overnight cultures grown in the casein- (Cow & 
Gate 1), whey- (SMA 1), and soy-based infant formulas (Cow & Gate Infasoy) were 
determined before the start of the biofilm experiment in order to see if there was any 
preference towards a particular growth medium. The highest counts were found with eight of 
the eleven strains in Infasoy. However, they were not consistently significant. The average 
overnight cell count was 8.8, 8.9, and 9.1 logio cfu/ml in SMA, Cow & Gate, and Infasoy 
respectively. Results are shown in Figure 5.1 
The doubling time oi Acinetobacter strains varied between the infant formulas used, though 
no apparent tendencies was found among different species or isolates from different sources 
(Figure 5.2). The mean time taken for the populations of test strains to double in numbers 
was 73.5 min in Infasoy formula, while that in Cow & Gate and S M A was 79.9 and 77.2 min 
respectively. When the strains were compared against each other, both A. baumannii 1102 
(NCTC 12156T) and A. calcoaceticus 418 appeared to be distinctly slower to double in all 
infant formulas (> 100 min). 
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Figure 5.1 Viable count of overnight cultures grown in casein- (Cow & Gate 1), whey- (SMA 1), and 
soy-based (Cow & Gate Infasoy) infant formulas. 
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Viable counts of overnight cultures in different types of infant formula were determined before the start of the 
biofilm experiment in order to see if there was any preference towards a particular growth medium. However, no 
significant difference was found. Strains 1095, 1096, 1098, 1099, 1102, 1183, and 1440 are A. baumannii; 418 and 
1097 are A. calcoaceticus; 415 and 1182 are Acinetobacter gensp. 3. Error bars represent the standard deviation of at 
least two independent results. 
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Figure 5.2 Doubling times of Acinetobacter cultures grown in casein- (Cow & Gate 1), whey- (SMA 
1), and soy-based (Cow & Gate Infasoy) infant formulas. 
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Doubling times of the test organisms in different types of infant formula were determined by plotting the viable 
counts of each bacterial dilution (from 10"2 to 10"8) against the values of time to detection (TTD) monitored by the 
RABIT instrument. The regression equations derived from these plots were then used to calculate the doubling time, 
which was performed once. The mean time taken for the populations of test strains to double in numbers was 73.5 
min in Infasoy formula, while that in Cow & Gate and SMA was 79.9 and 77.2 min respectively. Strains 418 and 
1102 were distinctly slower to double in all infant formulas (>100 min). Strains 1095, 1096, 1098, 1099, 1102, 1183, 
and 1440 are A baumannii; 418 and 1097 are A calcoaceticus; 415 and 1182 are Acinetobacter gensp. 3. 
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According to the Pearson correlation test, the biofilm density determined at 2h and the 
doubling time for all strains were very weakly correlated (positive correlation; r = 0.16). 
Only 2.42% (r2 = 0.024) of the variation in biofilm cell counts can be accounted for by the 
doubling time. When the same statistical analysis was applied, a positive correlation between 
the incubation duration and biofilm densities was found (r = 0.70, P < 0.001). Squared-r was 
0.49 meaning that 49.0% of the variation in biofilm cell counts can be explained by the length 
of time the feeding tube was placed at body temperature (37°C). The impact of the length of 
incubation time on the biofilm density was apparent. The numbers of cells forming biofilms 
progressively increased as the feeding tubes were left longer at the body temperature (Figure 
5.3-5.5). The results can be interpreted as a best-fit line of biofilm formation= 0.0556 x 
Incubation time + 4.45. In comparison with data collected at 2h, cell counts at 4h were not 
regarded as statistically significant (P > 0.05). In contrast, numbers of biofilm cells 
determined at 6 to 48h were generally significantly to highly significantly greater (P < 0.05 
and P < 0.01). However, some occasional drop in the biofilm density values was recorded 
during the time-course across all the test strains. These decreases did not exhibit a consistent 
trend that could be associated with an incubation time of the infant formula inside the enteral 
feeding tubes. 
Overall values of biofilms formed on enteral feeding tubes varied between strains in each 
formula (Figure 5.3-5.5). In contrast, the quantities of these biofilms did not differ 
significantly (P > 0.05) between the types of infant formulas over the time-course. The ability 
to attach to these tubes, within 2h of incubation at body temperature (37 C), was evident with 
all the test strains. Generally, 0.3-1.2, 0.6-1.2, and 0.6-1.1 logio cfu/2cm of the inocula in 
Cow & Gate, SMA, and Infasoy were found adhering, respectively (Figure 5.3-5.5). Cell 
counts of 1098, 415, and 1096 were 0.8, 7.9, and 15.5% higher than the initial inocula, after 
2h, when grown in Cow & Gate. This equated to an increase of 0.04, 0.4, and 0.7 log10 
cfu/2cm respectively (Figure 5.3). The remaining strains were counted at between 1.7 and 
4.8 logio cfu/2cm, decreasing by 3.4 to 0.1 logio cfu/2cm. In SMA, four strains (1099, 418, 
1098, and 1440) showed adherence percentages > 100.0%, with 0.2, 0.3, 0.4, and 1.2 logio 
cfu/2cm cell growth respectively (Figure 5.4). That of the other seven strains was 56.8-
99.3%) (2.2-0.03 logio cfu/2cm lower than the inocula). In Infasoy, nine of the eleven strains 
98 
Chapter 5. Biofilm Formation ofAcinetobacter Inside Enteral Feeding Tubes 
exhibited 56.6-99.6% attachment, while 1099 adhered at 108.5% and 1097 at 111.1% 
corresponding to increases of 0.4 and 0.5 log10 cfu/2cm respectively (Figure 5.5). 
At 24h, biofilm cell counts reached 4.2 to 8.2 log10 cfu/2cm (mean = 6.2) in Cow & Gate and 
5.0 to 8.0 logio cfu/2cm in S M A (mean = 6.9) (Figure 5.3 & 5.4). Those in Infasoy were 
averaged at 6.1 logio cfu/2cm, and ranged between 3.0 and 7.7 logio cfu/2cm (Figure 5.5). It 
was evident that biofilm formation was significantly high in Infasoy (p < 0.01), and also very 
significantly high in Cow & Gate and S M A (p < 0.001) in comparison to cell counts obtained 
at 2h post-infection of the enteral feeding tubes. The mean increase in the biofilms formed 
was 55.0, 60.6, and 78.6%> in Infasoy, SMA, and Cow & Gate respectively (2.1, 2.6, and 2.2 
logio cfu/2cm). By 48h, biofilm counts ranged from 4.4 to 8.6 logio cfu/2cm (mean = 6.5) in 
Cow & Gate (Figure 5.3), and from 5.7 to 9.2 logio cfu/2cm (mean = 7.6) in S M A (Figure 
5.4). In Infasoy, biofilm densities were between 2.9 and 9.1 logio cfu/2cm (mean = 6.3) 
(Figure 5.5). Bacterial cells adhered inside the enteral feeding tubes continued to grow by an 
average of 1.0 logio cfu/2cm in Cow & Gate, 1.1 logio cfu/2cm in SMA, and 1.4 logio 
cfu/2cm in Infasoy, relatively to values at 24h. 
The number of bacterial cells in the lumen, which would be flushed out with each feed and 
replaced with sterile infant formula, was determined by viable plate count (Figure 5.6-5.8). 
No significant variation was, generally, found between the different types of formulas apart 
from the cell counts in Infasoy at 48h, which were highly (p < 0.01) to very highly greater (p 
< 0.001) than those in Cow & Gate, and S M A respectively. When the data for all strains at 
each time point were pooled and compared, the number of bacterial cells in the fresh feeds, 
administered two hours after inoculation with 104-105 cfu/ml, was found to vary between 5.1 
and 8.9 logio cfu/ml. The average viable count that could have gained access to the neonatal 
stomach was 6.7 logio cfu/ml. Following incubation for 6 and 8 hours, the bacterial count had 
respectively increased by 0.1-2.9 logio cfu/ml and 0.3-3.3 logio cfu/ml compared to the 2h 
samples. At 24h, much higher (P < 0.001) levels of bacteria were detected in the lumen, 
reaching between 7.8 and 10.0 logio cfu/ml. After 48h, the lowest level of contamination 
detected was 6.9 logio cfu/ml, while the highest was 10.9 logio cfu/ml (P < 0.001). 
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Figure 5.3 Biofilm densities of Acinetobacter strains in casein-based infant formula (Cow & Gate 1). 
Cow & Gate 1 infant formula containing the test strains were inoculated into the enteral feeding tubes and incubated 
for 2h at 37°C. Fresh sterile infant formula was then flushed into these tubes at two hourly intervals for 48h. 
Quantification of biofilm cells attached the tubes was achieved using the direct rapid automated bacterial impedance 
technique at the sampling times specified above. The reduction in conductivity, due to the activity of the organism in 
the sample, was detected. The detection time was compared to that of the calibration curve to determine the number 
of bacterial cells forming the biofilm. Attachment to the feeding tubes was evident with all strains within 2h of 
incubation, and the majority of the biofilms formed by different strains reached their highest densities after 48h 
Some of the biofilm values displayed above were widely spread. These variations were assumed to be due to the loss 
of weakly adhered cells. Strains 1095, 1096, 1098, 1099, 1102, 1183, and 1440 are A baumannii; 418 and 1097 are 
A. calcoaceticus; 415 and 1182 are Acinetobacter gensp. 3. Error bars represent the standard deviation of two values 
per sampling point. 
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Figure 5.4 Biofilm densities of Acinetobacter strains in whey-based infant formula (SMA 1). 
Biofilm formation tendencies exhibited in the whey-based formula (SMA 1) were similar to those in the casein-based 
formula under the same experiment conditions. Within 2 h of incubation at body temperature (37°C), 0.6-1.2 loglO 
cfu/2cm of the inocula (T0 = 104-105 cfu/ml) were found adhering. At 24h, biofilm cell counts reached 5.0 to 8.0 logio 
cfu/2cm (mean = 6.9) and were very highly significant (p < 0.001) compared to those obtained at 2h. Cells adhered 
to the enteral feeding tubes continued to grow by an average of 1.1 logio cfu/2cm relatively to values at 48h. By 48h, 
biofilm counts ranged from 5.7 to 9.2 log10 cfu/2cm (mean = 7.6). Bacterial Strains 1095, 1096, 1098, 1099, 1102, 
1183, and 1440 are A. baumannii; 418 and 1097 are A. calcoaceticus; 415 and 1182 are Acinetobacter gensp. 3. 
Error bars represent the standard deviation of two values per sampling point. 
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Figure 5.5 Biofilm densities of Acinetobacter strains in soy-based infant formula (Cow & Gate 
Infasoy). 
By 2 hours of incubation, strains inoculated into the Infasoy formula exhibited 0.6-1.1 logio cfu/2cm attachment of 
the inocula. Biofilm cell counts ranged between 3.0 and 7.7 logio cfu/2cm and were highly significant (p < 0.01) after 
24h in comparison to cell counts obtained 2h post-inoculation of the enteral feeding tubes. The mean increase in the 
biofilms formed was 2.1 logio cfu/2cm. Bacterial cells continued to grow by an average of 1.4 logio cfu/2cm 
relatively to the values at 48h. By 48h, biofilm counts ranged from 2.9 to 9.1 logio cfu/2cm (mean = 6.3 logio 
cfu/2cm). Strains 1095, 1096, 1098, 1099, 1102, 1183, and 1440 are A. baumannii; 418 and 1097 are A. 
calcoaceticus; 415 and 1182 are Acinetobacter gensp. 3. Error bars represent the standard deviation of two values 
per sampling point. 
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Figure 5.6 Cell numbers of Acinetobacter strains in the residual casein-based infant formula (Cow & 
Gate 1) inside feeding tubes. 
The number of bacterial cells in the lumen, which would be flushed out with each feed and replaced with sterile 
infant formula, was determined by viable plate count. Two hours after inoculation with 104-105 cfu/ml, bacterial cells 
in the fresh feed were found to vary between 5.1 and 8.9 logio cfu/ml. The average viable count that could have 
gained access to the neonatal stomach was 6.8 logio cfu/ml. Following incubation for 6 and 8 hours, the bacterial 
count had respectively increased by 0.1-2.7 logio cfu/ml and 1.2-3.3 logio cfu/ml compared to the 2h samples. At 
24h, much higher (P < 0.001) levels of bacteria were detected in the lumen, reaching between 8.2 and 9.8 logio 
cfu/ml. After 48h, the lowest level of contamination detected was 8.5 logio cfu/ml, while the highest was 9.9 logio 
cfu/ml (P < 0.001). Strains 1095, 1096, 1098, 1099, 1102, 1183, and 1440 are A baumannii; 418 and 1097 are A 
calcoaceticus; 415 and 1182 are Acinetobacter gensp. 3. 
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Figure 5.7 Cell numbers ofAcinetobacter strains in the residual whey-based infant formula (SMA 1) 
inside feeding tubes. 
Two hours after inoculation, bacterial cells in the fresh feed were found to vary between 5.8 and 7.8 log10 cfu/ml. 
The average viable count that could have gained access to the neonatal stomach was 6.7 logio cfu/ml. Following 
incubation for 6 and 8 hours, the bacterial count had respectively increased by 0.4-2.1 logio cfu/ml and 0.3-1.8 logio 
cfu/ml compared to the 2h samples. At 24h, much higher (P < 0.001) levels of bacteria were detected in the lumen, 
reaching between 7.8 and 9.9 logio cfu/ml. After 48h, the lowest level of contamination detected was 6.9 logio 
cfu/ml, while the highest was 9.6 lo&o cfu/ml (P < 0.001). Strains 1095, 1096, 1098, 1099, 1102, 1183, and 1440 are 
A. baumannii; 418 and 1097 are A calcoaceticus; 415 and 1182 WQ Acinetobacter gensp. 3. 
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Figure 5.8 Cell numbers of Acinetobacter strains in the residual soy-based infant formula (Cow & 
Gate Infasoy) inside feeding tubes. 
Two hours after inoculation, bacterial cells in the fresh feed were found to vary between 6.2 and 7.5 logio cfu/ml. 
The average viable count that could have gained access to the neonatal stomach was 6.7 logio cfu/ml. Following 
incubation for 6 and 8 hours, the bacterial count had respectively increased by 0.3-2.9 logio cfu/ml and 0.5-2.2 logio 
cfu/ml compared to the 2h samples. At 24h, much higher (P < 0.001) levels of bacteria were detected in the lumen, 
reaching between 8.7 and 10.0 logio cfu/ml. After 48h, the lowest level of contamination detected was 9.1 logio 
cfu/ml, while the highest was 10.9 log10 cfu/ml (P < 0.001). Strains 1095, 1096, 1098, 1099, 1102, 1183, and 1440 
are A baumannii; 418 and 1097 are A calcoaceticus; 415 and 1182 WQ Acinetobacter gensp. 3. 
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5.4 DISCUSSION 
The exposure of neonates to Acinetobacter in the healthcare setting was simulated using 
enteral feeding tubes as an inert support, and sterile ready to feed infant formula (suitable for 
the needs of babies from birth to 3 months) as a nutrient source. The formula was spiked with 
the test organisms grown to the early stationary phase. This was standardized so that 
variations in the attachment and the formation of biofilm, owing to different physiological 
states of bacterial cells, were avoided. Of note is that bacterial cells were not exposed to 
desiccation stress, as would be the case with those present in PIF. 
This study showed no significant variation between strains of different Acinetobacter species 
in terms of the density of the biofilms formed. The biofilm cell density was not dependent 
upon strain source; follow up infant formula, food, or clinical. A l l tested strains persisted in 
the feeding tubes where cells adhered within 2h of inoculation and multiplied thereafter. The 
biofilm formation capacity of A. baumannii strain 1183 and Acinetobacter genosp. 3 
strainl 182, both isolated from follow up formula, was comparable to that of the other clinical 
strains giving support to the clinical significance of Acinetobacter contaminated feed. The 
ability of A. baumannii 1102 (ATCC 19606T) to form biofilm in the enteral feeding tube was 
consistent with Tomaras et al. (2003) who demonstrated the strain's capacity to colonise 
polypropylene, polystyrene, and Teflon. 
In a previous work by Hurrell et al. (2009a), the average cell density of biofilms formed by A. 
calcoaceticus strain 418 were 0.5, and 1.3 logio cfu/cm in different types of feeding tubes 
(polyurethane and polyvinylchloride respectively). The same strain in this current study 
showed greater biofilm densities (2.5, 3.5, and 2.5 log10 cfu/cm in casein-, whey-, and soy-
based infant formula respectively). Differences could be attributed to the different impedance 
technique applied in this study (indirect impedance) which appears to be more suited to the 
non-fermentative nature of Acinetobacter as opposed to the direct method previously used by 
Hurrell et al. (2009a). 
106 
Chapter 5. Biofilm Formation of Acinetobacter Inside Enteral Feeding Tubes 
Biofilm formation is influenced by the components of the medium in which the biofilm 
develops (Gerstel and Romling, 2001; Hood and Zottola, 1997; Kim et al, 2006; Stepanovic 
et al., 2003). This is due to changes in the characteristics of the bacterial cell surface (Kim et 
al., 2006). The biofilm production by organisms such as the Cronobacter spp. is higher under 
nitrogen-rich conditions (whey-casein) than under carbohydrate-rich conditions (Dancer et 
al, 2009). The infant formulas used were rich in milk protein and contained various nitrogen 
sources (casein, whey, and soy). The other components in these media were similar. 
Acinetobacter strains did not show significant differences in terms of the rates of cell growth 
or the levels of biofilm formation. The results are in agreement with Dancer's observation 
(2009) that the biofilm density of Cronobacter was similar in skimmed milk containing 
casein and that with added whey. To know whether various carbon sources would make any 
difference in terms of the biofilm formation, Tomaras et al. (2003) also examined 
Acinetobacter cells cultivated in a chemically defined medium (Simmons salts) supplemented 
with different carbon sources such as acetate, citrate, ethanol, lactate, pyruvate, or succinate. 
No significant effect was found in this respect. 
Adhesion characteristics oi Acinetobacter cells cultivated on innate surfaces can change as a 
response to the nutrient state (James et al, 1995). Infant formula is rich in nutrients and in 
such environments the attachment of Acinetobacter cells may become unstable and 
continuously migrate across the surface in what is called the spreading maneuver (Lawrence 
and Caldwell, 1987). A similar type of spreading behavior was observed during surface 
growth of Pseudomonas (Marshall, 1988). Although this dispersive surface colonization 
allows expansion of the population over a surface, these weakly attached cells may detach 
more easily due to the liquid flow of subsequent enteral feeds (James et al, 1995). The non-
uniform disruption of adhered cells due to the sheer forces of the liquid stream was apparent 
in the fluctuation in the biofilm viable count during the 48h time-course. An additional reason 
could be irregular colonization of the tube surface. This inconsistency of the biofilm density 
is of clinical importance as it underlines the fragile nature of the biofilm inside the enteral 
feeding tube and the frequent dispersion of bacterial clumps in fresh feeds as a consequence. 
Colonization of enteral feeding tubes by Acinetobacter may occur not only during placement 
but also as a result of the administration of contaminated feeds. Therefore, to reduce this risk, 
the microbiological safety of neonatal feeds should be ensured during the general preparation 
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and handling of formula and feeding systems. The time the feed is left at room temperature, 
after opening and before administration, should also be minimized. Reconsideration of the 
prolonged nasogastric positioning of the feeding tube is also advised. 
According to Hurrell et al. (2009b), the enteral nutritional regime given to hospitalized low 
birth weight infants in the NICUs involves regular fresh feeding every 2 to 3h via enteral 
feeding tubes. It is also reported that 13% of the feeding tubes are in place for more than 48h 
(Hurrell et al., 2009b). This study demonstrates the consequential contamination of feeds due 
to lumen bacteria. The time during which the tubes are in place at body temperature in the 
nasogastric tract may pose a greater risk for allowing bacterial proliferation, than during the 
actual feeding that may last less than 30 min (Hurrell et al., 2009b). The prolonged use of the 
same feeding tubes for enteral feeding allowed these tubes to serve as a reservoir for 
continuous exposure of the neonate to rapidly growing opportunistic pathogens. The average 
viable counts of Acinetobacter isolated from the lumen liquid increased to 9.3 log10 cfu/ml in 
48h and that reflects the number of bacterial cells that could be flushed, with the each regular 
feed, into the stomach of the neonate. The colonized tubes may also result in clumps of 
bacteria entering the stomach, protected from the low acidity due capsule formation. 
The bioburden of bacterial cells shed from the biofilm that could overcome the host defenses 
is unknown. The risk is not only the competency of the developing immune system and the 
lack of a competitive intestinal microflora, but also resistance to host defenses and antibiotics 
(Fux et al, 2004; Lee et al., 2008). Biofilm cells can grow and thrive in the presence of large 
concentrations of antibodies directed against epitopes on their surfaces, and can withstand the 
attack of activated phagocytes (Jensen et al., 1990). These cells can also be less sensitive to 
acidic conditions (Hurrell et al., 2009b), which is rarely sustained in the neonate stomach as 
the pH tends to be above 4.0 for prolonged periods of time due to frequent feeding (Hurrell et 
al, 2009b; Mitchell et al., 2001; Washington et al, 1999). Frequent and short intervals in 
feeding do not allow enough time for the pH to go down to levels similar to that in the adult 
stomach. The long maintenance of the high pH levels with the highest reached at feeding 
times (Sondheimer et al., 1985), when the organism in the contaminated feed is ingested, may 
offer a greater chance of bacterial survival, colonization, and potentially subsequent 
infections in the neonate. Although some pathogens lose their viability to a certain extent, 
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they are not completely killed or eradicated at such pHs (Edelson-Mammel et al, 2006; 
Koutsoumanis et al., 2004; Koutsoumanis and Sofos, 2004). 
Cells growing in biofilms are generally highly resistant to antimicrobial agents (Lee et al., 
2008). The enhanced rates of horizontal gene transfer and recombination between bacterial 
cells within biofilm communities facilitate the spread of antibiotic resistance (Bergogne-
Berezin and Towner, 1996; Donlan and Costerton, 2002), and provide biofilms a very high 
level of genomic diversity where it is expected that at least a small proportion of cells will 
withstand the impact of any antibiotic (Boles et al, 2004). Antibiotic pressure might also 
select for antibiotic resistant strains, which are capable of forming biofilm. The problem with 
the high levels of antibiotic resistance is that it may not only be challenging in terms of the 
choice of treatment and the difficulty to sometimes clear the infection but also lies in the 
possibility of severe consequences to vulnerable neonates. This could be caused as a result of 
the delay in recognising that the bacterium is actually resistant to the antibiotic of choice and 
hence the delay in using the effective treatment which takes between 24-48h for culturing and 
susceptibility testing (Hurrell et al, 2009b). 
In summary, this research study investigated the extent to which Acinetobacter strains form 
biofilms over 48h at the neonate's body temperature using an enteral feeding routine that 
mimics the healthcare practices in NICUs. Biofilm densities were also compared in three 
infant formula made by different manufacturers for our target age (0-3 months) to meet the 
different nutritional needs of neonates. This work also provided detailed evidence of the role 
that enteral feeding plays in prolonging the exposure to Acinetobacter commonly associated 
with multiple antibiotic resistances. It also highlighted that the enteral feeding tube serves as 
a risk factor by providing bacterial cells with an environment where they can establish 
themselves and increase in numbers, which may hence increase the risk of infections to 
infection-prone neonates. 
Although Acinetobacter strains have proven their ability to form biofilms on enteral feeding 
tubes, success in causing an infection through the ingestion route would also require them to 
survive during gastrointestinal passage. Therefore, the aim of the next chapter was to study 
the survival of this organism under conditions similar to those present in the gastrointestinal 
tract. 
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6.1 INTRODUCTION 
Acidity in the stomach acts as a major line of defence in protecting against infections through 
ingestion (Martinsen et al, 2005; Smith, 2003). The average stomach's pH value of neonates 
given ready-to-feed and powdered infant formulas ranges from 3.5 to 4.3 (Hurrell et al., 
2009b). According to Zhu et al. (2006), the majority of bacteria are killed at a pH lower than 
2.0. The bacterial killing in the stomach is also facilitated by the proteolytic activity of the 
gastric enzymes as they cause the release of peptides from, for example, lactoferrin which in 
turn act as antimicrobials (Nibbering et al., 2001; Ryley, 2001). Other studies showed that 
adding lactate can overcome the acid tolerance of E. coli 0157:H7 at a pH 3.0 and lead to cell 
death as a result of the drop in the pH of the bacterial cytoplasm (Jordan et al., 1999). 
Survivors of the acid barrier in the stomach will pass through the duodenum and jejunum in 
the small intestines where they would be subjected to the stress of the flushing forces of 
peristalsis, digestive enzymes, and bile secretions which all hinder the bacterial colonisation 
of these regions (Wilson et al, 2002). Digestive enzymes (e.g. lipase, nuclease, peptidase, 
and trypsin) aid the process of degrading food macromolecules in order to produce products 
which have low molecular mass and can be absorbed by the intestinal cells (Wilson et al, 
2002). This is not their sole activity as they also exert an antibacterial effect (Rubinstein et 
al, 1985; Wilson et al, 2002). Beside their main role in emulsifying and solubilizing lipids 
(Wilson et al, 2002), bile acids form another part of the intestinal defence system due to their 
ability to dissolve the proteins of cell membranes, phospholipids, and cholesterol, resulting in 
cell lysis (Flahaut et al, 1996; Hofmann, 1994; Kristoffersen et al, 2007; Leverrier et al, 
2003; Schmidt and Zink, 2000). Their antimicrobial effect is also caused by the oxidative 
stress and D N A damage (Kandell and Bernstein, 1991; Sokol et al, 1995). Bile secretion is a 
mixture of primarily bile acids found physiologically in the form of sodium salts. These bile 
acids (deoxycholic, cholic, and lithocholic acids) are synthesized and conjugated with either 
taurine or glycine in the liver. They are then stored and concentrated in the gallbladder during 
the fasting state (Hofmann and Mysels, 1992). The effects of bile salts have rendered them 
useful as selective agents, specifically against Gram-positive bacteria, in various growth and 
enrichment media. Considering the substantial challenge represented by the exposure to bile, 
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it has been argued that bile tolerance may be a prerequisite for organisms to survive and 
colonize the intestinal region (Begley et al., 2002). Intestinal pathogens as well as the 
commensal microbiota all possess such ability (Pace et al., 1997; Pope et al., 1995; Prouty et 
al, 2002; Thanassi et al, 1997; van Velkinburgh and Gunn, 1999). 
The effects of stress factors present in the gastrointestinal tract have not been explored with 
respect to Acinetobacter\ The role of the gastrointestinal juices in preventing the colonization 
by this organism is yet to be elucidated. The available information is mainly about the clinical 
isolation of the organism from neonates and adult patients admitted to ICUs. Isolation from 
the stomach was reported by Garvey et al. (1989), Garrouste-Orgeas et al. (1997), and M a et 
al. (1999). Colonization by Acinetobacter spp. (Ofori-Darko et al, 2000) and A. Iwoffii 
(Zavros et al, 2002) was also shown in the mouse stomach. A clinical isolate of A. Iwoffii 
was later found in a gastric tissue culture (Kim et al, 201 la). Parm et al. (201 la, b) reported 
the rectal colonization of neonates with Acinetobacter spp. during the first five weeks of their 
lives, while Thorn et al. (2010) identified 6 critically ill adult patients with A baumannii from 
perirectal cultures. A. baumannii was also found in the gut of 11% (25/228) of the neonates in 
NICUs (Roy et al, 2010). In addition, 23 cases of neonatal gut colonization with 
Acinetobacter spp. were described in another study (Parm et al, 2010). 
Limited information is available with respect to the capacity of Acinetobacter to colonize the 
gastrointestinal system. Hence, scientific evidence shedding light on this relatively 
unexplored topic would be of great importance. The aim of this study, therefore, was to 
assess the survival of Acinetobacter under different physiological elements, which can have 
implications on the establishment of this organism in the gastrointestinal environment. The 
effects of acidic pH, gastric and pancreatic enzymes, and the bile secretion were investigated 
for this purpose. 
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6.2 MATERIALS & METHODS 
6.2.1 Bacterial strains 
The same strains that were previously studied for their desiccation survival in infant formula 
(Chapter 4.) were also examined in this study in order to mimic their behaviour through the 
ingestion route. 
6.2.2 Inocula preparation 
Acinetobacter cultures were grown in °ml sterile ready-to-feed infant formula (Cow & Gate 
1) and incubated for 18h at 37°C. The cell density of these overnight cultures on the day of 
the experiment was ~106-108cfu/ml. 
6.2.3 Preparation of simulated gastrointestinal fluids and acidified infant formula 
6.2.3.1 Gastric fluid 
The gastric fluid was prepared as described by Charteris et al. (1998), as well as Huang and 
Adams (2004) with slight modifications. The gastric juice was simulated by dissolving 3g/l 
pepsin in 0.5% (w/v) saline before it was filter sterilised using a 0.45um pore diameter 
cellulose filter. However, the pH (7.0) for the pepsin solution was kept neutral and was not 
adjusted. This was on purpose in order to separately study the effect of the pepsin enzyme as 
a single stress condition in this experiment. 
6.2.3.2 Small intestinal fluid 
The small intestinal fluid was prepared according to Koo et al. (2001). Porcine pancreatin 
(Sigma-Aldnch, P8096) (3.5g/l) and 0.1g/l porcine trypsin type 1X-S (Sigma-Aldnch, 
T0303) were added together and dissolved in distilled water at pH 7.0. A 0.45um-pore 
diameter cellulose filter was used to sterilise this solution. 
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6.2.3.3 Biliary fluid 
Simulated biliary secretions (pH 7.0), which were described by Koo et al. (2001), consisted 
of 40g/l porcine bile (Sigma-Aldrich, B8631) dissolved in distilled water and filtered by a 
0.45 urn pore diameter cellulose filter. 
6.2.3.4 Acidified infant formula 
Sterile infant formula was acidified to pH 2.5, 3.5, and 4.5 using 1M HC1 (Sigma-Aldrich, 
HI758). The pH was determined aseptically by transferring 3ml of the acidified infant 
formula into a small bijou. The pH reading of the transferred volume was determined on a pH 
meter. The pH was adjusted to the desired value by the addition of small aliquots of 1M HC1 
whereas the 1M NaOH (Sigma-Aldrich, 72082) was added where the pH for the infant 
formula was lower than required. 
6.2.4 Acid, pepsin, small intestinal fluid, and bile salts tolerance assays 
To examine the effect of simulated acidic conditions in a neonatal stomach on the viability of 
Acinetobacter ingested through a contaminated feed, 15ul of the overnight (18h) cultures in 
infant formula were inoculated into 135ul of the pH adjusted formula, which was pre-
aliquoted into 96-well plates. The temperature of the formula at the time of the inoculation 
was 37°C. The inoculated plates were then kept at 37°C for 2h. At specific time points (0, 15, 
30, 45, 60, 90, 120 min), aliquots (15ul) were transferred into fresh 96 well plates containing 
sterile saline and then serially diluted. The viable count of these samples were enumerated on 
nutrient agar (NA) using the Miles and Misra method. 
Similarly to the acid survival assay, the viability of Acinetobacter during the exposure to the 
enzyme pepsin and the simulated small intestinal fluid containing porcine pancreatin and 
porcine trypsin was assessed using the Miles and Misra method. Overnight (18h) cultures in 
infant formula were inoculated (15ul) into 135ul of the test solution (37°C), which was pre-
dispensed into 96-well plates. Serial dilutions of the inoculated samples were prepared 
directly after inoculation (T0) and plated onto N A applying the Miles and Misra method. The 
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same plate count procedure was repeated after 15, 30, 60, 90, 120 min of incubation at 37°C. 
The plates remained at this temperature for the whole duration of the experiment and were 
only taken out of the incubator during the rapid transfer of the 15ul of all the samples at once, 
using a multi-channel pipette. The rest of the viable count steps (serial dilutions and plating) 
were carried out while the original inoculated solutions were kept at the required temperature 
(37°C). 
The presence or absence of Acinetobacter recovery was also examined in 0.125, 0.25, 0.5, 1, 
and 2% porcine bile solutions. Approximately lOul aliquots of the overnight cultures, diluted 
ten-fold in the specified bile solutions, were transferred onto N A plates after 5, 10, 15, 30, 45, 
60, 90, and 120 min of incubation at 37°C. The inoculated plates were incubated at 37°C and 
were checked 24h later. The initial inocula sizes were determined by carrying out the Miles 
and Miles plate count directly after inoculation (T0). To evaluate the viability of 
Acinetobacter strains in 4% porcine bile, the same procedure as those of the pepsin and 
intestinal survival assays was followed at 0, 30, 60, 90, and 120 min. A l l the experiments, 
described above, were conducted twice and the results were expressed as the average of the 
logio cfu/ml values. 
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6.3 RESULTS 
6.3.1 Acid tolerance 
Acinetobacter strains were challenged for 120 min under three acidic levels (pH 2.5, 3.5, and 
4.5). The upper value (pH 4.5) exhibited an initial effect on the viability of all 8 strains where 
there was an average decrease between 1.0 and 2.2 logio cfu/ml (strain 1099 and 1096 
respectively) during the first 15 min of acid exposure (Figure 6.1). The following sampling 
points did not show significant reduction in cell counts of seven of the test strains (P > 0.05). 
The exception was strain 418 after 60 min. Overall, survival tendencies of the different 
strains at this pH (4.5) were statistically similar (P > 0.05). When the pH was lowered to 3.5, 
acidity caused the number of viable cells to drop by 1.0 to 1.3 logio cfu/ml within 15 min of 
exposure (Figure 6.2). Persistence of the Acinetobacter strains at consistent levels (P > 0.05) 
was apparent afterwards for the remaining duration of the assay (120 min). The acidified pH 
2.5 solution caused a very highly significant (P < 0.001) decline of the bacterial populations 
which was evident in all test strains (Figure 6.3). The complete cell loss by the last detection 
times ranged between 2.9 and 5.8 logio cfu/ml. Different strains showed different acidity 
endurances and according to the comparison of their survival times they were categorised 
into acid sensitive, moderately acid tolerant, and acid tolerant at pH 2.5. A. baumannii (1096, 
1099), A. calcoaceticus (1097), and Acinetobacter gensp. 3 (415) all remained viable for 60 
min and therefore were regarded as acid tolerant. The, moderately, acid tolerant A. baumannii 
(1098) was last detected at 45 min of exposure to low acidity. A. baumannii A T C C 19606T 
(1102) and strain 1095, as well as A. calcoaceticus (418) all exhibited the shortest survival 
time at 30 min. 
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Figure 6.1 Survival curves of Acinetobacter strains in infant formula at p H 4.5. 
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Acinetobacter strains were challenged for 120 min under pH 4.5 and the viable counts were determined using the 
Miles & Misra method. This pH value exhibited an initial effect on the viability of all 8 strains where there was a 
decrease between 1.0 and 2.2 logio cfu/ml (strain 1099 and 1096 respectively) during the first 15 min of acid 
exposure. The following sampling points did not show significant reduction in cell counts of seven of the test strains 
(P > 0.05). The exception was strain 418 after 60 min. Overall, survival tendencies of the different strains at this pH 
were statistically similar (P > 0.05). Strain 415 is Acinetobacter gensp. 3.; 418 and 1097 are A calcoaceticus; 1095, 
1096, 1098, 1099, and 1102 are A. baumannii. Error bars represent the standard deviation of two independently 
repeated experiments. 
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Figure 6.2 Survival curves of Acinetobacter strains in infant formula at p H 3.5. 
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When the pH was lowered to 3.5, acidity caused the number of viable cells to drop by 1.0 to 1.3 log10 cfu/ml within 
15 min of exposure. Persistence of the Acinetobacter strains at consistent levels was apparent afterwards for the 
remaining duration of the assay (120 min). Strain 415 is Acinetobacter gensp. 3.; 418 and 1097 are A calcoaceticus; 
1095, 1096, 1098, 1099, and 1102 are A. baumannii. Error bars represent the standard deviation of two 
independently repeated experiments. 
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Figure 6.3 Survival curves ofAcinetobacter strains in infant formula at p H 2.5. 
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The acidified pH 2.5 infant formula caused a very highly significant (P < 0.001) decline of the bacterial populations 
which was evident in all test strains. The complete cell loss by the last detection time ranged between 2.9 and 5.8 
logio cfu/ml. Different strains showed different acidity endurances. A. baumannii (1096, 1099), A. calcoaceticus 
(1097), and Acinetobacter gensp. 3 (415) all remained viable for 60 min and therefore were regarded as acid tolerant. 
The moderately acid tolerant A baumannii (1098) was last detected at 45 min. A. baumannii ATCC 19606T(1102) 
and strain 1095 and A calcoaceticus (418) all exhibited the shortest survival time at 30 min. Error bars represent the 
standard deviation of two independently repeated experiments. 
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6.3.2 Pepsin tolerance 
The effect o f the pepsin enzyme on Acinetobacter was determined by the enumeration of 
viable cells at 0, 15, 30, 60, 90, 120 min (Figure 6.4). The presence of Acinetobacter cultures 
in the pepsin solution neither caused an early decrease in the numbers of viable cells nor a 
gradual decline over the period of 120 min. The only significant reduction was observed at 15 
min for strain 1097 (P < 0.05). In contrast, increases in survival rates were generally 
recognised by the end of the experiment in comparison to the initial cell counts (T0). Strain 
1095 increased by 0.2 log1 0 cfu/ml over the test period. A. baumannii A T C C 19606T (1102) 
was 0.4 log1 0 cfu/ml higher than the inoculum. Strain 1098 and 415 both showed a 0.5 log1 0 
cfu/ml growth. A notable recovery was exhibited by strains 1096 (0.9 logio cfu/ml), 418 (1.1 
logio cfu/ml), and 1099 (1.2 logio cfu/ml) (Figure 6.4). 
Figure 6.4 Survival curves of Acinetobacter strains in pepsin solution. 
The pepsin enzyme did not appear to cause an early decrease in viable counts nor a gradual decline over the period of 
120 min. The only significant decrease was observed at 15 min for strain 1097. In contrast, increases in survival rates 
were generally recognised by the end of the experiment in comparison to the initial cell counts (T0). Strain 415 is 
Acinetobacter gensp. 3.; 418 and 1097 are A. calcoaceticus; 1095, 1096, 1098, 1099, and 1102 are A. baumannii. 
Error bars represent the standard deviation of two independently repeated experiments. 
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6.3.3 Tolerance to the small intestinal fluid 
The simulated small intestinal juice was inoculated with Acinetobacter cultures and incubated 
for 120 min at 37°C. The viable counts of the bacterial suspensions, determined at 0, 60, 90, 
and 120 min, demonstrated the ability of all strains to sustain their viability during the 
complete time-course. Survival trends are illustrated in Figure 6.5. The recovered cells at the 
end of the assay were between 0.1 to 0.6 logio cfu/ml higher than the inoculum (T0) with the 
largest increase shown by strain 1097 (P > 0.05). 
Figure 6.5 Survival curves of Acinetobacter strains in small intestinal fluid. 
The simulated small intestinal juice, containing porcine pancreatin and porcine trypsin, was inoculated with 
Acinetobacter and incubated for 120min at 37°C. All the tested strains were able to sustain their viability during the 
complete time-course with no significant reduction or increase. Strain 415 is Acinetobacter gensp. 3.; 418 and 1097 
are A. calcoaceticus; 1095, 1096, 1098, and 1099 are A. baumannii. Error bars represent the standard deviation of 
two independently repeated experiments. 
121 
Chapter 6. Gastrointestinal Survival oi Acinetobacter 
6.3.4 Bile salts tolerance 
The presence and absence of recovery in 0.125, 0.25, 0.5, 1, and 2% porcine bile was 
examined. The specified concentrations had no effect on the viability of the evaluated strains, 
when tested after 0, 5, 10, 15, 30, 45, 60, 90, and 120 min of inoculation, as positive recovery 
was observed on the agar plates at these time points. Consequently, the concentration was 
increased to 4% and the viable counts were accordingly determined at the time points 
indicated in Figure 6.6. The order magnitude of viability remained the same for the complete 
exposure time. When data for the test strains at the first (T0) and the last (T12o) sampling time 
were compared, not only there was 0.0% inhibition but also cell counts of 7 of 8 strains 
increased by 0.4 to 0.8 logio cfu/ml. However, that of strain 1102 (A. baumannii A T C C 
19606 ) remained the same. 
Figure 6.6 Survival curves of Acinetobacter strains in 4% porcine bile solution. 
The viable counts of Acinetobacter strains in 4% porcine bile were determined at the time points specified in the 
figure. The order magnitude of viability remained the same for the complete exposure time. Strain 415 is 
Acinetobacter gensp. 3.; 418 and 1097 are A. calcoaceticus; 1095, 1096, 1098, 1099, and 1102 are A. baumannii. 
Error bars represent the standard deviation of two independently repeated experiments. 
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6.4 DISCUSSION 
In order for Acinetobacter to colonize the gastrointestinal tract and cause infections following 
ingestion of a contaminated enteral feed, it has to survive the multi-environments existing in 
this system starting in the stomach. The stomach environment is generally effective in 
microbial eradication (Wilson et al., 2002). However, a portion of some microorganisms 
survive. The levels of sensitivity to gastric acidity vary in bacteria as some are more acid 
tolerant than others and thus infectious at lower doses (Blaser and Newman, 1982; Lin et al., 
1996). Low acid levels are believed to be associated with an increase in infection potential 
(Martinsen et al, 2005). Acinetobacter in this study was considered resistant to pHs greater 
than 2.5, while 30-60 min of acid tolerance was shown at this pH level. Strains were only 
monitored for 2h at 37°C in accordance with the two hourly feeding intervals set for the 
nasogastric nutrition (Chapter 5). The exposure to low acidity was not gradual so it is 
unknown whether higher survival rates specifically at pH 2.5 could have been obtained. 
However, this is likely as the adaptive stress response is a well-known mechanism enabling 
microorganisms to withstand extreme acidity (pH < 4.0) through pre-exposure to sublethal 
pH values (4.5-5.5) (Seputiene et al, 2006). Pathogens such as Salmonella enterica serovar 
Typhimurium, Listeria monocytogenes, and E. coli are examples of bacteria possessing the 
acid tolerance response (ATR) systems and whose survival at low pHs is promoted by the 
expression of acid shock proteins (ASPs) which is induced by sublethal levels of acidity 
(Bang et al, 2000; Davis et al, 1996; Seputiene et al, 2006). 
Previous studies demonstrated marked inhibition of bacteria at pHs below 2.0 (Zhu et al, 
2006) while those between 4.0 and 7.0 did not have such impact on bacterial survival 
(Waterman and Small, 1998). Maintaining the pH of the stomach at low levels (< 4.0) is 
therefore critical in terms of the extent of the bactericidal effect. Exposure to high acidity for 
20 to 30 min can achieve this damage (Zhu et al, 2006). Nevertheless, this level of acidity is 
rarely sustained in the neonate stomach as the pH tends to be above 4.0 for prolonged periods 
of time (Mitchell et al, 2001). Milk is known for its neutral pH and buffering activity 
(Washington et al, 1999). In NICUs, infant formula feeding is frequent and usually every 2 
to 4 h (Hurrell et al, 2009a; Mitchell et al, 2001; Washington et al, 1999). Mitchell et al, 
(2001) reported gastric pH greater than 4 for 29 to 212 min after feeds. In another study 
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(Omari and Davidson, 2003), the pH was lower than 4, in healthy premature neonates who 
received feeding every 4 h, for an average of 52.7% of the time. Within the first hour of 
feeding the mean pH was as high as 6.9, 6.0, and 5.7. Those recorded in the next hour 
dropped to 6.0, 3.7, and 3.5. According to Sondheimer's investigation (1985), the mean 
gastric pH of healthy premature babies less than 7 days old was greater than 4 for 3h before 
and following infant formula feeding. Another group of 7- 15 days old neonates who were 
also premature but healthy had an average fasting stomach pH of 2.9 which rose to 5.2 within 
15 min of receiving the feed and remained above 3.0 for the 3h before the next feeding point 
was due (Sondheimer et al., 1985). This meant longer maintenance of high pH levels with the 
highest reached at feeding times and this is specifically when the bacteria in the contaminated 
feed are ingested. 
The composition of the milk consumed has also been shown to offer some degree of 
protection against low pHs (Charteris et al., 1998; Conway et al, 1987; Kos et al, 2000). 
The gastric transit tolerance of some organisms such as Bifidobacterium and Lactobacillus 
sp. was generally improved and with two strains in particular exhibiting 100.0%) gastric 
tolerance. This was when milk proteins (whey protein, and sodium caseinate) were added 
singly or in combination to simulated gastric juice containing 0.5%) sodium chloride and 
0.3%) pepsin and adjusted to pH 2.0 (Charteris et al., 1998). Kos et al. (2000) also described 
45.0% transit survival of Lactobacillus acidophilus from gastric juice (pH 2.0) similar to that 
described by Charteris et al. (1998) as a result of adding whey proteins concentrate. This was 
in contrast to the 15.0% in the absence of this type of milk protein. Lactic acid bacteria 
(Streptococcus thermophilus, Lactobacillus bulgaricus, and Lactobacillus acidophilus) were 
also shown to survive better in gastric juice (pH 1.0 - 5.0) in the presence of skimmed milk 
(Conway et al, 1987). 
Even during the pH decrease before the next feed is due, organisms can still survive i f they 
exit the stomach environment due to gastric emptying. This relies on the time taken by the 
stomach to gradually empty its contents. In other words, fast gastric emptying from the 
stomach may enable the bacterium to be delivered into the small intestines before the pH 
decreases and hence enhances the likelihood that a larger number of live cells reach the 
duodenum. According to (Cavell, 1981, & 1982), the average time for half of the stomach 
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contents to be emptied after receiving infant formula feeds was 51.9±9.8 min and 78.0±14.0 
min in healthy preterm and term neonates respectively. These values may however vary 
between different infant formula according to their compositions of fat and carbohydrates 
(Siegel et al, 1985). The short gastric emptying time may accordingly be associated with 
longer time the pH of the stomach is below 4.0 (Vandenplas et al, 1988). 
Although acidity provides an effective antibacterial activity against infections, critically ill 
neonates can be at risk of acute bleeding resulting from gastric mucosal lesions, which are 
induced by the low acidity of the stomach (i.e. pH 2.05) (Kuusela, 1998). Histamine 2 
receptor blockers such as ranitidine and cimetidine are used in these cases as a prophylactic 
or a therapeutic option by suppressing the production of acid in order to increase the pH in 
the stomach (Kuusela, 1998). The main effect of these medications is the increase of the 
gastric pH which permits the colonization of this area by opportunistic pathogens including 
A. baumannii (Garrouste-Orgeas et al., 1997; Zavros et al, 2002). 
Proteolysis has a bactericidal effect that is associated with the pH. A combination of pepsin 
and acid has proved to be more effective than the pH alone as it may increase the 
susceptibility of bacterial cells to this enzyme (Zhu et al, 2006). Incubating E. coli K12 in 
solutions containing pepsin (0.5, 1.0, and 2.0mg/ml) and pre-acidified to a range of pHs 
decreased the viability of the strain by 100.0%, relative to the control (without pepsin), after 
100 min at pH 3.5. On the other hand, the incubation in l.Omg/ml pepsin (pH 2.5, 3.0, and 
3.5) reduced the viable counts of H. pylori by 50.0% after 20 min (Zhu et al, 2006). In our 
study, there was no apparent kill observed with Acinetobacter strains in the pepsin solution. 
The pH of this solution was left neutral and as a result, the enzyme which only works at 
acidic pHs (Wilson, 2005), was deactivated. Therefore, strains are required to be re-tested in 
the same pepsin solution described but at different acidic pHs before an accurate statement 
about the resistance of Acinetobacter to this enzyme could be made. 
The enzymes in the pancreatic juice did not exhibit a real challenge to survival of 
Acinetobacter. The findings showed that Acinetobacter strains are resistant to many 
pancreatic enzymes, including protease, lipase, trypsin, amylase, and ribonuclease which 
composed the porcine pancreatin and trypsin used in this study. The absence of apparent loss 
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of viability in the pancreatic juice was not surprising as it is likely to be attributed to the 
neutral pH of this environment (Naim et al, 2004). Other organisms (e.g. E. coli and 
Streptococcus thermophilus) reported in the literature varied in terms of their sensitivity to 
pancreatic juice (Barmpalia-Davis et al, 2008; Charteris et al, 1998; Marteau et al, 1997; 
Naim et al, 2004), but cannot to be compared to the findings of the study herein due to 
experimental differences (compositions, conditions, or dynamics). 
Towards the ileum region conditions become less destructive for bacterial existence although 
the ones that survived would still have to avoid being swept away, oxygen restriction, limited 
nutrients and resist the antibacterial effect of bile salts (Engleberg et al, 2007). The pH in the 
ileum of an adult is approximately neutral, while that of the duodenum is between 5.7 and 6.4 
and it ranges between 5.9 and 6.8 in the jejunim. Along the different parts of the colon 
(caecum, ascending, transverse, descending, and sigmoid colon), the mean pH varies from 
5.7, 5.6, 5.7, 6.6, and 6.6 respectively (Wilson, 2005). These optimal pHs, compared to that 
in the stomach, may allow bacterial multiplication (Naim et al, 2004). Bacteria in the small 
intestines are also provided with a variety of nutrients from the chyme in the lumen. In 
addition, microbes themselves produce molecules which can be considered as a source of 
nutrients for other microbes, whether resident or transient to this region, by breaking down 
nutrients obtained from dietary compositions, or derived from gastrointestinal secretions or 
from the epithelial cells shed from the intestinal mucosa (Wilson, 2005). Regarding the 
oxygen availability, the condition in the lumen of the colon is anaerobic. However, the 
mucosal surface is supplied with high levels of oxygen content by the underlying tissue 
(Wilson, 2005). 
The awareness that a large proportion of sublethally injured cells may have been able to pass 
through the intestines where they could successfully survive and resume their growth activity 
suggests that they can potentially cause infections even at low ingestion doses. E. coli 
0157:H7, for example, is well known for its capacity to survive in the gastrointestinal tract, 
resume its growth after undergoing a lag phase of adaptability and reparation, and then cause 
subsequent illnesses at 10 to 100 ingested cells/g (Abdul-Raouf et al, 1993; Choi et al, 
2000; Lin et al, 1996; Marteau et al, 1997). 
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It has been argued that survival in the intestinal tract and the development of subsequent 
infection requires toleration of the effects of the biles secreted (Hofmann, 1994). Bile 
tolerance is a common feature of Gram-negative intestinal pathogens as for the commensal 
intestinal microbiota (Pace et al, 1997; Pope et al, 1995; Prouty et al, 2002; Thanassi et al, 
1997). Such bacteria produce stress proteins including molecular stress response chaperones 
(Breton et al, 2002; Flahaut et al, 1996; Leverner et al, 2003; Sanchez et al, 2005), 
proteins for oxidative stress relief (Bernstein et al, 1999; Lechner et al, 2002), efflux 
proteins to transport bile salts out of the cell (Begley et al, 2002; Hung and Mekalanos, 
2005; Lin et al, 2005; Prouty et al, 2004), and exporter proteins (Bron et al, 2004). 
The reported colonization of the gut by Acinetobacter spp. (Das et al, 2011; Parm et al, 
2010, & 2011a, & b; Roy et al, 2010; Thorn et al, 2010) indicates the ability of the organism 
to resist the antimicrobial activity of bile salts. This was confirmed by the findings of this 
study, as all the Acinetobacter strains tested were capable of maintaining their viability at 
various concentrations of porcine bile. The type of bile solution used herein was a porcine 
bile extract which contained glycine and taurine conjugates of deoxycholic acid and other 
unspecified bile salts (Sigma-Aldrich, UK). The response could be different towards un-
conjugated forms of bile which may also be produced in the intestinal lumen and were not 
included here (Wilson et al, 2002). According to Begley et al (2006), un-conjugated bile 
salts have greater antimicrobial activity than the conjugated compounds. 
The gastrointestinal survival of the Acinetobacter strains examined in this study may not be 
precisely reflective of the complex and sequential stresses as well as the changing dynamics 
that exist during the gastrointestinal passage. However, the physiological responses described 
in this study are the first to be explored in the literature and indicated the capacity of 
Acinetobacter strains to occupy different niches within the gastrointestinal system and 
successfully respond and adjust to stressful conditions faced during their passage. This is 
ultimately related to their virulence as opportunistic human pathogens and their potential risk 
of colonization and the development of a neonatal infection. Elucidation of the mechanisms 
underlying their survival in such environments is importantly required. Equally important 
was to follow up this study with an investigation of the potential consequences of this 
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survival, in the intestinal tract, through the organism's interaction with the epithelial and 
phagocytic cells, which is represented in the next chapter. 
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Chapter 7. In Vitro Studies ofAcinetobacter Infection Models 
7.1 INTRODUCTION 
Mucosal surfaces become colonized with potentially pathogenic Gram-negative bacteria 
immediately after birth (Parm et al, 201 lb). According to Metsvaht et al. (2010) and Parm et 
al. (2010), 52-83% of high-risk neonates in NICUs are colonized by Gram-negative 
microorganisms by the end of the first week of life. By 30 days, this percentage increases to 
almost 100% (Almuneef et al., 2001; Goldmann et al, 1978; Parm et al, 2010). Disturbance 
of the barrier integrity may cause the colonization state to turn into a case of an invasive 
infection (Graham et al, 2007). The documented colonization of the gastrointestinal tract 
with Acinetobacter spp. (Das et al, 2011; Garrouste-Orgeas et al, 1997; Kim et al, 2011; 
M a et al, 1999; Parm et al, 2010, & 2011a, & b; Roy et al, 2010; Thorn et al, 2010) is 
indicative of the successful establishment of the organism in this environment. In order to 
achieve this, the bacterium has to be able to adhere to the epithelial cells as a first step of the 
interaction with the host cell before subsequent colonization (Beachey et al, 1988). An 
important function of the epithelial layer coating the surfaces of the gastrointestinal tract is to 
protect the underlying tissues from inhabitant bacteria on the surfaces (Wilson et al, 2002). 
Adhesion to this layer can only be the starting point to a pathological process involving the 
invasion of the superficial layers of the tissue or deeper, in some cases, leading to 
dissemination of the bacterium throughout the body which can be life threatening (Wilson et 
al, 2002). An important risk factor for bloodstream infections in neonates is in fact 
considered to be the colonization of the gastrointestinal tract with opportunistic bacteria 
(Donskey, 2004; Graham et al, 2007; Westerbeek et al, 2006). It has been previously shown 
that the gut colonization with imipenem-resistant A. baumannii preceded the occurrence of 
bacteraemia in adult patients (Thorn et al, 2010). A genetic relationship was found between 
the perirectal cultures and blood cultures in 6 of 7 cases with the clinical infection (Thorn et 
al, 2010). 
In order to understand the pathogenicity of Acinetobacter, various animal models of infection 
have been studied. These included a rabbit endocarditis model (Rodriguez-Hernandez et al., 
2004), a rat soft tissue infection model (Pantopoulou et al, 2007), guinea pig (Bernabeu-
Wittel et al, 2005), murine (Knapp et al, 2006; Renckens et al, 2006), and rat pneumonia 
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models (Jacobs et al, 2010b; Russo et al, 2008). A range of epithelial cell lines have also 
been used as in vitro models to study the adhering capacity of A. baumannii. For example, A. 
baumannii 19606 was able to attach to human alveolar epithelial cells (A549) (Gaddy et al., 
2009a), and to human bronchial epithelial cells NCI-H292 (de Breij et al, 2009). A. 
baumannii A T C C 19606 as well as four clinical A. baumannii strains were also positive for 
the adhesion to and invasion of cervical carcinoma cells (HeLa, CCL-2) (Choi et al, 2008b; 
Jacobs et al, 2010b; Lee et al, 2001) and human laryngeal epithelial cells (HEp-2, CCL-23) 
(Choi et al, 2008b; Choi et al, 2005). Adherence of clinical A. junii, A. calcoaceticus, 
Acinetobacter gensp. 13TU, and Acinetobacter gensp. 3 strains to human bronchial epithelial 
NCI-H292 and BEAS-2B cells was observed by de Breij et al (2010) and Jacobs et al 
(2010a) respectively. In addition, the same cell line was used to evaluate clinical A. 
baumannii strains in terms of their adhesion capacity (de Breij et al, 2010; Lee et al, 2008a; 
Lee et al, 2006). Epithelial cells from human buccal mucosa also represented an in vitro 
infection model to assess the interaction of A. calcoaceticus RAG-1 (ATCC 31012) 
(Rosenberg et al, 1981), A. baumannii A T C C 14606 and five other A. baumannii strains 
found on intravascular catheter tips (Costa et al, 2006). Small pieces of rat bladder tissue 
(Sepulveda et al, 1998), and rat tracheal tissue (Ruiz et al, 1998) were employed for the 
same purpose using clinical A. baumannii strains. 
Strains examined in the above-mentioned studies all showed the ability to adhere to different 
types of cell lines. However, these infection models are clinically irrelevant to gastrointestinal 
illnesses and hence are unsuitable for studying factors contributing to the pathogenicity of 
Acinetobacter in the gastrointestinal tract. Relevant studies were mainly case reports and in 
vivo infection models. Zavros et al (2002) reported gastric mucosal inflammation, gastritis, 
hypergastrinemia and increases in gastric epithelial cell numbers caused by A. lowffii that was 
similar to that associated with the pathogenic organism Helicobacter pylori in infected mice. 
The latter is well-known as the causative agent of gastric adenocarcinoma, peptic ulceration, 
and chronic atrophic gastritis (Marshall and Warren, 1984; Nomura et al, 1991; Parsonnet et 
al, 1991). The inflammation described above represented a case of invasion with 
Acinetobacter. In such scenarios, epithelial cells respond by secreting cytokines involved in 
the activation of the immune system. However, sustained release or overproduction of these 
cytokines involved in the activation of the immune system may result in mucosal 
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inflammatory response. It is this response that may lead to modifications and damage to the 
mucosa through the cascade of events triggered (Forman, 1996; Rathinavelu et al., 2003). 
Kim et al. (201 la) reported a case of a 66 year old male who presented with abdominal pain, 
hematemesis, nausea, and vomiting, and who was diagnosed with acute phlegmonous 
gastritis. The gastric wall showed severe inflammation of the mucosa with purulent exudate 
covering necrotic areas (intramural abscess). This condition is often fatal and associated with 
high mortality rate (Kim et al., 2011). Both A Iwoffli and Klebsiella oxytoca were detected in 
the associated gastric tissue culture. According to Ofori-Darko et al. (2000), intubation of 
Acinetobacter spp. into the mouse stomach stimulates the secretion of the hormone gastrin, 
which is a growth factor for the oxyntic mucosa and regulates acid secretion (Dockray, 1999). 
The result is a subsequent proliferation of the epithelial cells and predisposed gastritis. 
Acinetobacter spp. has been isolated, amongst other Gram-positive and negative bacteria, 
from mice stomachs diagnosed with chronic gastritis (Stockbruegger, 1985; Stockbruegger et 
al, 1984). Grotiuz et al. (2006) reported the presence of A. haemolyticus as the cause of 
bloody diarrhoea in a 3 month old infant. 
With regard to In vitro studies involving the human colonic adenocarcinoma cell line (Caco-
2), Sechi et al. (2004) showed positive cell adhesion of 9 of 20 clinical isolates of A. 
baumannii. However, further virulence aspects such as the subsequent invasion were not 
examined in this study. Pavlov et al. (2004), on the other hand, assessed the adherence and 
invasive potential of various bacteria, including Acinetobacter, cultured from treated and 
untreated drinking water supplies, using the Caco-2 and HEp-2 cells. Amongst other isolates, 
Acinetobacter spp. was one of the most adherent Gram-negative bacteria on both cell lines. 
Of the 79 invasive isolates, 4.4% Acinetobacter spp. were able to invade HEp-2 cells, while 
2.8% invaded Caco-2 cells (Pavlov et al, 2004). 
Bacterial dissemination throughout the body following invasion of deep tissues can generally 
be achieved via the lymphatic system, blood stream, or survival within phagocytes 
(macrophages and neutrophils) (Wilson et al, 2002). Tuberculosis, meningitis, and typhoid 
diseases, for example, are all characterized by the dissemination of their causative pathogens 
from the original site of entry to other tissues (Wilson et al, 2002). Monocytes differentiated 
into macrophages play a key role in recognizing and killing invading bacteria by 
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oxidative/non-oxidative damage and phagocytosis as a part of the host innate immunity 
(Madigan et al., 2012). Microorganisms have developed mechanisms which enable them to 
evade this antibacterial defense. This depends principally on the inhibition of phagocytosis. 
Another strategy adopted by bacteria to evade the phagocytic destruction is to survive within 
phagocytes. Salmonella Typhimurium, and Yersinia spp. are examples of pathogens 
possessing this capacity (Hueck, 1998). 
The cytokine production by macrophages in response to infections with Acinetobacter has 
already been described in the literature (de Breij et al, 2010). Binding of A. baumannii 
A T C C 19606T to the surface of monocyte-derived macrophages (U937) and subsequent 
apoptosis has been identified by Choi et al. (2008b). However, a larger number of 
Acinetobacter strains and further studies regarding the interaction with macrophages and the 
consequences of this encounter on the bacterium and the phagocytic cell would be useful in 
developing a wider picture and in-depth understanding of the potential virulence of the 
organism. 
Clinical evidence of the damage caused to the epithelial tissues of different regions of the 
gastrointestinal tract as a result of the invasion process of Acinetobacter are already 
documented as described earlier. What is required though is to support this evidence with 
extensive research to characterize the pathogenesis of Acinetobacter spp. and its attributes. 
This has not been sufficiently explored in the literature. Implications of such studies in the 
context of consuming a contaminated feed would potentially signify the risk of exposure to 
this opportunistic pathogen which principally formed the aim of this present study. To 
accomplish this goal, the research objectives were defined as a set of criteria. These were 
adhesion, invasion, persistence within epithelial cells, cytotoxicity, macrophages uptake and 
subsequent internal survival. 
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7.2 MATERIALS & METHODS 
7.2.1 Bacterial strains and growth conditions 
In the preliminary experiments, 29 Acinetobacter strains were assessed. This number was 
then reduced to 9 strains for the remaining parts of the studies. Table 1 in Chapter 1 shows 
the Acinetobacter strains under evaluation, their sources and culture collection numbers. 
Invasive Salmonella Enteritidis (strain 358) was used in this study as a positive control 
whereas Escherichia coli K12 (strain 1230) was the negative control due to it inability to 
invade epithelial cells. Acinetobacter cultures were grown in TSB and incubated for 18h at 
37°C. 
7.2.2 Caco-2 cells and storage conditions 
The human colorectal epithelial cells, Caco-2 (ATCC; USA), were used to study bacterial 
attachment and invasion. Stock cultures of Caco-2 in the freeze mix fetal bovine serum: 
dimethyl sulfoxide (FBS: DMSO- 95:5; v/v) were kept in cryotubes in a liquid nitrogen store 
for long term preservation. 
7.2.3 Caco-2 growth and infection media 
The minimum essential medium (MEM) (Sigma, M4655) was used as the growth medium 
and contained 2mM L-glutamine, 1.5g/l sodium bicarbonate, l.OmM sodium pyruvate. The 
M E M was also mixed with 1% non-essential amino acids solution (M7145, Sigma), 10% 
fetal bovin serum (FBS) (Sigma, F7524), and 1% penicillin streptomycin solution (P4333). 
The infection medium consisted of M E M , 10%) FBS, and 1%> non-essential amino acids 
solution. 
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7.2.4 Caco-2 preparation and maintenance process 
When needed, a stock vial of Caco-2 cells was thawed rapidly (to prevent the toxicity, to 
cells, of the dimethyl sulfoxide (DMSO) in the freezing medium) by holding in the hands. 
The vial was wiped with 70% ethanol and dispensed into 25 cm2 flask (Sigma, CLS3056) 
containing 5ml of pre-warmed growth M E M . Fifty percent of the medium was replaced every 
two days until the cells were activated and growing. Cells were then transferred to 75 cm2 
flasks (Sigma, CLS430641) containing 20ml growth M E M . The medium was replaced and 
excess cells were removed twice a week to maintain the exponential growth of cells. The cell 
confluence was checked, on a daily basis, using an inverted microscope. 
7.2.5 Sub-culturing of mammalian cell line Caco-2 
When 70-80% confluence was reached, the cells were split into new flasks. To harvest the 
cells, the old medium was discarded using a sterile pipette, and the flask was washed twice 
with 2ml sterile warm Dulbecco's phosphate buffered saline (PBS) (Sigma, D8662). To 
detach cells from the flask, 5ml trypsin was added and the flask was placed in a 37 C 
incubator for 5-8 min in a 5% C 0 2 atmosphere. Detachment was observed under the inverted 
microscope to ensure dispersion of the cell layer. The flask was gently rocked to aid 
detachment. Detached cells were transferred into a sterile universal tube for centrifugation at 
1200rpm for 5 min to remove the trypsin. The supernatant was discarded and the pellet was 
re-suspended in 5ml fresh growth M E M in order to perform a 1:5 split. The pellet was broken 
up and the cells were mixed thoroughly but gently by pipetting up and down. One millilitre of 
the suspension was transferred into 19 ml growth M E M . 
7.2.6 Caco-2 cell count 
The number of cells obtained per 1ml of medium was determined as follows using a 
haemocytometer. A cover slip was positioned onto a haemocytometer, and then ~20 ul of the 
cell suspension was loaded into both chambers in the haemocytometer. The number of cells 
in 10 medium squares of the grid, and in each chamber was counted and averaged. This 
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average was then multiplied by 2.5xl05 to calculate the total number of cells per ml. 2xl05/ml 
was the required cell concentration per well. 
In order to obtain the required concentration of cells, the following formula was applied: 
C i V j = C 2 V 2 
Where Ci is the multiplication of 2.5xl05 by the average numbers of cells in both 
chambers in the haemocytometer, giving the actual concentration of the Caco-2 cells. 
C 2 is the required cell concentration per ml, which was 4x104 cells providing the 
doubling time for Caco-2 cells is ~20h and the final concentration needed for the assay 
after 48h incubation is 2x105 cells per well. 
V 2 is the final volume of the cell suspension in the growth M E M to be dispensed into 
the 24-well plates. Usually extra 2ml of the medium were added to allow for loss. For 
example, i f 48ml were required for 2 control strains and 6 test strains (triplicate 
wells/strain, and 0.5ml/well, as well as 1 plate for the association assay and 1 for the 
invasion assay). Then, in this case V 2 would be 50ml. 
Thus: V i (the volume of cell suspension to be added to the growth M E M ) = 
4x104 cells X 50ml 
cells/ml 
7.2.7 Seeding 24-well plates 
Collagen-coated 24-well plates were seeded with 0.5ml of the cell suspensions adjusted to the 
desired concentration per well. The plates were incubated at 37 C under in 5% C 0 2 for 2-3 
days until 80% confluence was achieved. 
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7.2.8 Preparation of inocula 
On the day of the tissue culture assays, the optical density of the overnight (18h) bacterial 
cultures was measured using the spectrophotometer at 620nm wavelength. The overnight 
cultures were then spun down for 1 min at 14,000 rpm. The TSB medium was discarded and 
the pellet was re-suspended in 1ml pre-warmed M E M (growth medium). The bacterial 
suspensions were diluted to OD 0.5, 0.05, or 0.005 according to the desired concentration. 
These optical densities equated to ~108, 107, and 106 cfu/ml respectively, which were 
determined experimentally (viable plate count) for all the test strains. The size of the inocula 
used to infect Caco-2 cells was also confirmed retrospectively by performing the Miles and 
Misra viable count method on the day of the experiment. 
7.2.9 The association assay 
When Caco-2 cells were 80% confluent, the medium in the wells was replaced with 0.5ml of 
the desired bacterial concentrations. These concentrations were 106, 107, 108 cfu/ml to 
achieve a multiplicity of infection (MOI) of 10, 100, and 1000 respectively. The test and 
control strains were all assigned 3 wells each. The infected cells were then incubated for 3h at 
37 C in a 5% C 0 2 atmosphere. After which, these cells were washed three times with 0.5ml 
pre-warmed PBS which was aspirated. Next, Caco-2 cells were lysed using 0.1ml of 0.5% 
Triton X-100 solution. Lysis of the cells was assisted by repeatedly pipetting up and down. 
The lysis procedure took approximately 10 min during which, according to the preliminary 
experiments, there was no reduction in the viability of bacteria. Viable counts of the 
associated cells (attached and internalised) were performed by serially diluting the lysate 
(1:10) in 96-well plates. Dilutions were then plated onto TSA plates applying the Miles and 
Misra method. Data are presented as the average log values of the experiments repeated at 
least 3 independent times. 
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7.2.10 The gentamicin protection assay 
The infection procedure for the invasion assay used the same method as that of the 
association assay but with added steps. Cells were infected with the bacteria followed by a 3h 
incubation period and then 3 washes with 0.5ml PBS. However, instead of adding the Triton 
X-100 next, the 24-well plates assigned for the invasion assay required the addition of 
250ug/ml gentamicin. Plates were then further incubated for 2h at 37 C in 5% C0 2 . Aspirates 
were plated onto TSA and incubated for 24h at 37 C to check for complete bacterial 
inhibition by gentamicin. Caco-2 cells were washed 3 times with 0.5ml PBS. To lyse cells, 
0.1ml Triton X-100 was added into each well and repeatedly pipetted. Finally, having added 
gentamicin to kill the external bacteria, only the internalised bacterial cells were counted by 
the Miles and Misra method. A l l the invasion assays in this study were conducted 
independently at least two to three times. In each experiment, wells were infected in triplicate 
with individual strains. 
7.2.11 Preliminary experiments 
7.2.11.1 Determination of the bactericidal concentration of gentamicin 
Before tissue culture assays could be carried out, preliminary experiments were needed in 
order to determine the susceptibility of test strains to gentamicin as this is used to 
discriminate between attached and internalized bacterial cells. Strains were tested at the 
gentamicin concentrations of 50 and lOOug/ml. Due to the resistance of some strains, this 
concentration was increased to 250ug/ml and strains were re-tested. The antibiotic sensitivity 
testing was conducted in accordance with the British Society for Antimicrobial 
Chemotherapy guidelines (BSAC, 2001). The inhibitory effects of the gentamicin were 
determined by the micro-dilution method (BSAC, 2001). Bacterial cultures were grown in 
TSB for 18-20h at 37°C. Their turbidity was adjusted to McFarland Standard 0.5 (~ 1.5xl08 
cfu/ml) before being diluted to 1:10 and 1:100. Equal volumes of these dilutions and the 
gentamicin solution were added at a final concentration of 50, 100, and 250ug/ml to 96-well 
plates. Blank bacterial suspensions (without gentamicin) were also included as controls for 
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each strain. Plates were incubated for 20h at 37 C. Aliquots (~10ul) of these overnight 
suspensions were inoculated into TSA plates. The presence or absence of growth recovery 
was checked 24h later. Duplicate results were recorded for each strain. 
7.2.11.2 Determination of bacterial viability in 0.5% Triton X-100 
The effect of 0.5% Triton X-100 solution (T9284) on Acinetobacter strains was examined. 
0.5% Triton X-100 was prepared in distilled water. The solution was then filter sterilised 
using 0.2 urn pore diameter cellulose filter. Viable counts were performed directly after the 
addition of the Triton-X solution at T0. Aliquots (15ul) of Acinetobacter 18h cultures were 
added to 135ul of the Triton-X solution and incubated at 37 C. At each time point (0, 15 and 
30 min), 20ul of the ten-fold serial dilutions were inoculated, in triplicate, onto TSA plates 
using the Miles and Misra method. Reduction in the viable count (cfu/ml) was calculated in 
comparison to T0for each test strain. The experiment was performed once. 
7.2.12 Effect of infection time course on the attachment and invasion levels of 
Acinetobacter 
Cells were infected with 18h Acinetobacter cultures at 10 cfu/ml and incubated for different 
durations (0, 90, 120, 150, 180 min) at 37 C in the presence of 5% C0 2 . The same 
association-invasion assay procedure, described above, was followed. Cells were washed 3 
times with PBS and lysed with Triton X-100, and finally the Miles and Misra plate count 
method was performed. For the gentamicin protection assay, 250ug/ml gentamicin was added 
and then plates were incubated for 2h at 37 C in 5% C0 2 . The Miles and Misra technique was 
also carried out on the invaded cells which were lysed with Triton X-100. The numbers of the 
associated bacterial cells were subtracted from the internalised ones in order to calculate the 
amount of colony forming units attached to Caco-2 cells. These were expressed as the 
percentage of the initial bacterial cell number, added to the Caco-2 cells at the start of the 
experiment, which was able to attach to the epithelial cells (attachment efficiency). The 
efficiency of invasion was defined as the percentage of the inoculum that was found to invade 
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Caco-2 cell monolayer. Both the attachment and invasion assays were carried out at least two 
to three times. 
7.2.13 Effect of different MOIs on the attachment and invasion levels of Acinetobacter 
The association and invasion levels of Acinetobacter were examined at different infectious 
doses. The ratios of the infected Caco-2 cells to the bacterial cells were 1:10, 1:100, and 
1:1000. This was achieved by infecting 105 Caco-2 cells with 106, 107, 108 cfu of each strain 
per ml. The association and gentamicin assays were conducted as detailed above. 
7.2.14 Intracellular survival 
The intracellular survival of Acinetobacter strains was also studied. Confluent Caco-2 cells 
cultivated in 24-well plates were infected in the order of 106 cfu/ml for 3h at 37 C in 5% C0 2 . 
The gentamicin protection assay was carried out as described earlier (Section 7.2.10). 
Briefly, bacterial suspensions were aspirated and Caco-2 cells were washed with PBS. 
Infection M E M containing 250ug/ml gentamicin was added and then incubated for 2h at 
37°C. Afterwards, a second washing step was carried out three times. Then, lOug/ml 
gentamicin was added and 24-well plates were incubated at 37 C in 5% C 0 2 for the duration 
desired. Twenty four hours later, the persistent bacteria were counted using the Miles and 
Misra technique on TSA plates. To determine the original number of internalised bacteria 
(T0), the lysates, which were treated with Triton-X 100 following the addition of 250ug/ml 
gentamicin and 2h incubation, were serially diluted (tenfold) and plated on TSA applying the 
Miles and Misra method. Viable counts were calculated for triplicate wells per strain. The 
assay was separately repeated twice. The values of the persistent bacteria were expressed as 
the percentage of the inoculum that survived for 24h inside the epithelial Caco-2 cells. 
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7.2.15 Cytotoxicity studies 
The aim for this part of the tissue culture studies was to assess the cytotoxic impact of an 
Acinetobacter infection on the colonic epithelial cells (Caco-2). The correlation between 
mitochondrial activity and the viability of eukaryotic cells was applied to measure this 
cytotoxicity. For this purpose, methylthiazolyldiphenyl-tetrazolium bromide (MTT) was used 
as a means of quantitatively assessing the cytotoxicity levels in these eukaryotic cells, 
whereby only metabolically active cells can reduce the yellow M T T to formazan crystals 
(purple). Hence, the darker the blue the more viable cells that are present which can be 
measured spectrophotometrically. 
7.2.15.1 Preparation of M T T 
M T T solution (Sigma-Aldrich, M2128) was prepared by dissolving 5mg in 1ml distilled 
water. The solution was then sterilised by filtration using a 0.2 urn pore diameter cellulose 
filter. Aliquots of the M T T stock solution were finally stored at -20°C. 
7.2.15.2 M T T viability assay 
Eighteen hour cultures of Acinetobacter in TSB were diluted to the equivalent of OD62onm 
0.005 (~10 cfu/ml) in M E M . Duplicate wells containing 80% confluent Caco-2 cells were 
inoculated with 0.5ml of each bacterial suspension prepared in the infection M E M . Plates 
were incubated for 3h at 37 C in the presence of 5% C0 2 . Cells were then washed with PBS 
(three times), and 250ug/ml gentamicin was added. One hour later, the washing step was 
repeated and a fresh medium containing lOug/ml gentamicin was added. Plates were 
incubated at 37 C for 24h before the spent medium was aspirated and cells were washed 
twice with 1ml PBS. For each tested strain, 50ul of the 5mg/ml M T T solution was dispensed 
into duplicate wells containing 450ul infection M E M for a final concentration 0.5mg/ml 
M T T . Plates were then incubated for l h at 37 C. The medium was aspirated and 200ul 
DMSO was added to each well. Plates were then placed on a shaker for 5 min at 200rpm. 
150ul of the solubilised solution was transferred to 96-well plates and the absorbance was 
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read at 570nm using a spectrophotometer. Control wells contained uninfected Caco-2 (zero 
killed cells). The readings obtained were compared to that of the control and the percentages 
of M T T reduction (viability) of the infected Caco-2 cells were calculated. This was separately 
repeated twice and the average was taken. 
7.2.16 Macrophage (U937) uptake and survival studies 
7.2.16.1 U937 cells and storage conditions 
The human monocyte cells U937 were used to examine the survival of Acinetobacter inside 
macrophages. These macrophages resulted from the maturation and differentiation of the 
monocytes U937 induced by soluble stimuli such as phorbol 12-myristate 13-acetate (PMA) 
used also in this study. Stock cultures of U937 cells in the freeze mix fetal bovine serum : 
dimethyl sulfoxide (FBS : DMSO- 95:5; v/v) were kept in cryotubes in a liquid nitrogen store 
for long term preservation. 
7.2.16.2 U937 growth and infection media 
The U937 growth medium consisted of RPMI-1640 (Sigma-Aldnch, R8758), 1% non-
essential amino acid solution, 1% penicillin streptomycin solution, and 10% fetal bovine 
serum. The infection medium is composed of RPMI-1640, 1% non-essential amino acid 
solution, and 10% FBS. 
7.2.16.3 U937 subculturing 
The cell density was maintained at ~105 cell/ml. The process of preparing, counting and 
maintaining U937 cells was the same as that of Caco-2 cell line. Cells were replenished twice 
a week with a fresh medium replacing 50% of the spent medium. The cells were harvested by 
centrifugation at 1200 rpm for 5 min. Re-suspension of the pellet was in RPMI-1640 growth 
medium containing 0.lug/ml P M A . The density of the U937 cells was counted using the 
haemocytometer as described in Section 7.2.6. To seed the 24 well-plates, 0.5ml of the cell 
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suspension (~105 cell/ml) were dispensed in each well and incubated for 48h at 37 C in the 
presence of 5% C0 2 . This was to allow the fixed monocytes to mature and grow. 
7.2.16.4 Preparation of PMA 
The stock solution of P M A (Sigma-Aldrich, PI585) was prepared at the concentration of 
O.lmg/ml by dissolving in DMSO. It was then divided into 200ul aliquots before stored at -
20°C. 
7.2.16.5 Bacterial strains and growth conditions 
The same strains involved in the previous tissue culture studies were also included in the 
macrophage survival assays. Citrobacter koseri (48) and Escherichia coli K12 (1230) 
represented the positive and negative control respectively. Cultures of the test organism were 
grown in TSB and incubated for 18h at 37 C. 
7.2.16.6 Preparation of inocula 
The optical density of the overnight (18-20h) cultures in TSB was measured using the 
spectrophotometer at a wavelength of 620 nm. The overnight cultures were then centrifuged 
for 1 min at 14,000 rpm. The TSB medium was discarded and the pellet was re-suspended in 
lml pre-warmed RPMI-1640 infection medium. The bacterial suspensions were diluted to the 
equivalent of the desired OD 0.005 (~106 cfu/ml). The size of the inocula used to infect U937 
was also confirmed retrospectively by performing the Miles and Misra viable count method 
on the day of the experiments. 
7.2.16.7 Macrophage uptake and persistence assay 
On the day of the experiment, the spent medium containing P M A was removed by aspiration 
and then the cells were washed with 0.5ml PBS to eliminate any residual P M A . The bacterial 
suspensions in RPMI-1640 were then added at an OD 0.005 (~106 cfu/ml). Each strain, 
including the controls, was used to infect 2 wells each. The infected cells were incubated at 
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37 C in 5% C 0 2 for 3 hours. After which these cells were washed three times with 0.5ml pre-
warmed PBS which was then removed. Next, 250ug/ml gentamicin was added and plates 
were incubated for 2h at 37 C in a 5% C 0 2 atmosphere. Wells were washed three times with 
500ul pre-warmed PBS. To lyse the macrophages, 0.1ml of the 0.5% triton-X solution was 
used. Lysis of the cells was assisted by repeated pipetting. Cell lysates were serially diluted 
1:10 in 96-well plates. Dilutions were then plated onto TSA applying the Miles and Misra 
method to determine the number of internalised bacteria during the 3h infection time course 
(To). 
With respect to macrophage persistence, bacterial cells detected after 24h of exposure to 
macrophages were counted using the same procedure described above. The gentamicin, 
however, was added twice, firstly at 250ug/ml for 2h as previously mentioned, and secondly 
at lOug/ml following three washes with 0.5ml PBS. Next, plates were incubated at 37 C 
under the standard 5% C 0 2 conditions for 24h. Cells lysed with 0.5% Triton-X were serially 
diluted and plated on TSA for 24h at 37 C. Assays in this study were conducted individually 
twice and the results obtained were averaged and expressed as the percentage of the inoculum 
persistent within macrophages. 
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7.3 RESULTS 
7.3.1 Determination of the bactericidal concentration of gentamicin 
The invasion assay required an optimisation of the gentamicin concentration. This was to 
ensure a complete kill of the external bacteria and hence eliminate false or inaccurate 
invasion levels. Bacterial suspensions were first prepared in 50 and lOOug/ml gentamicin and 
were incubated for 18h at 37°C. Aliquots (~10ul) of these overnight suspensions were plated 
out. The presence or absence of growth recovery was recorded 24h later. The bacterial load 
exposed to gentamicin was at 10 and 10 cfu/ml. These concentrations of Acinetobacter 
matched the sizes of inocula intended for the association and invasion protection assays. At 
106 cfu/ml, 11 out of 29 strains were found to be inhibited in the presence of 50 and lOOug/ml 
gentamicin (Table 7.1). One of these inhibited strains (1102) was able to grow at the same 
gentamicin concentrations when the bacterial count was 107 cfu/ml. Resistant strains, at either 
of the specified concentrations, were excluded from further studies and the 10 remaining 
sensitive strains (at 107 cfu/ml) were then used for a real time gentamicin sensitivity testing. 
Five of the included strains were A. baumannii (1112, 1099, 1102, 1111, 1183, 1440). Two 
strains were A. calcoaceticus (418, 1097), and the others were Acinetobacter gensp. 3 (415, 
1182). 
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Table 7.1 Sensitivity ofAcinetobacter strains to gentamicin. 
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For the optimisation of the gentamicin concentration, the positive and negative recovery bacterial cells in 50 and 
lOOLig/ml gentamicin was examined. Concentrations of bacterial cells exposed to gentamicin were 106 and 107 
cfu/ml corresponding to those intended for the association and invasion protection assays. At 106 cfu/ml, 11 out of 29 
strains were found to be inhibited in the presence of 50 and 100Lig/ml gentamicin. One of these inhibited strains 
(1102) was able to grow at the same gentamicin concentrations when the bacterial count was 107 cfu/ml. * Bacterial 
concentration (106 cfu/ml), ** Bacterial concentration (107 cfu/ml), ++ duplicate positive recovery, ~ duplicate 
negative recovery. 
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To confirm the above-mentioned results, in-situ testing was carried out. The gentamicin 
protection assay was performed and supernatants (0.5ml) were plated out at the end of the 5h 
incubation of the infected epithelial cells at 37°C. Complete inhibition of the external bacteria 
present in the supernatant was checked. Six of the 10 test strains were found to be gentamicin 
resistant to lOOug/ml at both bacterial concentrations (Table 7.2). Therefore, this 
concentration was increased to 250ug/ml and strain susceptibility was validated again using 
the same real-time method. This time the infection doses were 107and 108 cfu/ml to ensure 
there was no resistance associated with the increase in bacterial cells at MOI 100 and MOI 
1000 respectively. Strain 1112 (A. baumannii) sustained its resistance while the other nine 
strains were completely inhibited at all inocula sizes. The type A. baumannii strain N C T C 
12156T, however, was no longer sensitive to gentamicin (250ug/ml) when the bacterial 
suspension contained 108cfu/well (MOI 1000). 
Table 7.2 In-situ gentamicin sensitivity testing of Acinetobacter strains. 
Species Strain 
number 
Gentamicin concentration 
100ng/ml 250ng/ml 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. baumannii 
A. calcoaceticus 
A. calcoaceticus 
inetobacter gensp. 3 
inetobacter gensp. 3 
1099 
1102 
1111 
1112 
1183 
1440 
418 
1097 
415 
1182 
Acinetobacter strains that were sensitive to 100ug/l gentamicin (as shown by the micro-dilution method) were used 
for a real-time susceptibility testing. Six of the 10 test strains were found to be gentamicin resistant to lOOug/ml at 
MOI 100 and MOI 1000. Therefore, this concentration was increased to 250ug/ml and strain susceptibility was 
validated again using the same real-time method. Strain 1112 (A. baumannii) sustained its resistance while the other 
nine strains were completely inhibited at all inocula sizes. The type A. baumannii strain NCTC 12156T, however, 
was no longer sensitive to gentamicin (250ug/ml) when the bacterial suspension contained 108 cfu/well. * Bacterial 
concentration (107 cfu/ ml), ** Bacterial concentration (108 cfu/ ml), +++ triplicate positive recovery, — triplicate 
negative recovery. 
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7.3.2 Determination of bacterial viability in 0.5% Triton X-100 
The quantitation of the internalised acinetobacters was achieved by using Triton X-100 0.5% 
(v/v). This detergent was employed in the gentamicin protection assays to lyse the eukaryotic 
cells and consequently release the internal bacteria. The sensitivity of Acinetobacter strains to 
Triton X-100 was tested. Bacterial suspensions were prepared in Triton X-100 solution and 
incubated for 30 min at 21°C (room temperature). Aliquots (15ul) of Acinetobacter were 
plated out at 0, 15, and 30 min. The number of viable cells was calculated and survival rates 
in relation to T0 were established for each test strain. No apparent reduction in viability was 
observed for 7 of the 9 strains over 30 min of exposure (Figure 7.1). 
Figure 7.1 Effect of 0.5% Triton X-100 on the viability of Acinetobacter strains. 
The number of viable cells in 0.5% Triton X-100 was calculated using the Miles and Misra method at the time points 
indicated in the figure. The experiment was performed once, and the results showed no apparent reduction in the 
viability of 7 of the 9 strains over 30 min of exposure. Strains 1099, 1102, 1111, 1183, and 1440 are A baumannii; 
418 and 1097 are A calcoaceticus; 415 and 1182 are Acinetobacter gensp. 3. 
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7.3.3 Effect of the infection time course on the attachment and invasion levels 
The effect of infection duration on the levels of cells attached and internalised was examined. 
Caco-2 cells were infected with Acinetobacter cultures at MOI 100, and then were incubated 
for different durations (90,120, 150,180 min) at 37°C. Six of the nine test strains displayed an 
increase in their attachment efficiency 120 min post infection (Figure 7.2). This increase, 
however, was only significant (P < 0.05) with A. baumannii ATCC 17978 (1440) and A. 
calcoaceticus (418). The latter was particularly interesting in that associated cells went from 
undetected, after 90 min, to 35% attachment efficiency 120 min later. This was followed by a 
notable yet non-significant (P > 0.05) decrease of 19% (T150) before it plateaued by the end of 
the experiment. Cell association of strain 1099, and 1183 (both A. baumannii) levelled after 
120 min of infection, whereas that of strain 1440 decreased marginally. Adhered cell 
numbers of strain 1097 (A. calcoaceticus N C T C 7844) and 1182 (Acinetobacter gensp. 3) 
both declined to different extents after 150 min, but this was not considered statistically 
significant (P > 0.05). A steady increase in the attachment levels was exhibited by the type 
T 
strain A. baumanii N C T C 12156 (1102) all the way through the assay from 74% up to 90% 
(P > 0.05). On the other hand, strain 415 (Acinetobacter gensp. 3) decreased from 72% to 
70% as the infection period increased.The highest value for A. baumannii 1111 was recorded 
at 90 min (P > 0.05). In general, the attachment of strains 415, 418, and 1111 to the Caco-2 
cells appeared to be lower than that of the remaining strains. 
The impact of the infection time-course on the levels of invasiveness was also investigated as 
a means of optimising the gentamicin protection assay. Eight out of the nine test strains were 
able to invade the colonic epithelial cells (Figure 7.3). In contrast, no invasion was detected 
with A. calcoaceticus (418) despite its ability to adhere. The increase in the invasion 
efficiency was observed in 7 strains 120 min post-infection. It ranged between 4% and 26%), 
and was particularly significant (P < 0.05) with strain 1182. The internalised cell counts of 
the invasive strains 1097, 1099, 1102, and 1182 continued to increase for up to 180 min. The 
invasion efficiency of strain 1183, however, plateaued after 150 min while that of strain 415 
non-significantly decreased by 1%. The invasion rates for strain 1111 increased to 35%) (120 
min) and then steadily dropped to 27% (P > 0.05) by the end of the assay. Although strains 
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415 and 1111 had low levels of attachment as indicated in Figure 7.2, their invasiveness was 
not distinctively different from those with higher attachment values. In comparison with the 
majority of Acinetobacter test strains, the length of infection time-course did not seem to 
have a notable impact on the invasion levels of strain 1440. Its internalised counts remained 
stable for the first 150 min of incubation. It then rose by 1% the next 30 min. In general, the 
highest increases in invasion efficiencies of the majority of strains (5 out of 8) were recorded 
at 180 mm. Three of which (1099, 1102, and 1182) were statistically significant (P < 0.05). 
Therefore, the infection time-course was designed to last for 180 min as a means of 
maximizing the invasion levels. 
Figure 7.2 Effect of infection time course on the attachment levels of Acinetobacter strains. 
The figure shows the percentages of the inocula that attached to Caco-2 cells over 180 min of infection. The highest 
increases in attachment efficiencies of the majority of strains (4 out of 9) were recorded at 120 min. Three of which 
were statistically significant. Strains 1099, 1102, 1111, 1183, and 1440 are A. baumannii; 418 and 1097 are A. 
calcoaceticus; 415 and 1182 are Acinetobacter gensp. 3. Inoculum size was 107cfu/ml (MOI 100). Error bars 
represent the standard deviation of two independently repeated experiments. 
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Figure 7.3 Effect of infection time course on the invasion levels of Acinetobacter strains. 
The figure shows the percentages of the inocula that invaded the Caco-2 cells over 180 min of infection. Eight of the 
nine strains proved to be invasive. The increase in the invasion efficiency was observed in seven strains 120 min 
post-infection. In general, the highest increases in invasion efficiencies of the majority of strains (5 out of 8) were 
recorded at 180 min. Strains 1099, 1102, 1111, 1183, and 1440 are A baumannii; 418 and 1097 are A calcoaceticus; 
415 and 1182 are Acinetobacter gensp. 3. Inoculum size was 107 cfu/ml (MOI 100). Error bars represent the standard 
deviation of two independently repeated experiments. 
7.3.4 Effect of different MOIs on the attachment levels of Acinetobacter 
Following the optimisation of the gentamicin concentration and the infection duration, the 
attachment trends of Acinetobacter were examined at different infection doses. The MOIs 
employed were 10, 100, and 1000. The lowest attachment efficiency was exhibited by strain 
418 at all 3 MOIs (Figure 7.4). Strain 1099, on the other hand, showed the highest 
attachment levels at M O I 10 (99%). At MOI 100, the maximum percentage (90%) of adhered 
cells was obtained by strain 1097. Four out of the nine Acinetobacter strains; Acinetobacter 
T 
gensp. 3 (415),A. calcoaceticus (418),A. baumanWHCTC 12156 (1102), andA baumannii 
(111 1); increased in adherence efficiency as the inoculum size increased. This also applied to 
both E. coli K12 1230 and Salmonella Enteriditis 358. These increases in numbers from M O I 
10 to 1000 were statistically significant (P < 0.05) with strain 415, 418, 1111 and 1230 but 
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not with strain 1102 and 358. In contrast to these progressive increases shown by the above-
mentioned strains, strain A. calcoaceticus N C T C 7844 (1097), A. baumannii (1099), 
Acinetobacter gensp. 3 (1182), and A baumannii ATCC 17978 (1440) were at their highest 
attachment values at the M O I of 10. These were significantly (P < 0.05) higher than the other 
MOIs with strain 1099, and 1182 (greater than M O I 100 only) but not with strains 1097 and 
1440 (P > 0.05). Strain 1183 (A. baumannii), on the other hand, showed the maximum 
attachment levels at M O I 100. However, it was not significantly different to that at MOIs 10 
and 1000. 
Figure 7.4 Effect of MOIs on the attachment levels of Acinetobacter strains. 
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The figure shows that the highest attachment levels were observed with 4, 2, and 3 of the Acinetobacter strains at 
MOI 10, 100, and 1000 respectively. These were calculated as the percentages of the inocula that were able to adhere 
to Caco-2 cells. Strain 1102 was not tested at MOI 1000 due to its gentamicin resistance at this level, as shown by 
the preliminary experiments. Strains 1099, 1102, 1111, 1183, and 1440 are A. baumannii; 418 and 1097 are A. 
calcoaceticus; 415 and 1182 are Acinetobacter gensp. 3. Salmonella Enteritidis (358) and Escherichia coli K12 
(1230) were used as positive controls for attachment. Error bars represent the standard deviation of at least two 
independent experiments. 
152 
Chapter 7. In Vitro Studies oi Acinetobacter Infection Models 
7.3.5 Effect of different MOIs on the invasion levels of Acinetobacter 
With regard to the levels of invasion when applying different bacterial concentrations, there 
was no general observation that applied to all strains or strains from certain species owing to 
the strain-specific variations (Figure 7.5). Five strains (415, 1102, 1111, 1183 apart from at 
MOI 1000, and 1440) were seen to increase as the M O I increased. The rate of increase from 
an M O I of 10 (18%) to MOI 1000 (25%) was most significant with strain 415 (P < 0.05). 
Strains 1099 and 1182 exhibited the highest numbers of internalized cells (58, and 47%) 
respectively) at an M O I of 10 and then stabilized at higher MOIs. A. calcoaceticus N C T C 
7844 (1097) exhibited higher numbers of internalized cells (P > 0.05) at an MOI of 10 and 
100 (54% each) compared to M O I 1000. 
The highest invasion efficiency (58%>) was achieved by strain 1099 at M O I 10 and was 18%) 
lower than that of the positive control (358). Conversely, strain 415 was the lowest in the 
invasion numbers (10%) at the same MOI. Overall, all invasive Acinetobacter strains (8/8) 
were above the invasion efficiency 30%> at M O I 1000. At MOI 100, all strains excluding 
(415) were also above the level of 30% at M O I 100. Two (415, 1183) out of the 8 strains 
were below the above mentioned percentage at M O I 10. The positive control (358) remained 
above 50%) regardless of the MOI, while strain 415 was the only strain whose invasion was 
below 20%. 
When the efficiency of the attachment and invasion were compared (Figures 7.4 & 7.5), 
internalised Acinetobacter cells appeared to be on average 44, 43, and 44% less than the 
adhered cells for 7 out of the invasive test strains at M O I 10, 100, and 1000 respectively. In 
comparison to all the invasive Acinetobacter strains tested, strain 1111 showed distinctively 
the smallest difference between the percentages of the internalized cells and those of cell-
adhered. The attachment efficiency for this strain was 1, 8, and 30%> higher than the invasion 
efficiency at M O I 10, 100, and 1000 respectively. 
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Figure 7.5 Effect of MOIs on the invasion levels of Acinetobacter strains. 
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The percentages illustrated indicate the efficiencies of the inocula in invading the Caco-2 cells. Acinetobacter 418 
was the only strain unable to invade the epithelial cells. Overall, the invasion levels of five of the nine Acinetobacter 
strains increased with the increase in the bacterial dose (except at MOI1000 with strain 1183). Strains 1099, 1102, 
1111, 1183, and 1440 are A baumannii; 418 and 1097 are A calcoaceticus; 415 and 1182 are Acinetobacter gensp. 
3. The invasive Salmonella Enteritidis (358) was used as a positive control while Escherichia coli K12 (strain 1230) 
was the negative control. Error bars represent the standard deviation of at least two independent experiments. 
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7.3.6 Intracellular survival 
To study the intracellular survival of Acinetobacter strains, the gentamicin protection assay 
was used and the bacterial counts were determined 5h (T0) and 24h post-infection. Of the 8 
invasive strains used in this study, strain 1097 (A. calcoaceticus N C T C 7844), 1099 and 1183 
(both A. baumannii) were able to persist inside the epithelial cells (Caco-2) for 24h (Figure 
7.6). The highest survival was shown by strain 1099 (55%), which was 19% lower than the 
positive control (358), followed by strain 1097 (37%), and 1183 at 11%. When compared to 
the values at T0, it was found that the survival efficiency of the positive control (358) was 
100.4%. In other words, all the internalised cells managed to maintain their viability for up to 
24h of infection duration. This was not observed with the Acinetobacter strains. Strain 1097 
dropped significantly by 13% (P < 0.05), whereas the viable counts of strain 1099 and 1183 
decreased by 1% and 10% respectively (P > 0.05). 
Figure 7.6 Levels of intracellular survival of Acinetobacter strains inside Caco-2 epithelial cells. 
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The results show the ability of three of the invasive strains to survive for up to 24h of infection duration in Caco-2 
cells. Internalised bacteria were determined after 5h of inoculation, while the values of the persistent bacteria were 
taken after 24h and were expressed as the percentages of the inocula that survived for 24h inside the epithelial cells. 
Strains 1099, 1102, 1111, 1183, and 1440 are A. baumannii; 418 and 1097 are A calcoaceticus; 415 and 1182 are 
Acinetobacter gensp. 3. The invasive Salmonella Enteritidis (358) was used as a positive control while Escherichia 
coli K12 (1230) was the negative control. Inoculum size was 106 cfu/ml. Error bars represent the standard deviation 
of at least two independent experiments. 
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7.3.7 Cytotoxicity of Acinetobacter 
The effect of Acinetobacter strains on the viability of the epithelial Caco-2 cells was 
indicated by the percentage of the M T T reduction. This was shown to be greater than 80% in 
relation to the uninfected cells (Figure 7.7). Cells infected with A baumannii 1440 (ATCC 
17978) showed the lowest reduction percentage (78%) which was 8% higher than that 
infected with Salmonella Enteriditis (358). The highest was calculated at 101% and colonized 
with Acinetobacter gensp. 3 (1182). Of note is the non-significant difference between the 
invasive 358 and non-invasive 1230 strains. The toxicity of Escherichia coli K12 (1230) 
appears to be attributed to the attachment of this organism to the epithelial cells and not a 
result of the invasion process. 
Figure 7.7 Levels of Acinetobacter cytotoxicity. 
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The average MTT reduction percentages were calculated in relation to the uninfected epithelial Caco-2 cells (MTT 
reduction = 100.0%). MTT was used to measure cytotoxicity levels of Acinetobacter where only the viable 
eukaryotic cells can reduce this substance to purple formazan crystals. Cells infected with strain 1440 showed the 
lowest reduction percentage (77.5%). The highest was calculated at 101.19% and colonized with strain 1182. Strains 
1099, 1102, 1111, 1183, and 1440 are A. baumannii; 418 and 1097 are A. calcoaceticus; 415 and 1182 are 
Acinetobacter gensp. 3.; 358 and 1230 are Escherichia coli K12 and Salmonella Enteritidis respectively. Inoculum 
size was 106 cfu/ml. Error bars represent the standard deviation of two independent experiments. 
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7.3.8 Persistence within U937 human macrophage cells 
Macrophage uptake oi Acinetobacter and subsequent persistence was observed with 8 of the 
9 Acinetobacter strains (Figure 7.8). Survival of A baumannii (1099 and 1111), and A. 
calcoaceticus N C T C 7844 (1097) was above the 50%> exhibited by the positive control 
(Citrobacter koseri 48). The highest percentage was observed with strain 1111 at 90% (P < 
0.05). This was 41%) greater than the positive control. In comparison, strain 1440 (A. 
baumannii ATCC 17978) showed the lowest number of surviving cells (13%>). The 
T 
intracellular counts of A. calcoaceticus N C T C 7844 (1097), A. baumannii N C T C 12156 
(1102), Acinetobacter gensp. 3 (1182), and A. baumannii (1183 and 1111) increased within 
24h. Compared to those determined at 5h, the numbers of 1097, 1111, and 1182 rose by 36% 
(P < 0.05), 19% (P = 0.05), and 13% (P > 0.05) respectively. Strain 1102 and 1183, in 
particular, were not detected after 5h of infection, but their survival at 31% and 47% was 
evident after 24h respectively. While the five strains mentioned above proliferated within 24h 
of incubation, strains 1099 (A. baumannii), 1440 (A. baumannii ATCC 17978), and 415 
(Acinetobacter gensp. 3) exhibited a decrease in survival by 12% (P > 0.05), 23% (P < 0.05), 
and 30% (P < 0.05) respectively. 
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Figure 7.8 Levels of Acinetobacter persistence within macrophages. 
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Levels of uptake of Acinetobacter strains by macrophages were calculated at 5h, while that of the persistence was 
determined at 24h and was expressed as the percentage the inoculum that was able to survive within the macrophage. 
Eight of the nine Acinetobacter strains were detected after 24h of inoculation. Five of the Acinetobacter strains 
survived in higher counts than the positive control. Citrobacter koseri 48 was used as the positive control, whereas 
Escherichia coli K12 (1230) was the negative control. Inoculum size was 106 cfu/ml. Strains 1099, 1102, 1111, 
1183, and 1440 are A. baumannii; 418 and 1097 are A. calcoaceticus; 415 and 1182 are Acinetobacter gensp. 3. 
Error bars represent the standard deviation of two independent experiments. 
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7.4 DISCUSSION 
The human colonic adenocarcinoma cell-line (Caco-2) used in this study mimics the 
intestinal crypts, caecum, and the lower small intestinal sites (Lee et al, 1986; Newell and 
Pearson, 1984). When they are differentiated, Caco-2 cells express intestinal-like microvilli 
and form monolayers with tight junctions resembling the gut epithelia (Pinto et al, 1983). 
For this reason, it is considered a suitable in vitro model for studying the bacterial effects and 
interactions with the intestinal epithelial cells (Bolton et al., 2000) while avoiding the 
extensive use of animal models. For qualitative and quantitative infection studies, the 
gentamicin protection assay has been commonly applied based on the principle that the 
negligible amounts of the antibiotic pass into eukaryotic cells and therefore intracellular 
bacteria are protected. In this study, the detection of viable bacterial cells, despite the 2h 
exposure to lOOug/ml gentamicin, shows that they were partially protected from the 
gentamicin effect. This was possibly due to biofilm formation or clumping (Hertle and 
Schwarz, 2004) which hindered the complete access of the antibiotic to those aggregates and 
hence achieving complete kill of the bacterial population. Lee et al. (2008b) observed clusters 
of A. baumannii cells forming microcolonies at localized areas of the human bronchial cells 
(NCI-H292) as well as dispersed cells on surface of the monolayer. 
The findings of this study demonstrated the ability of all Acinetobacter strains to attach to the 
intestinal epithelial cells. The levels of adherence were, however, strain-specific. The food 
isolates Acinetobacter gensp. 3 (415) and A. calcoaceticus (418), as well as A. baumannii 
(1111) isolated from a clinical specimen, were generally the lowest in their adhesion 
capacity. Following the colonisation of the host cells, the majority (8/9) oi Acinetobacter 
strains was able to enter the epithelial cells; including 415 and the isolates form follow-up 
formulas (1182 and 1183). Strain 418 was the only Acinetobacter strain to adhere but not 
show any invasion capacity. The invasion values varied according to strain; with the highest 
(A. baumannii 1099) being 0.6% of the initial inoculum. This was greater than those recorded 
with other neonatal invasive pathogens such as Cronobacter sakazakii implicated in cases of 
meningitis, sepsis, bacteraemia, and necrotizing enterocolitis (Townsend et al., 2008). In 
contrast to the other Acinetobacter strains, A. calcoaceticus (1097), A. baumannii (1099), and 
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Acinetobacter gensp. 3 (1182) were the most invasive since the smallest MOI (MOI 10) was 
sufficient for maximum invasion. Overall, the adherence did not correlate to the invasiveness 
of strains since comparable invasion levels was obtained with both the strongly and the less 
adherent strains. 
Strain specificity was not the sole factor accounting for the differences in the attachment and 
invasion efficiencies between the Acinetobacter strains, as the M O I was also a contributory 
factor. Increasing the infection dose was found to lead to the detachment of the HEp-2 cell 
monolayer consequently to the acidification of the medium caused by the metabolism of 
Salmonella Typhimurium (Douce et al, 1991). Hertle and Schwarz (2004) also described that 
at an M O I greater than 10 for Serratia marcescens caused the epithelial RT112 and HEp-2 
cells to lyse within 15 min of exposure as a result of hemolysin production. An association 
between the higher concentration of Acinetobacter and possible epithelial cell damage can be 
represented by the various degrees of reduction in the invasion levels of A. calcoaceticus 
(1097), A baumannii (1099 and 1183), and Acinetobacter gensp. 3 (1182) at M O I 100, 1000, 
or both. 
The numbers of bacteria adhering to and invading epithelial cells can also be influenced by 
the exposure duration (Friis et al, 2005). For example, A. baumannii strains infecting NCI-
H292 cells required an incubation period ranging from 60 to 90 min to reach their maximum 
adherence, while at 120 min the decrease in adherence values was evident (Lee et al., 2006). 
In the present study, the attachment levels of the majority of strains did not significantly 
change from 120 and 180 min of incubation. The exceptions were A calcoaceticus (418) and 
Acinetobacter gensp. 3 (1182) whose efficiencies to adhere to Caco-2 cells decreased after 
120 and 150 min of exposure respectively. With regard to invasion, Choi et al. (2008c) 
described a consistent increase in the internalisation of A. baumannii A T C C 19606 into 
NCI-H292 cells for up to 7h. In comparison, the maximum invasion obtained here was 
reached at 180 min for five of the eight invasive Acinetobacter strains tested. However, no 
significant (p > 0.05) reduction was shown by any of the remaining strains. 
The invasion ability of Acinetobacter may be indicative of their pathogenic potential to the 
neonatal host. According to Townsend et al. (2008) Cronobacter sakazakii strains which 
caused fatal meningitis and necrotizing enterocolitis in neonates, also showed the highest 
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percentages of invasion in intestinal cells (Caco-2). However, the levels of invasion are not 
always an indicator for the virulence capacity. Campylobacter jejuni can be used as another 
example in this respect. Although the organism is the most common cause of bacterial 
foodborne diarrhoeal disease worldwide, internalization of only 1 to 3 cells per intestinal 
INT-407 cell has been detected even with the most invasive strains (Biswas et al, 2000; 
Biswas et al, 2004). 
Comparisons with Acinetobacter adhesion and invasion data from previous studies cannot 
always be accurately made. This is not only due to experimental differences, strains, and 
bacterial inoculation size, but also because of the variability of the presentation and 
interpretation of the data. Bacterial invasion may be expressed as the number of the 
internalised bacteria per cell or per well. Others represent their findings as the percentage of 
the epithelial cells infected. In this study, however, data were shown as percentages of the 
inocula found intracellularly or attached. 
Invasion of intestinal epithelial cells is a crucial characteristic of many pathogens. It allows 
them to reach a protected environment where they can subsequently proliferate and /or spread 
from cell to cell and be less subject to therapeutic interventions or the host immune defenses 
(Pereira et al, 2008). Three of the eight invasive Acinetobacter strains were found to survive 
for 24h inside the Caco-2 cells. The internalised cells of A. baumannii (1183) and A. 
calcoaceticus (1097) decreased by 10% and 13% respectively. On the other hand, A. 
baumannii (1099) maintained its persistence for the time-course. Therefore, it seems 
reasonable to speculate that the intracellular survival of these strains after 24h of infection 
may provide a reservoir for prolonged colonization of the infected neonate even i f an 
appropriate antibiotic treatment is used. A persistent diarrhoeal disease caused by 
enteroaggregative Escherichia coli (EAEC) has been associated with the ability of this 
organism to survive for long periods (72h) within the human colorectal epithelial cells (T84), 
and in some cases the intracellular multiplication (Pereira et al, 2008). Helicobacter pylori 
and uropathogenic Escherichia coli (UPEC) are examples of extracellular pathogens which 
transiently colonise the intracellular environment of mucosal epithelia as a means for 
prolonged persistence (Mulvey et al, 2001; Necchi et al, 2007). 
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The absence of internalised cells, observed with some Acinetobacter strains at 24h, could be 
the result of their inability to survive prolonged periods of time inside the epithelial cells due 
to fusion with endosomes or lysosomes (Kahl et al, 2000). On invasion, bacteria become 
enclosed within a vacuole in which they remain, or are able to escape and persist in the 
cytoplasm (e.g. Listeria monocytogenes (Tang et al, 1994)) or extracellularly (e.g. Neisseria 
meningitidis (Join-Lambert et al, 2010)). Intracellular A. baumannii A T C C 19606T has been 
reported to persist in a membrane-bound vacuole compartment for up to 5h (Choi et al, 
2008c). The risk of being inside the membrane-bound vacuole it that it may fuse with 
endosomes which then matures to an acidic lysosome (~ pH 5.0) containing hydrolytic 
enzymes which can lead to degradation of bacteria (Wilson et al, 2002). However, according 
to Choi et al (2008c), the majority of pathogenic bacteria are able to evade the fusion with 
endosomes or lysosomes as a means of survival. Whether this is the case or not with the 
Acinetobacter tested here is unknown. Further elucidation is required in this respect. 
The effect of the Acinetobacter invasion on the intestinal epithelial cells has been assessed in 
this study, by measuring the viability of eukaryotic cells through mitochondrial activity, using 
the M T T assay. The maximum loss of viability of the infected Caco-2 cells was 20% relative 
to controls. Although the nature of the damage has not been illustrated by imagery, this 
percentage indicated some degree of cell death. Loss of viability of the epithelial cells may be 
caused by the consumption of the available nutrients in the medium, the accumulation of 
bacterial waste products, or the medium becoming acidic (Wilson et al., 2002). Cell death can 
also occur in a controlled mechanism termed 'programmed cell death' or 'apoptosis', which 
is distinguishable from necrotic cell death by the characteristic changes of the cell (presence 
of apoptotic bodies, chromatin fragmentation and condensation, membrane blebbing). 
Induced apoptosis as a consequence of bacterial invasion including Acinetobacter has been 
previously described. Lee et al. (2001) have, for example, shown that HeLa epithelial cells 
undergo apoptosis 8h following infection with A. baumannii. Cell death was also observed, 
by Choi et al. (2005), after 12h as the result of A. baumannii A T C C 19606T targeting the 
mitochondria of the human laryngeal epithelial cells (HEp-2). In addition, the interaction of 
A. baumannii A T C C 19606T with human alveolar epithelial cells (A549) has been shown to 
cause the apoptotic death of these cells (Gaddy et al, 2009a). The death of intestinal 
epithelial cells may have important implications for the development of infections. The 
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release of the bacteria following the disruption of the mucosal lining may allow them to enter 
the deep tissues (Choi et al, 2005). Therefore, it can be expected that the potential pathology 
of Acinetobacter infections might be extended in this respect. 
The mechanism responsible for the adherence and the interaction of Acinetobacter spp. with 
the intestinal epithelial cells facilitating the entry to the host cell was beyond the scope of this 
study. However, Lee et al. (2006) has demonstrated that A. baumannii bind to the smooth 
areas of the epithelial NCI-H292 cell surface. The bacterial surface displayed a thin fimbrial-
like structure which extended and firmly anchored to the surface of the epithelial cells. Gohl 
et al. (2006) has also reported the involvement of thin pili in the adherence of Acinetobacter 
strain BD413 to the biotic surface of erythrocytes. De Breij et al. (2010), on the other hand, 
found that the pilus-like structure and other long extensions, which were irregularly 
distributed over the cell surface of A. baumannii strains and occasionally connected the cells, 
did not always associate with the adherence capacity. 
Choi et al. (2008c) identified the zipper-like mechanism by which A. baumannii invade the 
epithelial NCI-H292 cells. Once loosely attached, the bacterium was wrapped with the 
extended membrane of the epithelial cells and then internalised. The cell membrane was 
finally closed at the invasion site. Based on these cellular changes, the invasion mechanism 
was characterised as a zipper-like process rather than a trigger mechanism. The former 
requires the direct contact between the bacterial ligands and the host cell receptors to cause a 
local cytoskeletal rearrangement instead of injecting bacterial effector proteins which trigger 
dramatic rearrangements, such as membrane ruffles, of the cytoskeleton (Choi et al, 2008c). 
Further research work needs to be undertaken in order to confirm Choi et al.'s (2008) 
observation using the strains and intestinal cell line used here. 
Survival of the bacteria when facing host defenses within the circulation is a prerequisite for 
diseases such meningitis or septicemia. One important defense of the innate immune system 
is microbial uptake by macrophages, which exhibit antibacterial strategies such as nutrient 
deprivation, acidic compartmentalization, and oxidative burst (Townsend et al., 2007). The 
ability of pathogens to evade phagocytic killing either by the inhibition of the uptake or 
survival within the macrophage represents a substantial virulence mechanism against one of 
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the major innate immune defenses (Wilson et al, 2002). The interaction oi Acinetobacter 
with the innate immunity, represented by phagocytosis as a classical model (Greenberg, 
1999), was studied. The human macrophage U936 was employed for this purpose. Despite 
strain to strain variations, the detection of internalised acinetobacters inside the macrophages, 
at T0 (5h), using the gentamicin protection assay shows that Acinetobacter did not block the 
phagocytosis process and that the organism was actually phagocytosed. 
A. calcoaceticus 418 (food isolate) was the only strain unable to escape the phagocytic killing 
as no viable cells were detected at any sampling point. The same strain also did not have the 
T 
capacity to invade the epithelial Caco-2 cells. A. baumannii N C T C 12156 (1102) and 1183 
were not detected at the first time point (T0) as opposed to after 24h possibly because the 
internalised cells were below the detection limit. A. calcoaceticus N C T C 7844, Acinetobacter 
gensp. 3 (1182), and A. baumannii (1102, 1111, 1183) did not only persist within 
macrophages but also replicated indicating their potential to cause systematic infections in 
neonates (Fields et al, 1986; Ohl and Miller, 2001). Maintaining the organism's viability 
inside the macrophage renders it safe from the activity of humoral components such as 
antibiotic peptides, antibodies, and complement. It also protects the bacterium from being 
washed away, and saves it the need to adhere to host cells (Wilson et al, 2002). However, the 
intracellular bacterium would still be susceptible to macrophage activation (Wilson et al, 
2002). The prolonged persistence of Acinetobacter within macrophages suggests that the 
organism has developed a mechanism to avoid being killed when living intracellularly. 
Overall, intra-macrophage survival data showed wide differences between strains of the same 
species. This may be reflective of the levels of pathogenicity in neonates. According to 
Schwan et al. (2000), Salmonella Enteritidis and S. Typhimurium, which generally tend to 
cause localized infections in humans, such as mild gastroenteritis, do not survive well in 
human macrophages when tested in vitro. The multiplication in the number of internalized 
cells within the macrophage also suggests that the strains did not have a cytotoxic effect on 
the phagocytic cells. In contrast, the reduction observed with A. baumannii A T C C 17978 
(1440) and 1099 could be attributed to either an activation of phagocytic killing or a 
programmed death (Wilson et al, 2002). Explaining this and understanding the mechanism 
underlying the persistence within macrophages are areas for future research. 
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Establishing an infection in the small intestinal tract requires invasive and immune evasion 
capabilities. The different mechanisms potentially contributing to intestinal infections in 
neonates was investigated in this study and provided a novel insight into the pathogenicity of 
Acinetobacter. A human colonic adenocarcinoma cell line (Caco-2) was used to elucidate the 
interaction of Acinetobacter spp. with the complex epithelia similar to that of the gut (Bolton 
et al., 2000). The in vitro infection assays were optimized and the findings obtained provide 
clear evidence that Acinetobacter not only have the ability to adhere to and invade the 
intestinal epithelial cells but also demonstrate that these capacities are widespread across the 
Acinetobacter genus and not restricted to strains from clinical sources. Furthermore, the 
pathogenic advantage some strains have over others was shown by their persistence inside the 
epithelial cells. Human macrophages U937 were also used to determine the interaction with 
phagocytic cells. The results represent an original contribution to our knowledge about the 
fate of the Acinetobacter as a consequence of encountering a major player in the innate 
immune defense system. To our knowledge, this study is also the first in the field to 
characterize the pathogenic potential of strains isolated from desiccated milk formulas (1182 
and 1183). The implications of this research support and deepen our concern regarding the 
risk of the neonatal exposure to Acinetobacter through the ingestion of contaminated feed. 
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8.1 INTRODUCTION 
In the previous Chapter, Acinetobacter exhibited a number of virulence traits including 
adherence to the intestinal (colonic) epithelial cells, invasion, and associated cytotoxicity. 
The latter can be defined as the damage inflicted on the host cells during the infection 
process. Such an effect may be direct by the impairment of the functionality of the cell or by 
causing it to die (Wilson et al., 2002). On the other hand, indirect damage can be caused by 
the over-induced or prolonged host responses such as the overexpression of pro-inflammatory 
cytokines in response to, for example, survival and growth of the bacterium (Wilson et al., 
2002). The first category is represented by exotoxins which are exported by some disease 
causing organisms or released on cell lysis (Wilson et al, 2002). The exposure to these toxins 
produces an array of pathogenic effects that is responsible for the symptoms of the diseases 
(Hacker and Heesemann, 2002) which vary in severity depending on the activity of the toxin 
involved. Membrane disturbing toxins for instance may enzymically cause membrane 
damage either by acting as pore-forming toxins or hydrolases (Wilson et al, 2002). The 
second category includes enzymes, such as lecithinases and phospholipases (A, C, and D), 
which degrade the phospholipids of the cell membrane and thus destroys its integrity (Hacker 
and Heesemann, 2002). 
Bacterial phospholipases comprise a range of proteins classified based on the site of action on 
the phospholipid molecule (Wilton and Waite, 2002). The phospholipases A (PLAs) 
hydrolyses the acyl group and are categorised according to the position of the acyl ester 
group hydrolysed (1 or 2-acyl ester; PLA1 and PLA2). Phospholipase B hydrolyses both acyl 
groups. Phospholipase C (PLC), on the other hand, cleaves the glycerophosphate bond of the 
phospholipids while the phospholipase D (PLD) catalyzes the hydrolysis of the 
phosphatidylcholine to phosphatidic acid and choline (Exton, 1997; Jones et al, 1999; Waite, 
1999; Wilton and Waite, 2002). 
The activities of the phospholipases indicate their importance as virulence factors of many 
bacterial pathogens (Titball, 1998). Phospholipase A2 has been implicated in the 
inflammation and mucosal damage associated with peptic ulcer formation caused by 
Helicobacter pylori (Langton and Cesareo, 1992). The colonisation of the gastric tissues of 
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mice infected with this organism has also been associated with the presence of the P L A gene 
(Dorrell et al, 1999). Phospholipase C protein has also been involved in the virulence of 
many pathogenic bacteria most notably Clostridium perfringens (a toxin), Listeria 
monocytogenes, and Pseudomonas aeruginosa (Songer, 1997; Titball, 1998, & 1993). The 
necrotic and cytolytic activity of the enzyme (a toxin) produced by C. perfringens is a 
characteristic trait of this pathogen (Boquet et al, 1998). The expression of the acidic 
phospholipase C type H has also been linked to the strong hemolytic activity produced by P. 
aeruginosa (Vasil et al, 2009). Furthermore, P L C mediates the escape of L . monocytogenes 
from the phagosomes in the macrophages (Camilli et al, 1993; Poussin et al, 2009) and in 
the epithelial cells (Grundling et al, 2003; Marquis et al, 1995) hence contributing to the 
organism's intracellular existence. Another phospholipase protein with a major role in the 
pathogenesis of bacteria is the phospholipase D. It contributes to the hematogenous 
dissemination of Corynebacterium pseudotuberculosis within infected animals (Batey, 1986) 
as well as the macrophage death by this pathogen (McKean et al, 2007). The involvement of 
this exotoxin in the invasion of epithelial cells has also been observed with Neisseria 
gonorrhoeae during the infection of cervical epithelial cells where it was required for the 
adherence and potentiation of bacterial internalisation by the host cell via the membrane 
ruffling mechanism (Edwards et al, 2003). 
Although genes encoding for phospholipases A , C, and D have been found in sequenced 
genomes of A. baumannii (AB0057, AB900, AB307-0294, A Y E , ACICU, SDF, and A T C C 
17978) (Adams et al, 2008; Antunes et al, 2011c; Camarena et al, 2010; Jacobs et al, 
2010a; Vallenet et al, 2008), the role of phospholipases in the virulence of Acinetobacter has 
received little attention. One of the earliest studies concerning these enzymes in 
acinetobacters was conducted by Lehmann (1973) who described the ability of phospholipase 
C to release 69% of the red cell membrane-bound acid soluble phosphorus by hydrolysing the 
sphingomyelin, phosphatidylethanolamine and lecithin of the cell membrane (Lehmann, 
1973). The enzyme also contributes to the cytotoxicity of A. baumannii. A deletion mutant 
for this protein (PLC1) has been shown to decrease the cytotoxic effect on the FaDu 
epithelial cells (Camarena et al, 2010). The P L D protein has also been recognised as a 
virulence factor of the wild type A. baumannii as it is believed to be involved in both 
epithelial cell invasion and human serum proliferation (Jacobs et al, 2010a). 
168 
Chapter 8. Detection of Phospholipase Genes: Preliminary Genetic Analysis 
Given the role of bacterial phospholipases in the pathogenicity of A. baumannii and other 
pathogens in terms of facilitating their invasion, persistence, and collectively circumventing 
the host defenses, it was of interest to explore the presence of phospholipase genes in 
Acinetobacter strains, using a PCR detection analysis. This examination could potentially be 
correlated to the invasion ability exhibited previously by those strains which may serve as a 
prospect for future in-depth virulence studies. 
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8.2 MATERIALS & METHODS 
8.2.1 Bacterial strains and culture preparation 
A. baumannii (1099, N C T C 19606T/1102, 1111, 1183, 1440/ATCC 17978), A calcoaceticus 
(418, and 1097), and Acinetobacter gensp. 3 (415, and 1182) that were involved in the 
virulence in vitro studies (Chapter 7) were also included for the genetic screening. A. 
baumannii strain A T C C 17978/ NTU1440 (accession numbers GenBank: CP000152 and 
Refseq: NC_009085) was used as a positive control for the validity of the screening 
procedure. This strain was isolated from a fatal case of meningitis in a 4 month old infant 
(Smith et al, 2007). Bacterial cultures were grown in TSB at 37°C for 18h before the D N A 
extraction. 
8.2.2 Isolation of genomic DNA 
Pure D N A extraction was achieved using the GenElute™ Bacterial Genomic D N A Kit 
(Sigma-Aldrich, NA2120). The manufacturer's protocol was followed. Overnight 
Acinetobacter cultures (108-109 cfu/ml) were centrifuged for 2 min at 12000g. The 
supernatant was discarded and the pellet was resuspended in 180ul Lysis Solution T (Sigma-
Aldnch, B6678). For RNA-free genomic D N A , 20ul RNase Solution (Sigma-Aldnch, 
R6148) was added, mixed, and then incubated at room temperature for 2 min. Twenty 
microliters of 20mg/ml Proteinase K Solution (Sigma-Aldrich, P2308) was added and mixed 
with the sample before 30min incubation at 55°C. To lyse bacterial cells, the added Lysis 
Solution C (Sigma-Aldrich, B8803) was mixed thoroughly for 15 sec using vortex mixing. 
The mixture was then incubated at 55°C for 10 min. The following step required adding 
500ul of the Column Preparation Solution (Sigma-Aldrich, C2112) to a pre-assembled 
GenElute Miniprep Binding Column (Sigma-Aldrich, C9471), seated in a 2ml Collection 
Tube (Sigma-Aldrich, T7813), followed by 1 min centrifugation at 12000g. The eluate was 
discarded and 200ul of 100% ethanol was added to the lysate which was then mixed 
thoroughly by vortexing for 10 sec. The contents of the tube were transferred into the Binding 
Column, using a wide bore pipette tip to reduce shearing the D N A , and then centrifuged at 
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6500g for 1 min. The collection tube containing the eluate was discarded and the column was 
placed in a new 2ml Collection Tube. For washing, 500ul Wash Solution 1 (Sigma-Aldrich, 
W0263) was added to the column and centrifuged at 6500g for 1 min. The collection tube 
containing the eluate was again discarded and the column was placed in a new 2ml Collection 
Tube. 500ul Wash Solution 1 was added to the column, for the second washing, and 
centrifuged for 3 min at 12000g to dry the column. If residual ethanol was seen, then the 
column would be centrifuged for an additional 1 min at 12000g. The Collection Tube 
containing the eluate was discarded and the column was placed in a new 2ml Collection 
Tube. Next, to elute the D N A , 200ul of the Elution Solution (Sigma-Aldnch, B6803) was 
pipetted onto the centre of the column. This was then incubated at room temperature for 5 
min before centrifuged for 1 min at 6500g. The same elution step was repeated for a second 
time in the same Collection Tube in order to improve the yield. For short-time storage, the 
eluate containing the genomic D N A was stored at 4°C. 
8.2.3 Targeted genes and primer design 
A set of 3 phospholipase genes was selected based on their presence in the sequenced A. 
baumannii strain A T C C 17978. The nucleotide sequences of the desired genes were obtained 
from the National Center for Biotechnology Information using the Refseq accession number 
(NC_009085) and the name of the gene. The primers were then designed and provided by 
Sigma-Aldrich. The details for the selected genes are presented in Table 8.1. 
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Table 8.1 Details of the phospholipase genes selected for PCR analysis in Acinetobacter. 
Accession Annealing Gene I
 T Gene ID Primer Sequence (5'-3') Number 4 Temp (°C) 
Phospholipase A l 4920063 pk"F GCCGACACCTTAGCCCCTGT 
precursor* " pla-R TCCGCGCAGCTTGCCACTAA 
D, . . . _ „ A1_ „ „ . „ . „ . plc-F AACCCAGCAACGGCAGACCG „ . 
Phospholipase C * A1S 2055 6234072 68.0 
v
 ~ plc-R GACCCAACCGCCACGACTCC 
i w i, ur n * AIQ ™«o AoimM Pld"F GGTTGCGCTTATTGGTGGGCG „ . 
Putative phospholipase D * A1S 2989 4920117 59.3 
_ _ - pld-R ACGCCGAACGTGGGTCAAAGT 
* (Iacono et al., 2008; Smith et al., 2007). 
8.2.4 Polymerase chain reaction (PCR) procedure 
The PCR mix consisted of: 5ul of 5* GoTaq Green Flexi buffer (Promega, M891 A), 5ul of 
25mM MgCl 2 (Promega, M351B), lu l of deoxynucleoside triphosphate (dNTP) mix (lOmM 
each) (Promega, U1330), 2.5ul of each primer, 0.25ul of l x GoTaq D N A polymerase 
(Promega, M830B), 1 (al D N A samples, and 8.75ul of nuclease free water. To generate the 
amplicons of interest, the following settings for the polymerase chain reactions (PCR) were 
applied: Initial denaturation 95°C for 5 min followed by 95°C for 1 min, annealing ranged 
(according to the probes) from 59.3 to 68.0°C for 1 min, and extension at 72°C for 1 min, 
final extension at 72°C for 5 min. The numbers of cycles of these PCRs were 35. To separate 
the D N A fragments into different band sizes, agarose gel electrophoresis was performed. One 
percent of agarose (Sigma-Aldrich, A9539) was prepared in I X T A E buffer from a 50X 
ready-made T A E buffer (Fisher Scientific, FERB49), and then heated up until completely 
dissolved. 10% S Y B R safe stain (Sigma-Aldrich, S9430) was added to the agarose and 
mixed. The agarose gel was poured and left to set before loading 4ul of the D N A samples as 
well as the lkb ladder (Promega, M7541). The gel was allowed to run at 100V for 40 min. 
Finally, the amplified products were visualised under the U V light and photo images were 
captured. 
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8.3 RESULTS 
The results of the PCR detection of the phospholipase genes in the 9 Acinetobacter strains are 
summarised in Table 8.2. Figure 8.1 showed that the gene encoding for the P L A protein 
(A1S_1919) was observed in 6 of the Acinetobacter strains. Exceptions were Acinetobacter 
gensp. 3 (415), A. calcoaceticus (418), and 1182 (Acinetobacter gensp. 3). The pic gene was 
detected in all the strains apart from 415 and 418 (Figure 8.2). Strains 415, 418, and 1182 
also appeared to be negative for thepld gene (A1S_2989) (Figure 8.3). 
Table 8.2 Detection of phospholipase genes in Acinetobacter strains. 
Gene 
Phospholipase A l precursor 
Phospholipase C 
Putative phospholipase D 
1099 
+ 
+ 
+ 
1102 
+ 
+ 
+ 
Acinetobacter strains 
1111 1183 1440 415 1182 418 1097 
+ + + - - - + 
+ + + - + - + 
+ + + - - - + 
Strains 1099, 1102, 1111, 1183, and 1440 are A baumannii; 415 and 1182 are Acinetobacter gensp. 3; 418 and 1097 
are A. calcoaceticus. 
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Figure 8.1 Detection of phospholipase A gene. 
Lane 1 in the agarose gel represents the positive control 1440 (A baumannii ATCC 17978). Lane 2: strain 1099. 
Lane 3: strain 1102. Lane 4: strain 1111. Lane 5: strain 1182. Lane 6: strain 1183. Lane 7: strain 1097. Lane 8: strain 
415. Lane 9: strain 418. Lane 10: the negative control (with no bacterial DNA). Strains 1099, 1102, 1111, 1183, and 
1440 are A baumannii; 415 and 1182 are Acinetobacter gensp. 3; 418 and 1097 are A calcoaceticus. 
Figure 8.2 Detection of phospholipase C gene. 
Lane 1 in the agarose gel represents the positive control 1440 {A. baumannii ATCC 17978). Lane 2: strain 1099. 
Lane 3: strain 1102. Lane 4: strain 1111. Lane 5: strain 1182. Lane 6: strain 1183. Lane 7: strain 1097. Lane 8: strain 
415. Lane 9: strain 418. Lane 10: the negative control (with no bacterial DNA). Strains 1099, 1102, 1111, 1183, and 
1440 are A baumannii; 415 and 1182 are Acinetobacter gensp. 3; 418 and 1097 are A calcoaceticus. 
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Figure 8.3 Detection of phospholipase D gene. 
Lane 1 in the agarose gel represents the positive control 1440 (A. baumannii ATCC 17978). Lane 2: strain 1099. 
Lane 3: strain 1102. Lane 4: strain 1111. Lane 5: strain 1183. Lane 6: strain 1182. Lane 7: strain 1097. Lane 8: strain 
415. Lane 9: strain 418. Lane 10: the negative control (with no bacterial DNA). Strains 1099, 1102, 1111, 1183, and 
1440 are A baumannii; 415 and 1182 are Acinetobacter gensp. 3; 418 and 1097 are A calcoaceticus. 
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8.4 DISCUSSION 
The PCR method was used in this study to screen for three phospholipase genes in three 
different species of Acinetobacter that were isolated from clinical and non-clinical sources 
(A. baumannii, A. calcoaceticus, and Acinetobacter gensp. 3). Those obtained from food 
samples; Acinetobacter gensp. 3 (415), and A calcoaceticus (418); did not appear to have the 
pic gene. Strain 418, in particular, was also unable to invade the epithelial Caco-2 cells as 
described in the previous chapter (7). Camarena et al. (2010) has shown that a phospholipase 
C (pic; A1S_0043) mutant decreased the cytotoxic effect of A. baumannii ATCC17978 on 
FaDu epithelial cells. The wild type, on the other hand, caused the host cell monolayer to 
become permeable before undergoing extensive detachment and eventually death after 18h of 
infection. This is consistent with previous reports describing several physiological and 
morphological changes, such as cell shrinkage, monolayer detachment, and loss of epithelial 
cell viability due to colonization by A. baumannii (Choi et al., 2005; Lee et al., 2001). 
However, according to results of the M T T assay in Chapter 7, the viability loss of Caco-2 
cells infected with both the strains positive and negative for this gene was similar. Vallenet et 
al. (2008) stated that the hemolytic activity of the pic genes in A. baumannii could not be 
conclusively confirmed. This is since, on one hand, the sequences of two 50% identical 
copies of pic genes found in the genome of A. baumannii A Y E and SDF are best matched 
with P L C - N encoded by the plcN gene which does not have any hemolytic activity as 
opposed to its counterpart P L C - H encoded by the plcS gene which is strongly hemolytic 
(Titball, 1993). These proteins, on the other hand, have a pi lower than seven which is a P L C -
H feature. Adams et al. (2008) also identified two P L C encoding genes (A1S_0043 and 
A1S_2055) that shared 72% similarity (Camarena et al., 2010) and were present in all the 
clinical A. baumannii strains (AB0057, AB900, AB307-0294, A Y E , ACICU, and A T C C 
17978) but absent from the non-pathogenic soil bacterium A. baylyi ADP1 (Adams et al, 
2008). These two genes have 75% homology with those from Burkholderia pseudomallei 
(Rossier and Cianciotto, 2005). One of the two pic genes (plc-2) carried by Burkholderia 
pseudomallei contributes significantly to the cytotoxicity towards HeLa cells (cell membrane 
damage) compared to the minor activity ofplc-\ (Korbsrisate et al, 2007). 
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Examination of the Acinetobacter strains did not indicate the presence of the genes encoding 
for the P L A (A1S_1919) and P L D proteins (A1S_2989) in strains 415, 418, and 1182. Jacobs 
et al. (2010a) revealed that the A1S_2989 gene contributes to the ability of A. baumannii to 
colonise the pericardial membrane of infected mice, and to invade the human bronchial 
epithelial BEAS-2B cells, as well as to proliferate in human serum during infection. Strain 
415 and 1182 herein did not appear to have the gene but had an apparent invasion capacity 
(Chapter 7). One to several copies of pla and pld have been found in the genomes of A. 
baumannii A Y E , SDF, ADP1 (Vallenet et al, 2008) and A T C C 17978 (Jacobs et al, 2010a). 
In the A. baumannii A Y E genome, one copy was speculated to be necessary for utilizing 
phosphorous sources while the other three, although possibly active, are likely to be 
employed only when under certain environmental conditions such as the infection process 
(Vallenet et al, 2008). The disruption of one pld gene (A1S_2989) resulted in the inability to 
invade (Jacobs et al, 2010a). These multiple copies could presumably be a way of avoiding 
the host's immune response, which accordingly gives more significance to the activity of this 
gene during invasion. 
In summary, this preliminary study exploring a sample of phospholipases genes showed that 
all the clinical isolates of A. baumannii (1099, 1102, 1111, and 1440) and the follow on 
formula isolate (1183) harbored the target genes. These were also found in the clinical isolate 
of A. calcoaceticus (1097), but on the other hand, may be lacking from strain 418 obtained 
from food. Similarly, all the phospholipase genes were not detected in Acinetobacter gensp. 3 
(415), which is also from a food origin, while the pic was present in strain 1182 (follow on 
formula). Confirmation of the genes' absence may be required. It is, therefore, of interest to 
investigate this further at the molecular level, and search for trends potentially separating the 
clinical and non-clinical isolates of various Acinetobacter species using larger numbers of 
strains and various virulence determinants. 
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Chapter 9. Conclusion 
The nutrient compositions of infant formulas aim to provide the necessary nutrient 
requirements of growing infants. The Codex Alimentarius Commission, established by the 
W H O and F A O developed a global safety, quality, and compositional standard for infant 
formula. However, despite these 'good manufacturing practices' regulations, bacterial 
contamination of powdered infant formulas remains an issue since sterilization cannot be 
achieved during production. Together the early stages of the development of the immune 
system and the intestinal flora as well as the external attenuating factors such as 
administration of antibiotics, mentioned above, all present neonates in ICUs as a high-risk 
group among hospitalized patients, due to their increased susceptibility to infections. A n 
important way of preventing exogenous infections is to prevent their exposure to pathogens. 
In order to control this risk, an analysis of whether the pathogen would be able to cause a 
potential infection through a specific route of exposure is deemed necessary (FAO-WHO, 
2006). 
Although the ingestion route has not been epidemiologically linked to acquiring 
Acinetobacter infections, clinical features of gastrointestinal and bloodstream Acinetobacter 
infections has been reported in the literature (Grotiuz et al, 2006; Mader et al, 2010; Mishra 
et al, 1998; Thorn et al, 2010). Some of these reports were unable to identify the 
contamination source despite comprehensive clinical and environmental surveillance (Mader 
et al., 2010). Therefore, it was sensible not to exclude the ingestion factor although it was 
unclear what the feeding methods was and whether these were indeed investigated. This 
might not always be possible i f the potentially contaminated batch is no longer available for 
analysis. The possibility of neonatal infections resulting from consuming enteral feeds 
contaminated with Acinetobacter have not been explored before and is believed to be worthy 
of consideration because of the particular vulnerability of the neonates in ICUs. The data 
presented in this research project began to fill in this knowledge gap and give a new insight 
into the organism's activities that can potentially result in recognisable pathology locally in 
the gastrointestinal environment and systematically. Moreover, it provides scientific research 
evidence that complement the existent reports describing the clinical manifestations of the 
relevant Acinetobacter infections. This research work also highlights the wider picture of the 
risk imposed on the neonate right from the persistence of Acinetobacter in desiccated infant 
formula, the consumption of the contaminated feed, and the multiplication of the bacterial 
179 
Chapter 9. Conclusion 
cells inside the enteral feeding tubes, followed by gastrointestinal survival and finally 
consequences of the interaction with the epithelial cells and the response to an immune 
mechanism. This understanding provides a critical platform for future work where the 
molecular and genetic mechanisms underlying different aspects of interaction between the 
bacterium and the host during the gastrointestinal infection process can be elucidated. 
The knowledge of risk factors presented by this work scientifically justifies and supports the 
inclusion of Acinetobacter in the list of pathogens posing a risk to neonates (Food and 
Agriculture Organization-World Health Organization F A O - W H O , 2006). It also stresses the 
importance of following strict hygienic practices by health-care personnel when preparing, 
handling, and storing of the powdered infant formula feeds as a means of controlling 
potential Acinetobacter infections in NICUs. Although the intrinsic susceptibility of the 
neonates may not be controlled, what can be done to prevent potential Acinetobacter 
infections is to reduce the risks of exposure to this organism. For safe consumption of 
powdered infant formula, the guidelines issued by the Codex Alimentarius Commission 
(2008) state the use of sterilized equipment for the preparation of the powdered infant 
formula feed and that that feed should be rehydrated at 70°C or above and only be prepared 
once needed. Feeds should never be stored in the fridge for longer than 24 hours must also be 
thrown away i f not consumed within two hours. To prevent heavy colonization and 
subsequent invasive diseases in high-risk infants, avoiding the long placement of enteral 
feeding tubes is also recommended. However, since it can be costly to replace these tubes 
very frequently, the risk control target has to be the quality of the feeds given enterally. 
In summary, the contributions of this research work to the existing knowledge of 
Acinetobacter are represented by the following: 
1. Developed, and evaluated the D D A medium and other Acinetobacter selective-
differential media. 
2. First to study the persistence of clinical and food isolates of Acinetobacter strains in 
desiccated infant formula and to demonstrate their prolonged survival over 2 years 
period. 
3. Determined the ability of the organism to form biofilms on nasogastric feeding tubes 
as a risk factor for repeated and increased contamination. 
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4. First to demonstrate the Acinetobacter survival in simulated gastrointestinal 
conditions that can influence the probability of infection. 
5. First to examine the adherance of Acinetobacter, to human colonic epithelial cells, and 
the consequent invasion using optimised assays. 
6. Established the effect of the infection duration and MOI on the attachment and 
invasion levels of Acinetobacter'. 
7. Showed the moderate levels of cytotoxicity of invasive Acinetobacter. 
8. First to prove the capacity of some Acinetobacter strains to survive inside the colonic 
epithelial cells as a consequence of the invasion process. 
9. First to demonstrate the persistence and replication within macrophages as a means of 
evading the adaptive immune response by the host. 
10. Detected the presence of genes encoding phospholipases in all the clinical isolates 
tested. 
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